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Abstract
Lysyl oxidase initiates cross-linking in collagens and elastin by the
conversion of specific lysine (and, in collagen, hydroxylysine) residues to
peptidyl a-aminoadipic-S-semialdehyde. Porcine skin lysyl oxidase (Mr = 32-
34K) and a protein (Mr = 24K) with which the enzyme co-purifies have been
isolated and characterised. The 24K protein was originally thought to be a
degradation product of lysyl oxidase but this study shows it to be a distinct
protein. Four variants of lysyl oxidase and five variants of the 24K protein
were identified by Mono Q anion exchange Fast Protein Liquid
Chromatography (FPLC). Each lysyl oxidase variant was subjected to amino
acid analysis, which did not reveal any differences between variants, and to
mass analysis, which showed small incremental changes between the
variants. All the 24K protein variants were also indistinguishable by amino
acid analysis, though the protein was clearly distinct from lysyl oxidase. As
with lysyl oxidase, however, mass analysis showed small incremental
changes between each 24K variant. Both lysyl oxidase and the 24K protein
were found to be N-terminally blocked. A variety of cleavage methods was
employed and the resulting peptides were subjected to mass and sequence
analysis. Lysyl oxidase was cleaved using cyanogen bromide, and the N-
terminal fragment was found and sub-digested with endoproteinase-Asp-N.
The peptides formed were sequenced and from these studies it was possible
to suggest the N-terminus of lysyl oxidase. The 24K protein was cleaved with
cyanogen bromide and digested with various enzymes which included
pyroglutamate aminopeptidase, clostripain, protease V8, and
endoproteinase-Asp-N. The 24K protein was found to be unrelated to lysyl
oxidase, but comparison with a protein sequence database showed it to be
the same as a recently described protein from bovine skin that is associated
with dermatan sulphate proteoglycans. The complete amino acid sequence of
the 24K protein was determined and found to be relatively rich in tyrosine.
Sequence analysis and chromatofocussing, using a Mono P
chromatofocussing column, showed the protein to be acidic. In view of these
properties the name TRAMP (Tyrosine Rich Acidic Matrix Protein) was
proposed to identify the 24K protein. Though TRAMP appears not to be
glycosylated, several experiments indicated the presence of sulphotyrosine
residues. When assayed using an elastin substrate, the activity of lysyl
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Lysyl oxidase initiates cross-linking in collagens and elastin. A
description of different collagen types and elastin is given in order to
understand the role of lysyl oxidase. The function of TRAMP is not fully
understood, and it is for this reason that details of other extracellular matrix
proteins are provided to allow comparisons to be made between protein size,
structure and function. Lysyl oxidase is then reviewed in detail followed by a
description of TRAMP.
1.2 The extracellular matrix
Connective tissues include skin, tendon, blood vessels, cartilage and
bone. They are systems of insoluble fibres and soluble polymers which have
evolved to provide mechanical support in higher animals. All connective
tissues consist of a number of matrix molecules, almost all of which are
involved in interactions with other matrix components to form a composite
material. Skin, tendon and blood vessels contain a range of different collagen
types, elastin, proteoglycans and glycoproteins. Major constituents of
cartilage are collagen fibres and proteoglycans. In bone the matrix is
mineralised, and much of the hydroxyapatite mineral occurs within the
collagen fibrils, while other matrix components may regulate the timing of
mineral deposition and growth of crystals. Much of the assembly of the matrix
is extracellular and a variety of components, and cell-matrix interactions, are
involved in the assembly process. Different components of the extracellular
matrix are discussed below.
1.3 Collagens
1.3.1 Introduction
Collagens are a large group of insoluble fibrous proteins which have
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high tensile strength (reviewed by Mayne and Burgeson, 1987; van der Rest
and Garrone, 1991; Hulmes, 1992). They form the major fibrous elements in
skin, tendon, blood vessels, cartilage, bone and teeth, and are the most
abundant proteins in mammals where they form about 25% of total body dry
weight. Collagens are present in most organs and serve to hold cells together
in units. This wide ranging variety of function is reflected in the diversity of
collagen structure.
The name collagen is derived from the French 19th century word
collagene used to describe the constituent of connective tissue that produces
glue, or gelatin on boiling. At this time early histologists discovered fibres in
sections of connective tissue. In the 1920s it was discovered that collagen
could be solublised in acid and precipitated as collagen fibres. In 1956 the
existence of the monomeric unit of collagen (tropocollagen; reviewed by
Gross, 1956) was found but today it is known as the collagen molecule.
1.3.2 Collagen structure
A collagen is defined as a structural protein of the extracellular matrix
which contains one or more domains containing three polypeptide chains,
which may or may not be identical, which combine together to form a triple
helix. The primary structure of each polypeptide chain contains at least one
region of the repeating amino acid sequence (Gly-X-Y)n where X and Y can
be any amino acid. It is a characteristic feature of collagens that they have a
high imino acid (proline and hydroxyproline) content and that they contain
hydroxylysine, a post-translational modification rarely found in other proteins
(van der Rest and Garrone, 1991).
Different collagens are classified into types using Roman numerals to
indicate the chronological order of their discovery (Table 1.1). Collagen I was
the first collagen type to be isolated, primarily from skin and tendon. The
molecule has two identical a1 chains and one distinct a2 chain. Today the
nomenclature [a1 (I)]2a2(l) is used to describe collagen I. In 1969 collagen II
was isolated from chick cartilage and found to be a homotrimer with the
structure [a1(ll)]3 (Miller and Matukas, 1969). Shortly afterwards collagen III
was isolated from foetal skin and found to be a homotrimer with the structure
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Table 1.1. Vertebrate collagens
Type g-chaing
Fibrillar collaaens










































skin, tendon and bone
cartilage and vitreous humour
skin, lung and vascular system
collagen I containing tissues





cartilage and vitreous humour
hypertrophic zone of cartilage
tendon and skin
skin and intestine
collagen I containing tissues
not determined
not determined
[a1(lll)]3 (Miller et al., 1971). Collagen III is similar to collagens I and II but
contains disulphide bonds. In the early 1970s collagen IV was isolated from
basement membranes. Its amino acid composition and size were similar to
collagens I, II and III (Kefalides, 1973). However later work showed that
collagen IV formed a meshwork of filaments in different planes rather than
classical linear fibrils (Yurchenco and Schittny, 1990). The most common form
of collagen IV, has the structure [a1 (IV)]2a2(IV).
At present there are 16 recognised vertebrate collagen types (Hulmes,
1992; Pan et al., 1992). In addition there are proteins with collagen-like
features that are not called collagens. Such proteins contain (Gly-X-Y)n
sequences, e.g. the complement component Clq (Sellar eta!., 1991).
Vertebrate collagens can also be classified according to their size and
structure (Mayne and Burgeson, 1987; van der Rest and Garrone, 1991;
Hulmes, 1992). There are three main groups. The fibrillar (D-staggered)
collagens (I, II, III, V, and XI) form fibrils with a rod-like structure (diameter 20-
500 nm) and characteristic 64-67 nm (distance D) repeating banding pattern
as seen with the electron microscope. The non-fibrillar collagens (IV, VII, VIII,
IX, X, XII, XIII and XIV) can be classified according to their structure and
function. They can be subdivided into basement membrane collagens, short
chain collagens and £ibril-Associated £ollagens with interupted Triple
helices (FACIT collagens). Collagen VI forms fibrils but these are distinct from
classical collagen fibrils as they do not have a D-periodic banding pattern.
FACIT collagens (IX, XII and XIV) are found attached specifically to the
surface of fibrillar collagen fibrils. Collagen IX was the first to be discovered
and was found to be associated with collagen II (van der Rest and Mayne,
1988). Collagens XII and XIV have since been discovered and found to be
associated with collagen I (Shaw and Olsen, 1991). Collagen IX is unusual as
it carries a glycosaminoglycan (GAG) chain, although a form of collagen IX
has been described which lacks a GAG chain (Ayad et al., 1991).
Most collagen fibres are composed of two or more different types. In
cartilage, the fibrils contain collagens II, IX, and XI, while skin fibrils contain
collagens I and III.
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1.3.3 Collagen biosynthesis
All fibrillar collagens (I, II, III, V and XI) are initially synthesised in
precursor form, as procollagens, in fibroblasts, chondrocytes or smooth
muscle cells. Most information on collagen biosynthesis comes from studies
on procollagen I (Byers, 1990; Kuivaniemi et al., 1991) which probably acts as
a model for the rest of the collagen family.
Procollagen I consists of two a1 chains and one a2 chain, each
consisting of about 1500 amino acids (Mr ~ 150K). Globular domains are
located at both amino (N-) and carboxyl (C-) termini of the procollagen
molecule straddling the (mainly) triple-helical collagen domain. The N-
propeptide domain of each chain consists of about 150 amino acids (Mr ~
15K) and the C-propeptide domain (each chain) is about 250 amino acids (Mr
~ 30K). The N-propeptides contain intra-chain disuphide links, whereas the
C-propeptides are linked by inter-chain disulphide bonds (Fessler et al.,
1985). Disulphide bonds are not normally found in the triple-helical region of
the mature collagen molecule.
Procollagens are subject to a large number of post-translational
modifications. Certain of these enzymic modifications can only take place
before triple-helix formation. Procollagen mRNA is translated to form a
preprocollagen chain, with a short hydrophobic sequence at the N-terminus,
the signal peptide, that is involved in translocation into the Golgi apparatus
(Palmiter et al., 1979). After insertion into the cisternae of the rough
endoplasmic reticulum, proa chains are subject to inter-chain disulphide
cross-linking, prolyl 4-hydroxylation (and also prolyl 3-hydroxylation), lysyl
hydroxylation, hydroxylysine O-linked glycosylation in the triple helical region
and N-linked glycosylation in the C-propeptide region. The enzyme protein
disulphide isomerase (PDI) is involved in the formation of these inter-chain
cross-links. Hydroxyproline and hydroxylysine are formed by post-
translational modification.
Following transport through the Golgi system, procollagen molecules
are packaged into secretory vesicles, where they become aligned together
side-by-side, and then secreted into the extracellular matrix, The propeptides
are cleaved in the matrix, where fibril formation (Kuivaniemi etal., 1991) and
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cross-linking ensue (Seyedin and Rosen, 1990). The N-propeptides are
removed by procollagen N-proteinase and the C-propeptides are removed by
procollagen C-proteinase (Prockop and Kivirikko, 1984). Both these enzymes
are extracellular, neutral, calcium-dependent metalloproteinases (Hojima et
a/., 1989). Collagen cross-linking is described in Section 1.8.2.
1.4 Elastin
1.4.1 Introduction
Elastin is a connective tissue protein which confers the properties of
extensibility and elastic recoil to tissues where it is found (reviewed by
Gosline, 1976; reviewed by Foster, 1982; Mecham and Heuser, 1991).
Tissues which are subject to frequent deformation, tension and pressure
changes, such as blood vessel walls and elastic ligaments (e.g. ligamentum
nuchae), contain high concentrations of elastin. Lower concentrations of
elastin are found in the parenchyma of lungs, in skin, tendon, ear cartilage
and pericardium.
The name elastin is one of a number of related terms (others include
"elacin", "elastica", "collacin" and "collastin"), in common usage in the mid
19th century. In 1836 Eulenberg isolated elastin from vascular walls using
boiling water, and in 1841 Henle identified elastica in the walls of blood
vessels. In 1880 it was discovered that elastin could be solubilised and
reversibly precipitated by adjusting the temperature up to 60°C (reviewed by
Hass, 1939). The first amino acid analysis of elastin was described by Stein
and Miller (1938).
1.4.2 Elastin structure
Elastic fibres are made up of both microfibrillar and amorphous
components. The microfibril component consists of filaments (diameter ~ 10-
20 nm), with a characteristic!^ high, polar amino acid content and many
disulphide cross-links. The microfibrils are composed of a number of
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glycoproteins such as fibrillin (Sakai et al., 1986), 31K microtibril-associated
glycoprotein (Gibson et al., 1986) and a 36K microfibril-associated
glycoprotein (Kobayashi et al., 1989). The amorphous component is
composed of elastin, and is found in close association with the microfibril
component. Elastin consists of 95% non-polar amino acid residues,
predominantly valine, alanine, glycine and proline. Although rich in proline,
elastin is very low in hydroxyproline, and it contains no hydroxylysine,
tryptophan, cysteine or methionine (Partridge, 1962). Within the elastin fibre,
the individual elastin polypeptide chains are covalently linked together by the
elastin specific cross-links desmosine and isodesmosine which are derived
from oxidation of lysyl residues by lysyl oxidase (Pinnel and Martin, 1968;
Section 1.8.3). Elastin contains several short repeating peptide sequences,
e.g. the pentapeptide VPGVG which occurs 11 times in one section of the
molecule, the hexapeptide VAPGVG and the tetrapeptide VPGG. All three
repeating sequences contain the dipeptide sequence PG which is important
in the formation of the (3-turn structure. The p-turn is a 10 atom ring with the C-
O of residue 1 hydrogen bonded to the N-H of residue 4 and the dipeptide PG
residues 2 and 3. It is thought that the repeating peptides of elastin are
arranged in p-turns to form helical p-spirals (Arad and Goodman, 1990). The
polypentapeptide is responsible for the elastic properties of elastin, while the
hexapeptide is a more rigid structure with hydrogen bonding between
repeats. Hydrophobic association of the hexapeptide in this region could
result in aligning and interlocking of chains and there are 6-fold hexapeptides
repeats near the cross-linking regions (Foster et al., 1973). Within the cross-
linking regions, lysine residues are interspaced with alanine rich sequences
(Section 1.8.3).
1.4.3 Elastin biosynthesis
Elastin is synthesised and secreted in precursor form, tropoelastin, a
soluble, single polypeptide chain (Mr ~ 70K; Sandberg etal., 1969; Foster et
al., 1975). The initial mRNA translation product pre-tropoelastin, has an N-
terminal signal peptide which is cleaved after translocation into the cysternae
of the rough endoplasmic reticulum (Mecham, 1991), where the tropoelastin
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chains are subject to hydroxylation of prolyl residues. In contrast to collagen
biosynthesis, post-translational hydroxylation of proline residues appears to
be relatively unimportant. Only about 8% of proline residues in tropoelastin or
mature elastin become hydroxylated. Lack of hydroxyproline does not affect
secretion of tropoelastin monomers (Uitto et al., 1976; Kao et al., 1982), or
oxidation of lysyl residues (Mecham, 1991). However, over-hydroxylation may
affect the ability of tropoelastin to form mature fibres (Barone et al., 1985).
Tropoelastin molecules are secreted into the extracellular matrix, where they
become deposited on to microfibrils (Rosenbloom, 1987). At least one protein
has been identified that is involved in delivery of elastin to the microfibrils.
This is a 67K cell surface associated elastin binding protein which binds to
the hydrophobic hexapeptide VGVAPG (Mecham et al., 1989). Cross-linking
of elastin is described in Section 1.8.3.
1.5 Proteoglycans
1.5.1 Introduction
Connective tissues are also rich in proteoglycans (reviewed by
Heinegard and Sommarin, 1987; Wight et al., 1991). Proteoglycans are found
in the extracellular matrix, on cell surfaces, and in intracellular granules. The
large proteoglycans are important in the visco-elastic properties of joints and
other tissues which are subject to physical deformation. The small
proteoglycans often interact specifically with collagens (Scott, 1988). Cell
surface proteoglycans are believed to take part in cell substrate adhesion, cell
recognition and growth regulation (Piepkorn etal., 1990).
1.5.2 Proteoglycan structure
Proteoglycans are heavily glycosylated proteins with covalently
attached glycosaminoglycan (GAG) chains (Lohmander, 1988). The GAGs are
large polysaccharides composed of repeating disaccharide units. There are
four main types of GAGs: heparan/heparan sulphate, chondroitin
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sulphate/dermatan sulphate, keratan sulphate and hyaluronic acid. The first
three GAGs are always protein bound and sulphated, while hyaluronic acid
lacks sulphate and is synthesised as a free GAG chain.
GAGs, especially sulphated GAGs, are strongly negatively charged,
enabling them to bind to many substances, for example many growth factors
and cytokines bind to heparan sulphate proteoglycans. The binding of
fibroblast growth factors (FGFs) to syndecan (Section 1.5.2.3) appears to
protect the growth factor from degradation (Ruoslahti and Yamaguchi, 1991).
At least one growth factor, transforming growth factor (3 (TGFP) binds to
proteoglycans via the core protein, as found with betaglycan (Andres et a!.,
1989; Section 1.5.2.3).
In the absence of methodical nomenclature, the practice has arisen of
identifying families of proteoglycans according to their protein cores. There
are many different types of core protein, which vary in size and structure, and
these are described below.
1.5.2.1 Aggrecan and versican
Aggrecan, found in articular cartilage, is a large proteoglycan (overall
Mr ~ 10^K, core protein Mr ~ 220K; Doege, 1991) which contains two types of
GAG, keratan sulphate and chondroitin sulphate, and can form large
aggregates with hyaluronic acid and link protein. In human articular cartilage
the structure of the aggrecan molecules changes with increasing age
(Bayliss, 1990). This is due to a decrease in the number and size of the
chondroitin sulphate chains, and increase in the number and size of the
keratan sulphate chains. Versican is a large, chondroitin sulphate
proteoglycan expressed by human fibroblasts (protein core Mr ~ 260K;
Zimmermann and Ruoslahti, 1989), which may be involved in cell recognition,
possibly by connecting extracellular matrix components and cell surface
glycoproteins.
1.5.2.2 Serglycin, biglycan, decorin, lumican and fibromodulin
Serglycin (core protein Mr ~ 20K), biglycan (core protein Mr = 38K),
10
decorin (core protein Mr = 36.5K), lumican (core protein Mr = 38.6K) and
fibromodulin (core protein Mr ~ 59K) are members of a family of small
proteoglycans. Serglycin is the smallest of this family and is named after the
24 consecutive serine-glycine repeats in its core protein (Bourdon et a/.,
1985). It is an intracellular proteoglycan found in storage granules of
hematopoetic cells and mast cells.
Biglycan, decorin, lumican and fibromodulin show homologous core
protein structures but represent different gene products (Hedbom and
Heinegard, 1989; Fisher et at., 1991; Blochberger et ah, 1992). They each
contain a central part with ten characteristic leucine-rich repeats and, close to
the C-terminus, a loop formed by disulphide bonds. In the most N-terminal
parts the four proteoglycans show less similar core protein structures and
markedly different post-translational modifications.
Decorin, lumican and fibromodulin bind to collagens types I, II, VI, IV,
and XI where binding is mediated by the protein core. These proteoglycans
interfere with collagen fibrillogenesis and may be important in determining the
surface properties of the completed fibril (Hedbom and Heinegard, 1989;
Fleischmajer et al., 1991). Collagen fibrils possess four sites that can bind
proteoglycans via their protein cores (Scott, 1992). Proteoglycan-GAG chains
can then aggregate to link adjacent fibrils, thereby preventing them from
slipping and increasing the tensile strength. Biglycan binds only to collagen
IV (Fisher et al., 1991).
1.5.2.3 Syndecan-1, fibroglycan, syndecan-3, ampiglycan,
glypican and betaglycan
Syndecans are a family of integral cell surface proteoglycans with
conserved intracellular and transmembrane domains, but, apart from the GAG
attachment regions, relatively variable extracellular domains. Syndecan-1
(protein core Mr = 85K; Saunders et al., 1989) interacts selectively with
extracellular matrix molecules, e.g. fibrillar collagens, fibronectin,
thrombospondin and tenascin, via its heparan sulphate side chains. The
binding of syndecan I to basic fibroblast growth factor (bFGF) suggests that
cell surface proteoglycans can be low affinity receptors for growth factors.
11
Fibroglycan, also known as syndecan-2, is a transmembrane, cell
surface heparan sulphate proteoglycan (core protein Mr= 48K; Pierce etal.,
1992). Syndecan-3 (Gould etal., 1992) is an integral membrane proteoglycan
identified from an embryonic chick wing bud cDNA library, which is structurally
related to syndecan-1 and fibroglycan. Ampiglycan is yet another
transmembrane, cell surface proteoglycan (core protein Mr = 35K; Lories et
al., 1992). Glypican is a cell surface heparan sulphate proteoglycan which
differs from syndecan-1, fibroglycan, syndecan-3 and ampiglycan in that it is
anchored to the membrane by a glycosylphosphatidylinositol (GPI) tail.
Betaglycan is a 250-300K cell surface proteoglycan (core protein Mr ~
120K; Andres etal., 1989) which carries chondroitin sulphate and/or heparan
sulphate GAG chains. Transforming growth factors (31 and (32 bind with high
affinity to the core protein of this proteoglycan.
1.5.3 Proteoglycan biosynthesis
During proteoglycan biosynthesis, core protein mRNA is translated and
newly synthesised chains are translocated into the rough endoplasmic
reticulum (Hascall etal., 1991). The heparan/heparan sulphate, chondroitin
sulphate, dermatan sulphate and keratan sulphate become attached to the
core protein in the Golgi apparatus. The completed monomer is then secreted
via secretory vesicles into the extracellular matrix. In the case of aggrecan, it
is believed that the link protein and hyaluronate are secreted separately, so
that aggregation occurs in the extracellular matrix.
1.6 Structural glycoproteins
1.6.1 Introduction
Structural glycoproteins play an important role in many cell surface
interactions (reviewed by Yamada, 1991). Each of these glycoproteins can
participate in a range of functions using different specific domains, e.g. the
RGD cell binding sequence, to bind to cell surface receptors or other
12
extracellular matrix macromolecules.
1.6.2 Fibronectin and vitronectin
Fibronectins are a family of matrix glycoproteins that enable cells to
interact with the extracellular matrix (Ruoslahti et al., 1982). Fibronectin was
first identified in plasma but has since been widely found. The fibronectin
molecule is a dimer with two large polypeptide chains (Mr~ 220K) which are
linked by a disulphide bridge near their C-termini. In the centre of the
molecule there is an RGD cell-binding site (Ruoslahti and Pierschbacher,
1986) which facilitates binding to cell surface integrin receptors. Other
domains of fibronectin interact with glycosaminoglycans and collagen fibres
(Kirchofer et al., 1991).
Vitronectin is a glycoprotein (Mr = 75K) which, like fibronectin,
promotes cell attachment and interacts with proteoglycans and GAGs. It also
contains an RGD cell attachment site (Suzuki et al., 1985).
1.6.3 Laminins and nidogen
Laminins are a family of large (unreduced Mr= 800-900K) multidomain
glycoproteins with multiple functions in cellular processes and in the
supramolecular assembly of basement membranes (Yurchenco and Schittny,
1990). Cellular functions attributed to laminin include promotion of growth
differentiation, neurite growth, cell mobility and attachment, and mediation of
cell communication (Hunter et al., 1989). Classical laminin is the most
abundant non-collagenous protein in basement membranes. It is composed
of three polypeptide chains. The central A chain (Mr ~ 400K) is flanked by B1
and B2 chains (Mr ~ 200K). The three chains are disulphide bonded at two
sites to form an asymmetrical four armed molecule.
Nidogen, also called entactin, is also a basement membrane
glycoprotein (Mr = 148K; Fox et al., 1991). The molecule consists of three
globular domains, G1, G2 and G3, a short link region connecting G1 and G2
and a rod-like domain between G2 and G3. Nidogen binds to collagen IV at
its G1 and G2 region and binds to laminin at its G3, C-terminal region. It is
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believed to play a key role in the assembly of basement membranes.
1.6.4 Fibrillin, 31K and 36K microfibril associated glycoproteins
and 34K structural glycoprotein
Fibrillin is a glycoprotein (Mr = 350K) that is associated with
extracellular microfibrils (Sakai et at., 1986). Fibrillin is widely found in
connective tissues of skin, lung, cardiovascular system, tendon, muscle and
cornea. It has recently been shown that mutations in the fibrillin gene are
responsible for Marfan's syndrome (Section 1.8.11.1; Dietz etal., 1991).
31K microfibril associated glycoprotein (31K MAP) is an acidic
glycoprotein that is associated with elastin microfibrils and which has been
isolated from bovine nuchal ligament (Gibson et at., 1986). The function of
31K MAP is unknown. It is of similar size to lysyl oxidase (Section 1.8), and it
has been suggested that 31K MAP may be an elastin-specific form of lysyl
oxidase. However, this suggestion is not supported by the amino acid
composition which, compared to bovine lysyl oxidase, is relatively rich in
glutamate, proline, valine, leucine, lysine and cystine, and low in glycine and
tyrosine. In addition anti-bovine lysyl oxidase antiserum shows no cross-
reactivity with 31K MAP (Gibson etal., 1986).
A 34K structural glycoprotein (SGP), containing 10% carbohydrate, has
been extracted from bovine ligamentum nuchae, which exhibits peptidyl-lysyl
oxidase activity (Serafini-Fracassini et a/., 1981). From its amino acid
composition SGP appears to be quite distinct from both lysyl oxidase and 31K
MAP. Compared to lysyl oxidase SGP is relatively rich in glycine, leucine and
lysine residues and has a lower tyrosine content. As SGP exhibits amine
oxidase activity towards free lysine as well as peptidyl-lysine, it would appear
to belong to a different class of enzymes to lysyl oxidase.
36K microfibril associated glycoprotein (36K MAP) is an adhesive
glycoprotein which has been isolated from porcine aorta and shown to
contain an RGD cell binding sequence in its N-terminal region (Kobayashi et
at., 1989). It is found associated with elastin microfibrils and is distinct from the
31K microfibril associated glycoprotein and SGP.
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1.6.5 Tenascins, thrombospondin, cartilage oligomeric matrix
protein (COMP) and von Willebrand factor (vWF)
Tenascins are a family of large six armed extracellular matrix
glycoproteins (unreduced Mr ~ 1.300K; Erickson and Inglesias, 1984;
Vaughan et al., 1987). Tenascin molecules are homohexamers with one arm
corresponding to one subunit (Mr ~ 190-340K). Several tenascin variants
have been described, which arise from alternative splicing, and all contain
cell binding (RGD) and heparan binding sequences. Tenascin shows a very
interesting tissue distribution as it appears in large amounts in a very
restricted manner during embryonic development (e.g. extracellular regions of
developing or regenerating tisue). In adult tissues tenacins can be found in
tendons, ligaments, pericardium and periosteum (Nies et al., 1991).
Tenascins identified include tenascin, restrictin and tenascin-MHC (major
histocompatability complex).
Thrombospondin is an adhesive glycoprotein (unreduced Mr ~ 600K,
Gehron-Robey eta!., 1989). Endothelial cells can synthesise and incorporate
newly synthesised thrombospondin into their extracellular matrix where it
interacts with macromolecules such as fibronectin and collagen V.
Thrombospondin is synthesised by different cell types, e.g. platelets,
endothelial and smooth muscle cells, and the protein can modulate in vitro
cell adhesion, spreading and mobility. Thrombospondin is composed of three
identical disulphide-linked subunits (subunit Mr ~ 180K) and the molecule
has a calcium-dependent conformation. As found in other extracellular matrix
proteins, thrombospondin possesses several structural domains which exhibit
different functions, including an RGD cell binding sequence.
Cartilage Oligomeric Matrix Protein (COMP) is a five-armed matrix
protein isolated from articular cartilage (unreduced Mr~ 500K; Morgelin etal.,
1992; Hedbom et al., 1992), with a similar structure to thrombospondin. The
function of COMP is unknown.
Von Willebrand factor (vWF) is a large oligomeric glycoprotein (Mr ~
260K), synthesised by endothelial cells and deposited in their extracellular
matrix (Sadler, 1991). vWF has two important functions in haemostasis. First, it
is required for adhesion of platelets to sites of vascular damage and, second,
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it binds to and stabilises blood coagulation factor VIII (antihaemophilic factor)
in the circulation. vWF binds to fibrillar collagens, collagen type VI, heparin
and sulphated glycolipids. An RGD sequence has been identified near its C-
terminus.
1.6.6 Bone sialoprotein (BSP), osteopontin, secreted protein
acidic and rich in cysteine (SPARC) and osteocalcin
Two human bone sialoproteins (BSP I and BSP II; Mr = 70-80K) have
been isolated (Fisher et al., 1987). They differ in their sialic acid content, their
amino acid composition, and their phosphate content. BSP II has a core
protein (Mr= 33.6K), which contains a RGD cell binding sequence and binds
to cells via a vitronectin-type integrin receptor (Oldberg et al., 1988a, b). BSP
II also contains a repeating sequence motif of up to ten adjacent residues
which may confer calcium binding properties to the protein, and the protein is
tyrosine sulphated (Ecarot-Charrier et al., 1989). The precise role of bone
sialoproteins is unknown.
Osteopontin is a bone glycoprotein (Mr = 32.6K) that is similar to bone
sialoprotein but with a lower carbohydrate content (Heinegard and Oldberg,
1989). Osteopontin also contains a RGD cell binding sequence,
phosphorylated serines and a sequence of adjacent aspartic acid residues.
Osteopontin may be involved in recruiting osteoclast precursor cells and
binding them to the mineralised matrix of bone.
Secreted Protein Acidic and Rich in Cysteine (SPARC), also known as
osteonectin and BM40, is a developmentally regulated, secreted, calcium
binding glycoprotein (Mr = 33K), which is associated with cellular events
requiring tissue remodelling, cell movement and/or proliferation. SPARC
contains no RGD sequences (Heinegard and Oldberg, 1989; Lane and Sage,
1990).
Osteocalcin is a low molecular weight protein (Mr = 5.8K) found only in
bone and teeth (Heinegard and Oldberg, 1989). The presence of three y-
carboxyglutamic acid residues per molecule confers calcium binding so it has
been suggested that osteocalcin can act as an inhibitor of calcification.
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1.7 Connective tissue degradation
There are several classes of proteinases involved in connective tissue
degradation and these are described below.
1.7.1 Metalloproteinases
The metalloproteinases are a family of enzymes that can degrade most
of the components of the extracellular matrix (Okada et al., 1986). They can
be subdivided into three major classes, collagenases, gelatinases and
stromelysins. These potent enzymes are secreted in proenzyme form and
require activation before the substrate can be digested. This can be achieved,
at least in vitro, by proteinases such as trypsin or plasmin.
Once activated, collagenase activity can be inhibited by tissue
inhibitors of metalloproteinases (TIMP-1 and TIMP-2; Osthues et al., 1992).
TIMP-1 is glycoprotein (Mr = 28.5K), while TIMP-2 is non-glycosylated (Mr =
21K). These proteins inhibit the activity of matrix metalloproteinases by
forming a one to one complex with the enzyme.
There are several possible control points where the level of
metalloproteinase activity could be regulated These include synthesis,
secretion and activation of the enzyme, and production of inhibitors. Although
a plethora of cytokines and growth factors have been shown to modulate
levels of collagenase and TIMP, little is known concerning feedback
mechanisms and controls (Bertraux etal., 1991; Hayakawa et al., 1992).
1.7.2 Other proteinases
Polymorphonuclear leucocyte elastase, a serine proteinase, can
degrade various collagen types, collagen telopeptides, proteoglycans as well
as elastin (Rosenbloom, 1984). Macrophage elastase can degrade elastin
and collagen IV. During various pathological processes, such as emphysema
or atherosclerosis, elastin is degraded by elastases. Soluble elastin peptides
are then released into the blood stream. The complete amino acid sequence
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of cathepsins B, D, H and L have been determined (Bechet et al., 1991).
These proteinases can degrade various collagen types, elastin and
proteoglycans.
1.7.3 Regulation of matrix synthesis and degradation
A number of mediators have been found which regulate production of
matrix components. Growth factors, e.g. fibroblast growth factors (FGFs) and
transforming growth factor (3 (TGFJ3), increase the rate of proliferation of
fibroblasts, chondrocytes and osteoblasts (Rifkin and Moscatelli, 1989). As the
synthesis of collagen, proteoglycans and GAGs increases, the secretion of
metalloproteinases decreases. Cytokines, e.g. interleukin-1, have an
antagonistic effect. They decrease the synthesis of collagen, proteoglycans
and GAGs and increase the release of collagenase (Redini et al., 1988).
1.8 Lysyl oxidase
1.8.1 Introduction
Lysyl oxidase (protein-lysine-6-oxidase, E.C.1.4.3.13.) initiates cross-
linking in collagens and elastin by the extracellular conversion of specific
lysine (and, in collagen, hydroxylysine) residues to a-aminoadipic-8-
semialdehyde (allysine, or hydroxyallysine; Fig. 1.1; Pinnel and Martin, 1968;
reviewed by Siegel, 1979; reviewed by Kagan, 1986). Spontaneous
condensation between these aldehyde groups, and other vicinal aldehydes
and unmodified lysine (or hydroxylysine) residues leads to the formation of a
variety of intra- and inter-molecular cross-links (Fig. 1.2). These reactions
convert soluble precursor forms of collagen and elastin to insoluble fibres.
The formation of cross-links enables these fibres to withstand tensile stress.
The existence of a cross-linking enzyme was implied from studies of
lathyrism, a connective tissue disorder in which no cross-links are formed.
Symptoms of lathyrism, which can be induced experimentally by supplying (3-
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Fig. 1.2. Reactions of peptidyl lysine and hydroxylysine in the biosynthesis of
cross-links in collagen and elastin
After oxidative deamination to form reactive aldehydes, subsequent condensation
reactions lead to the formation of di-, tri-, and tetrafunctional cross-links. The number of
residues involved in each cross-link are shown by the column headings 2, 3, and 4. Cross-links
common to both collagen and elastin are shown in hatched boxes, cross-links specific to elastin
are shown by the stippled boxes and cross-links specific to collagen are shown by open boxes.
Abbreviations used are: LO (lysyl oxidase), AL (allysine), HAL (hydroxyallysine), ACP (aldol
condensation products), LNL (lysinonorleucine), HLNL (hydroxylysinonorleucine), h-HLNL
(histidine-HLNL), DHLNL (dihydroxylysinonorleucine), HMD (hydroxymerodesmosine), OHP
(hydroxypyridinium), LP (lysylpyridinium), and PA (pyridinium analogue; from Reiser et al.,
1992).
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rupture, skeletal deformities, and skin fragility. In 1968, lysyl oxidase was
discovered and its activity shown to be inhibited by (3APN (Pinnel and Martin,
1968).
1.8.2 Cross-linking in collagen
Lysyl oxidase initiates cross-linking in fibrillar collagens by the
oxidation of specific lysine, or hydroxylysine residues, located in the short l^-
and C-terminal, non-triple-helical telopeptide regions of the collagen
molecule.
Cross-linking occurs in the extracellular matrix and requires specific
alignment of collagen molecules (Fig. 1.3). Lysines, or hydroxylysines, in the
N- and C-terminal telopeptide regions of each a chain become cross-linked to
triple helical regions of neighbouring molecules within the collagen fibrils.
The structures of some typical difunctional cross-links are shown in Fig. 1.4.
Glycosylated as well as hydroxylated residues may also play a part in
collagen cross-linking (Section 1.8.11.3; Kagan, 1986; Reiser et al., 1992).
1.8.3 Cross-linking in elastin
The same lysyl oxidase enzyme appears to be involved in both
collagen and elastin cross-linking (Siegel, 1979). Cross-link formation in
elastin follows the same course as in collagen but with three major
exceptions. Hydroxylysine is not involved as it is absent in elastin; histidine is
also not involved; and the final, tetrafunctional cross-links, desmosine and
isodemosine, are not found in collagens (Figs. 1.2 and 1.5).
Tropoelastin isolated from copper-deficient pig aortas contains
approximately 47 lysine residues per molecule, while mature elastin contains
approximately five lysine residues per molecule (Sandberg etal., 1981). This
decrease in the number of free lysine residues is explained by the
involvement of the remaining lysines in lysyl oxidase initiated cross-links. This
relatively large number of cross-linked lysines in elastin contrasts with the
limited number of lysines oxidised per a chain of fibrillar collagen.









































Fig. 1.4. Structures of difunctional cross-links
Aldol condensation product (ACP, formed from two adjacent allysine residues) is an
intramolecular cross-link, while lysinonorleucine (LNL) is the reduced form of the intermolecular
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Fig. 1.5. Cross-linking of soluble elastin into insoluble elastin
(adapted from Sandberg eta!., 1981)
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separated by one to three alanine residues. Preceding such sequences are
as many as eight alanine residues in continuous sequence. This feature of
alanine enrichment is unique to elastin (24% of total amino acids are alanine)
and essential for cross-link formation.
Cross-linking in elastin involves oxidation, by lysyl oxidase, of three out
of four lysine side chains in two adjacent chains (Fig. 1.5). Two difunctional
cross-links, dihydrolysinonorleucine (DHLNL; formed from one residue of
allysine and one lysine) and aldol condensation product (ACP; formed from
two residues of allysine) condense to form desmosine or isodesmosine,
thereby linking two chains with tetrafunctional cross-links (Fig. 1.5; Reiser et
al., 1992).
1.8.4 Molecular weight and enzyme variants
Molecular weight values for lysyl oxidase have largely been
determined by SDS-PAGE analysis. Lysyl oxidase has been purified from a
variety of tissues and from a number of organisms (Table 1.2), and there is a
wide diversity in the reported molecular weights. The highest molecular
weights (170-180K) are from salt extracts of bovine aorta (Shieh etal., 1975),
and chick cartilage (Siegel et al., 1970b). In contrast, when urea is used in the
extraction of the enzyme, the apparent molecular weight is in the range 28-
34K, with 32K being the most frequently reported value (Kagan etal., 1979).
Lysyl oxidase is known to form high molecular weight aggregates in the
absence of urea (Kagan et al., 1979).
A number of procedures have been used to purify lysyl oxidase from
the initial extracts. These include DEAE ion exchange chromatography, gel
filtration chromatography, and a variety of affinity binding steps (to collagen,
elastin, etc.; Table 1.2). When a DEAE column is the first stage in purification,
molecular weight values of between 59-62K have been reported. This was
found to be the case for bovine aorta (Vidal et al., 1975), chick aorta (Harris
et al., 1974), and chick cartilage (Siegel and Fu, 1976). In certain cases it was
noted that the 32K protein slowly degrades in vitro into a 24K protein and
other products (Sullivan and Kagan, 1982). The human placental lysyl
oxidase (Mr = 30K) was found to co-purify with a 24K protein, and this was
24
Table 1.2. Review of methods for purifying lysyl oxidase
Source Reference Purification Variants Mr
1.Bovine
aorta Shieh etal., 1975 PBS,ASP,DE,HA,BG,AF-ConA 2 180 (BG)
Vidal etal., 1975 U,DE,AF-OCMP 2 59,61
Jordan etal., 1977 U,AF-Col, DE, S-200 3 ~30 (SDS)
Kagan et al., 1979 U,AF-Col,DE,S-200 4 32 (SDS)
Tang etal.,1983 U,AF-Col,DE,S-200 32 (SDS)
Gacheru etal., 1990 U,CM-T,DE-T,AF-CB,S-200
Trackman etal., 1990 U,CM-T,DE-T,AF-CB,S-200 32
cartilage Sulivan and Kagan,1982 U,AF-Col,DE,S-200 32 (SDS)
ligament Jordan etal., 1977 U,AF-Col,DE.SX 4 -30 (SDS)
lung Shieh and Yasunobu,1976 U,ASP,DE,AF-Col 2 80,160 (Native)
28,53 (SDS)
2. Calf
aorta Ferrera etal., 1982 U,AF,DE,E-H,SW-300 -30 (HPLC)
Williams and Kagan,1985 U.CM-T, DE-T,AF-CB, S-200 4 32 (SDS)
cartilage Han and Tanzer, 1979 U,CM-T,DE-T,S-200 4 32 (SDS)
3.Chick
aorta Harris etal.,1974 U,DE,AF-OCMP 2 59,61 (SDS)
cartilage Siegel et al., 1970b PBS,ASP,PHP,BG 170 (Native)
Narayanan etal., 1974 PBS, ASP, U, ASP,AF-Col ND
Siegel and Fu,1976 u,de.af-coi.de 2 62 (SDS)
Stassen,1976 U,AF-Col,DE.DE 4 28 (SDS)
4.Human
placenta Kuivaniemi etal., 1984 U,AF-Col,DE,S-200 4 30 (SDS)
umbilical Burbelo etal., 1986 U,AF-CB,DE,S-200 4 30 (SDS)
- cord Tang et at., 1989 U,AF-Gel, 32
Wakasaki and Ooshima, 1990b U,AF-CB,DE,S-200 32
5.Porcine
skin Shackleton and Hulmes,1990a U,DE,S-200 34 (SDS)
6. Rat
liver Wakasaki and Ooshima, 1990a U 32 (SDS)
(48, precusor)
lung Almassian efa/.,1991 U,DE-T,HA,S-200 32 (SDS)
skin Romero-Chapman efa/.,1991 U,AF-EI,S-200 32 (SDS)
(40, precursor)
7.Tricho
-derma sp. Laugalene etal., 1990 HIC,BSC-80,AF 43 (SDS)
8.Turkey
aorta Narayanan etal., 1982 U,AF-Col,DE 100,77,52
+ others (SDS)
Abbreviations are as follows: AF, affinity chromatography, AF-CB, Cybachrome Blue affinity
chromatography, AF-Col, collagen-Sepharose affinity chromatography, AF-ConA, ConA affinity
chromatography, AF-EI, elastin affinity chromatography, AF-Gel, gelatin affinity chromatography, AF-
OCMP, chromatography with chick embryo aorta organ culture media proteins coupled to Sepharose,
ASP, ammonium sulphate precipitation, BG, chromatography with BioGel, BSC-80, HPLC with BSC-80,
CM-T, chromatography with CM-Tris-acryl, DE, DEAE chromatography, DE-T, chromatography with DE-
Tris acryl, EH, chromatography with elastin coupled to Hydrogel, HA, hydroxyappatite chromatography,
HIC, hydrophobic interaction chromatography, HPLC, high pressure liquid chromatography, PBS,
phosphate buffered saline, S-200, chromatography with Sephacryl S-200, SDS, SDS gel
electrophoresis, SW-300, SX, chromatography with Sephadex, HPLC with TSK SW-300, U, 4M or 6M
urea.
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also believed to be a degradation product of lysyl oxidase (Kuivaniemi et al.,
1984).
Different variants of lysyl oxidase have been found by gradient elution
anion exchange columns. Four variants have been isolated from bovine aorta
(Kagan et al., 1979; Cronlund et al., 1985), bovine ligament (Jordan et al.,
1977), chick cartilage (Stassen, 1976), and human placenta (Kuivaniemi et
al., 1984), and two variants from bovine aorta (Vidal et al., 1975) and chick
cartilage (Siegel and Fu, 1976; Table 1.2).
1.8.5 Co-factors
Copper is essential for lysyl oxidase activity (Kagan, 1986; Iguchi and
Sano, 1985; Gacheru et al., 1990), and the enzyme from chick bone and
bovine aorta contains 1g atom of copper per molecule (Kagan and Trackman,
1991). Recently, a putative copper binding site has been suggested in the
predicted 32K lysyl oxidase sequence which is consistent with the probable
location of the active site (Trackman etal., 1990; Trackman et al., 1991).
A second co-factor in lysyl oxidase has long been suspected and this
was initially thought to be pyridoxal phosphate (PLP; Rucker and O'Dell,
1970; Bird and Levene, 1982), though the presence of PLP in the bovine
aortic enzyme has since been disproved (Williamson etal., 1986a). Raman
spectroscopy of an active site peptide of calf aorta lysyl oxidase is consistent
with the presence of a pyrroloquinoline quinone (PQQ, or methoxatin) co-
factor (Williamson et al., 1986b), and the presence of PQQ has also been
reported in a proteolytic fragment of human placental lysyl oxidase (van de
Meer and Duine, 1986). The identification of PQQ in mammalian enzymes is
difficult, however, as mg amounts of pure enzyme are required (Paz et al.,
1989). Also harsh extraction conditions may create PQQ artificially (Mclntire,
1992). When rats were fed on a PQQ deficient diet, however, they showed
lathyritic symptoms and had lower levels of both lysyl oxidase protein and
activity, and these effects were reversed by a PQQ supplementation (Killgore
etal., 1989).
Recently, it has been suggested that topa quinone (6-hydroxydopa
quinone) may be the co-factor in lysyl oxidase (Janes etal., 1990; Thomson,
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1991; Duine, 1991). Topa quinone is a contiguous part of the polypeptide
chain in the form of a modified tyrosyl residue. Lysyl oxidase, however, does
not posess the consensus sequence for this co-factor (Mu et al., 1992; Janes
etal., 1992; Section 4.3.1).
1.8.6 Kinetics and mechanism of action
The enzyme kinetics of lysyl oxidase are complex (Gacheru et al.,
1990; Kagan and Trackman, 1991). At low substrate concentrations, activity
does not follow Michaelis-Menton kinetics, perhaps because lysyl oxidase
has both catalytic and non-catalytic binding sites for elastin and collagen
substrates, by analogy with myosin I (Lynch et al., 1986).
Lysyl oxidase appears to follow a ping pong mechanism with an
ordered substrate binding and product release. The proposed mechanism is
as follows. The amine substrate is initially oxidised to the aldehyde by
passage of two electrons from the a-carbon of the substrate to the enzyme,
PQQ-like, co-factor. The reduced catalytically inactive form can then be
reoxidised to the catalytically active form by binding oxygen to which the two
electrons are passed to form and release H2O2. The precise role of copper is
unclear but it is essential for the first part of the reaction. A greater
understanding will become apparant with unequivecal identification of the co-
factor of lysyl oxidase.
1.8.7 Inhibition by (3-aminopropionitrile (PAPN)
In 1933 it was found that connective tissue disorders could be induced
by feeding rats on sweet peas (Lathyrus odoratus ; Geiger et al., 1933). The
compound responsible for this effect was found to be pAPN (Schilling and
Strong, 1954). Lysyl oxidase was found to be inhibited by pAPN which
consequently inhibited cross-linking in collagen and elastin (Siegel etal.,
1970a). Fifty percent inhibition occurred at concentrations of 3-5 pM pAPN
(Narayanan etal., 1972). pAPN initially inhibits lysyl oxidase competitively but
eventually it binds covalently to the active site and inhibition becomes
irreversible (Tang et al., 1983).
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1.8.8 Precursor form
Recently a precursor of lysyl oxidase (Mr= 40-48K) has been found, in
fibrotic rat liver (Wagasaki and Ooshima, 1990a), in rat skin and uterine tissue
(Romero-Chapman etal., 1991) and rat aorta smooth muscle cells (Trackman
et al., 1992). The cDNA sequences of the rat aorta lysyl oxidase precursor
(Trackman et al., 1990; Trackman et a/.,1991), the human lysyl oxidase
precursor (Hamalainen et al., 1991), and the chick aorta lysyl oxidase
precursor (Wu et al., 1992) have also been described.
The precursor from rat aorta smooth muscle cells (Mr = 50K) is N-
glycosylated (Trackman et al., 1992; Section 1.8.1), though the active enzyme
is not glycosylated. N-glycosylation therefore occurs in the propeptide region,
although a N-glycosylation recognition sequence has been identified in the
32K enzyme region. A 47K non-glycosylated enzyme precursor has also
been identified in cell cultures (Trackman et al., 1991). Thus the glycosylated
structure on the 50K precursor is believed to have Mr= 3K. The 50K protein is
soluble and believed to be secreted into the extracellular matrix where it is
cleaved to give the 32K lysyl oxidase (Trackman et al., 1992). The precise site
of cleavage is controversial (Chapter 3).
1.8.9 Hormonal control and other mechanisms
The activity of lysyl oxidase is also under hormonal control. For
example, in hypophysectomised rats, (i.e. rats in which the hypophysial blood
vessels, which link the hypothalmus to the pituitary gland, are removed), lysyl
oxidase activity and cross-linking in vivo were reduced, which indicates the
effect of pituitary hormones on lysyl oxidase (Shoshan and Finkelstein, 1976).
Lysyl oxidase activity in rat skin was also found to be 91% inhibited by
injection of a synthetic glucocorticoid (Benson and LuValle, 1981). The two
effects may be related as corticosteroids inhibit secretion of
adrenocorticotrophic hormone (ACTH) from the anterior pituitary gland.
As a further example of hormonal control, synthetic oestrogen was
found to increase lysyl oxidase activity in skin and bone when supplied to
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ovariectomized rats. Oestrogen also increases the activity of mouse cervical
lysyl oxidase (Ozasa et al., 1986). Testosterone increases lysyl oxidase
activity in skin, but not bone, in ovariectomized rats (Sanda etal., 1978), and
testosterone also increases activity in cultured aortic smooth muscle cells
(Bronson et al., 1987). Hormone-receptor complexes may regulate
transcription of lysyl oxidase DNA (Vannice et al., 1984).
Lysyl oxidase activity may also be controlled by interaction with other
matrix components. For example, a lysyl oxidase enhancer protein has been
isolated from porcine skin and shown to enhance lysyl oxidase activity up to 3
fold in vitro. The identity of this protein is unknown (E. Forbes, personal
communication).
1.8.10 Nutritional effects
Starvation of rats for 15 hours decreased lung lysyl oxidase activity by
approximately 25% compared to controls (Madia et al., 1979), and normal
lysyl oxidase activity was restored three hours after re-feeding. Thus lysyl
oxidase activity may be modulated by a poor diet. Copper deficiency is the
likely cause of this effect as shown by 95% decrease in lysyl oxidase activity
observed when chicks were fed on a copper-deficient diet (Harris et al.,
1982). When CUSO4 was subsequently injected into these animals 50-100%
lysyl oxidase activity was restored after 6-20h. It is thought that copper may
have a regulatory role in the biosynthesis of lysyl oxidase in addition to being
a co-factor (Harris etal., 1982).
Ascorbate levels may also regulate lysyl oxidase activity (Faris et al.,
1984). When supplied in low concentrations (0.5 (ig/ml) to ascorbate deficient
cultures of rabbit smooth muscle cells, lysyl oxidase activity and soluble
elastin levels remained constant but collagen levels increased. At higher
levels of ascorbate, both lysyl oxidase activity and soluble elastin synthesis




There are several inherited diseases which lack or have reduced
levels of lysyl oxidase, and these result in symptoms that resemble induced
lathyrism. However, in many cases, it is likely that the deficiency of lysyl
oxidase is due to a disruption of copper metabolism. In contrast, there are a
number of diseases characterised by an excess of lysyl oxidase. Such
conditions lead to an excessive amount of collagen and elastin in tissues
(fibrosis). A number of diseases which were previously attributed to lysyl
oxidase deficiency, e.g. Marfan's syndrome and osteogenesis imperfecta,
have recently been found to be due to other causes. Marfan's syndrome is a
dominantly inherited connective tissue disorder, characterised by
musculoskeletal and cardiovascular abnormalities and lens dislocation.
Most cases of Marfan's syndrome are caused by mutations in the fibrillin gene
on chromosome 15 (FBN 1) which leads to low concentrations of fibrillin in
cells and tissues (Dietz et ai, 1991). Several forms of osteogenesis
imperfecta, characterised by, brittle bones, hearing loss and blue sclerae
have been shown to be caused by mutations in type I collagen (Byers, 1990).
1.8.11.2 Diseases due to deficiency of lysyl oxidase
At least five mutations in the mottled locus on the murine X-
chromosome have been described (Royce and Steinmann, 1990). Some of
the phenotypes are lethal. The blotchy male variant exhibits bone deformities,
extensible skin, aortic aneurisms (swelling and distension of the aortic wall)
and defects in lung elastin. The viable brindled variant shows a decrease in
desmosine concentration in aortic elastin. In both variants, lysyl oxidase
activity is reduced, by 50% and 67% respectively, and this is due to a
disruption of copper metabolism (Rowe et at., 1974). These symptoms
resemble Menke's syndrome in humans.
Menke's syndrome is a lethal X-linked, recessively inherited disorder
(Royce and Steinmann, 1990). It has a frequency of 1 in 50,000 to 100,000
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births. This disorder is characterised by growth retardation, severe cerebral
degeneration, kinky hair, hypothermia and generalised arterial disease. The
lysyl oxidase activity in Menke's fibroblast cultures was reduced by more than
50% compared to controls. In a severe case of the disease skin and aorta
lysyl oxidase was reduced by 86-94% of control levels. Again, the enzyme
deficiency appears to be secondary to disturbances in copper metabolism.
Ehlers-Danlos syndrome is a group of inherited connective tissue
disorders characterised by joint hypermobility, hyperextensibility, thinness and
fragility of skin. The syndrome has been divided into 10 subtypes according to
clinical, genetic and biochemical criteria. Ehlers-Danlos syndrome subtype IX
shows similar symptoms to Menke's syndrome, but the patient's hair is
coarse, not kinky, and there are no neurological abnormalities. Copper
content is low in skin and hair and there are reduced levels of lysyl oxidase in
the media of the cultured fibroblasts form affected individuals. Ehlers-Danlos
syndrome subtype V was thought to be caused by a defect in the lysyl oxidase
gene (Siegal, 1979), though this is now thought to be unlikely (Kagan, 1986).
Cutis laxa is a rare, heterogeneous disorder of elastic tissues affecting
the skin, cardiovascular system and lungs (Uitto et al., 1982). It may be
inherited as an autosomal dominant, autosomal recessive or a X-linked
recessive disease, or it may occur as an acquired form. The molecular basis
of the disease remains elusive. In all cases examined so far, light and electron
microscopy have shown that dermal elastin content is severely reduced,
which suggests that the abnormality might lie in elastin metabolism.
Biochemical and molecular analysis of the fibroblasts have confirmed defects
in elastin synthesis or gene expression in some but not all cases examined.
However, in some patients alteration of the collagen component, such as
fusion of fibrils, has been described. Deficiency of lysyl oxidase has been
observed in cultured fibroblasts from two patients with X-linked cutis laxa
(Byers et al., 1980). The reduction in lysyl oxidase activity may be a
secondary effect of deficient copper metabolism.
Some of the above deficiencies in lysyl oxidase activity can be at least
be partially reversed. For example, subcutaneous injections of copper to the
brindled aneurism prone mouse was found to increase lysyl oxidase activity
(Royce et al, 1982). Furthermore, administration of propanolol was found to
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stimulate lysyl oxidase activity in aneurism prone turkeys (Boucek et al.,
1983).
1.8.11.3 Diseases due to an excess of lysyl oxidase
Excess lysyl oxidase activity is associated with a number of
cardiovascular diseases. For example, early lesions in atherosclerotic arterial
walls are associated with greater deposition of collagen and elastin, lysyl
oxidase levels increasing 2.5 times in a rabbit model of atheroscleosis
(Kagan etal., 1981). Collagen biosynthesis and deposition on vascular walls
also increases in hypertensive rats (Ooshima et al., 1974), and treatment with
(3APN restores collagen biosynthesis to normal levels (Sheridan et al., 1979).
It is possible, therefore, that anti-fibrotic drugs, through their effect on lysyl
oxidase, may be useful in the treatment of hypertension. Myocardial lysyl
oxidase activity also increases in experimental rabbits after induction of
myocardial infarction (Lerman etal., 1983).
Lysyl oxidase is also important in lung disease. For example, lung
fibrosis can be induced by exposure to bleomycin sulphate (Counts et
al., 1981), and this is associated with a six-fold increase in lysyl oxidase
activity. Lung fibrosis can also be induced by inhalation of cadmium vapours,
where lysyl oxidase activity increases 14-fold (Chichester etal., 1981). The
cadmium-induced lysyl oxidase has been isolated and resolved into four
peaks of activity when separated by anion exchange (Almassian et al., 1991).
When cadmium chloride is fed to chicks, bone lysyl oxidase activity
decreases. This is thought to be due to cadmium being incorporated into lysyl
oxidase in preference to copper (Harris, 1986).
Increased collagen synthesis and deposition is found in human liver
from alcoholic patients (Chen and Leevy, 1975). Liver fibrosis can be induced
by repeated injections of carbon tetrachloride into rats. It was found that
hepatic lysyl oxidase activity increased 30 times in such circumstances
(Siegel etal., 1978). Assay of serum lysyl oxidase activity has been found to
be a sensitive indicator of liver fibrosis. Activity increased 1.6 fold in chronic
persistent hepatitis, 4.4 fold in chronic active hepatitis and 11.8 fold in
cirrhosis, when compared to controls (Murawaki etal., 1991).
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Drug induced diabetes in rats leads to increased lung lysyl oxidase
activity, collagen biosynthesis and deposition (Madia et al., 1979). The activity
of other enzymes involved in collagen biosynthesis are also increased
(Kagan, 1986). It has been found in the skin collagen from patients with
insulin-dependent diabetes mellitus (IDDM), that the amounts of the lysyl
oxidase dependent difunctional cross-link dihydroxylysinonorleucine
(DHLNL) and the Afunctional maturation product hydroxypyridinium (OHP),
both increase, while all other cross-links remain normal. The skin also shows
an increase in non-enzymic glycosylation of lysine and hydroxylysine which
results in the formation of hexosyl-lysine and hexosyl-hydroxylysine. Some of
these early products are believed to form Schiff bases and then undergo an
amido-rearangement to form ketoamines (Buckingham and Reiser, 1990).
The non-enzymic glycosylation of collagen may affect formation of specific
lysyl oxidase dependent cross-links and this may cause long term skin and
cardiovascular complications for diabetic patients.
The administration of (3APN as a means of controlling fibrosis has been
studied in various tissues (Kagan, 1986). As (3APN is a powerful inhibitor of
lysyl oxidase, care must be taken not to over-prescribe and thereby lead to
loss of tensile strength.
1.9 Tyrosine Rich Acidic Matrix Protein (TRAMP)
Tyrosine Rich Acidic Matrix Protein (TRAMP) is a new protein of the
extracellular matrix (Mr = 24K) that has been found to co-purify with lysyl
oxidase from porcine skin (Chapter 3; Cronshaw et al., 1993). The purification
of lysyl oxidase involves an initial DEAE ion exchange chromatography step
followed by an unususal chromatographic procedure in which the enzyme
binds selectively to Sephacryl S-400 an a low ionic strength neutral buffer.
When eluted from the Sephacryl column, lysyl oxidase (Mr = 32K) appears
with a 24K contaminant. Such a contaminant had previously been reported in
the lysyl oxidase literature (Sullivan and Kagan, 1982; Kuivaniemi et al.,
1984; Burbelo et al., 1986) and it was thought to be a degradation product of
the enzyme. The work discussed in this thesis shows that the 24K
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contaminant in porcine skin lysyl oxidase is a distinct protein, which, because
of its high tyrosine content and relatively low isoelectric point, has been called
TRAMP (Tyrosine Rich Acidic Matrix Protein). Analysis of the amino acid
sequence of TRAMP (Chapter 3) shows that it is almost identical to a bovine
22K extracellular matrix protein, which co-purifies with dermatan sulphate
proteoglycans (Choi et al., 1989; Neame et al., 1989).
The function of TRAMP is not well understood. It appears to have a
widespread tissue distribution (present in extracts of heart, lung, kidney,
spleen, skin, brain, skeletal muscle and liver; E. Forbes, unpublished
observations). A possible role in cell adhesion has been suggested for the
equivalent bovine 22K protein (Lewandowska et al., 1991). TRAMP does not
affect lysyl oxidase activity on an elastin substrate, nor does it affect the
activity of added lysyl oxidase (Cronshaw et al., 1993). TRAMP may be
involved in the assembly of collagen fibrils, as it has been found to accelerate
this process in vitro (MacBeath etal., 1993). Additional properties of TRAMP
are discussed in Chapters 3 and 4.
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2.1 Lysyl oxidase assay
The assay for lysyl oxidase (Shackleton and Hulmes, 1990b) involves
incubation of enzyme with an elastin substrate that has been labelled
biosynthetically with [4,5-3H]lysine. As a result of the reaction, tritium
exchanges with water and the 3HHO formed is separated by ultrafiltration
using Millipore Ultrafree-MC microconcentrators. Elastin is preferred as a
substrate as there are approximately 25 residues per molecule available for
lysyl oxidase activity compared to only a few residues per molecule in
collagen. Elastin is also more accessible as a substrate (collagen must be in
fibrillar form), it is easier to produce and assay results are comparable to other
assays. The disadvantage of using elastin is that due to its particulate nature,
both the molar concentration and the extent of cross-linking, are unknown.
For each assay, a 100 pi aliquot [3H]elastin substrate (containing 3 x
103 d.p .m.) suspended in assay buffer (0.1 M Na2B4C>7, 0.15M NaCI, pH 8.0),
was placed in a 1.5 ml microcentrifuge tube. To this, 700 pi assay buffer and
100 pi enzyme were added. The reaction mixture was vortexed and then
incubated at 37°C for 16h. The reaction was then stopped by the addition of
100 pi 50% (w/v) trichloroacetic acid to give a final concentration of 5% (w/v).
The bulk of the elastin substrate was then pelleted by centrifugation (IEC
Centra-M-Microcentrifuge) at 15,600 g at 2°C for 5 min. After this, 420 pi of the
supernatant was transferred to a Millipore Ultrafree-MC cellulose low binding
10,000 NMWL microconcentrator, which was then centrifuged at 4,200 g at
2°C for 1.5h in a Beckman JA-18.1, 45° fixed angle rotor. During
centrifugation, low molecular weight material passed through the ultrafiltration
membrane and collected in the lower chamber of the microconcentrator. To
measure the tritium release, 300 pi of the ultrafiltrate was mixed with 2.7 ml
Cocktail "T" scintillation fluid (BDH) in a plastic scintillation vial insert and then
counted (for 10 min) in a Packard Model 1900CA Tri-carb liquid scintillation
counter. Control assays contained 0.2 mM (3-aminopropionitrile (PAPN), a
specific inhibitor of lysyl oxidase.
Partial inhibition of lysyl oxidase activity in the presence of urea
(0.33M, 0.67M) was corrected by multiplying observed c.p.m. (above
background) by the appropriate correction factors (1.40 and 2.33 respectively)
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based on the linear inhibition of lysyl oxidase activity by urea concentrations
up to 1M (Shackleton and Hulmes, 1990b).
2.2 Protein assay
The protein concentrations of each sample were assayed by one of two
methods, depending on the approximate protein concentration. If adequate
protein was present a Bradford assay was used (Bradford, 1976). A standard
was established using 10-100 pg/ml bovine serum albumin (BSA). To each
aliquot (100 pi of BSA solution or sample) 1 ml Bradford Reagent (0.01%
(w/v) Coomassie Brilliant Blue G-250; 4.7% (w/v) ethanol; 8.5% (w/v)
phosphoric acid) was added, mixed and allowed to stand at room
temperature for 30 min. After this time the absorbance at 595 nm was
measured using an LKB Model 4050 Ultrospec II uv/visible specrophotometer.
If protein was present in low concentrations a micro bicinchoninic acid (BCA;
Pierce) protein assay was used (Smith et al., 1985). A standard curve was
established using 1-20 pg/ml bovine serum albumin (BSA). To each aliquot
(50 pi BSA solution or sample) 1 ml Micro BCA Reagent was added, mixed
and allowed to incubate at 60°C for 60 min. After this time the absorbance at
562 nm was measured. For plots of each assay absorbance versus known
protein concentration were fitted by linear regression analysis. Where
necessary the starting protein solutions were diluted to bring them within the
range of the standards.
2.3 Preparation of lysyl oxidase and TRAMP
2.3.1 Materials
Stillborn piglets were obtained from the Animal Breeding Research
Organisation, Dryden-Montmarle Field Laboratory, Roslin, Midlothian, U.K.
The skins were removed within 24h of death and stored at -20°C for up to one
week before use. CM-Sepharose Fast Flow, DEAE-Sepharose Fast Flow,
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Sephadex G-25 (medium grade), Sephacryl S-400, Mono Q HR5/5 and
ProRPC HR5/5 columns were purchased from Pharmacia Biotechnology Ltd.,
Milton Keynes, Bucks., U. K. p-aminopropionitrile, formate salt (pAPN) was
from Sigma Chemical Co. Ltd., Poole, Dorset, U.K. All other chemicals
(analytical grade) were from B.D.H., Merck Ltd., Poole, Dorset, U.K.
2.3.2 Deionisation of urea
All buffered urea solutions were prepared from fresh stock solutions of
8M urea which had been deionised at 4°C with BioRad AG 501-X8 mixed bed
resin immediately before use. The beads were removed from urea by filtration
through Whatman No. 113v filter paper.
2.3.3 Preparation of dialysis tubing
Approximately 2 m lengths of Visking cellulose tubing (BDH), were
boiled in 0.1% NaHC03 for 30 min, and washed in water before use. The
glassware used to contain the dialysis tubing was soaked in concentrated
HCI before use and then extensively washed with purified water (Section
2.8.10).
2.3.4 Extraction of lysyl oxidase and TRAMP
Piglet skin lysyl oxidase was prepared using a procedure similar to that
described by Shackleton and Hulmes (1990a) but with the following
modifications to improve separation, increase capacity, and reduce the time
required. Typically, skins from ten stillborn piglets were used (approximately 1
kg wet weight). All extraction and purification steps were carried out between
0 and 4°C. The skins were fed through a fine mincer before homogenisation
in phosphate buffered saline (PBS; 0.09M Na2HPC>4/0.01M NaH2PO4/0.15M
NaCI, pH 7.8), at 0.5 ml/g tissue, in a Waring Commercial Blender for 30s. The
volume of homogenate and buffer was sufficient to fill six 250 ml centrifuge
tubes. The homogenate was then centrifuged in a Beckman J2-21 centrifuge,
using a JA-14 fixed-angle rotor, at 12,400 g for 20 min, and the supernatant
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was discarded. This extraction was repeated twice. The pellet was then
washed three times in phosphate buffer (PB; 9mM Na2HPC>4/1mM Nah^PC^,
pH 7.8) at 0.5 ml/g, with homogenisation and centrifugation as above. The
pellet was then extracted four times in 6M PBU (PB containing 6M urea, pH
7.8) at 0.5 ml/g of original material, for 8-18h intervals, and centrifuged as
above. The four supernatants were pooled after recording their volumes. This
supernatant extract (E) was first filtered through a Whatman No.113v folded
filter paper (32 cm diameter) followed by filtration through a Whatman 3MM
filter paper (15 cm diameter), using a Buchner funnel and flask, before the first
chromatography step (Fig. 3.1).
2.3.5 Purification of lysyl oxidase and TRAMP from the extract by
large scale chromatography
The filtered extract (E) was diluted with PB to 2M PBU and loaded onto
a CM-Sepharose Fast Flow column (5 cm x 25 cm; volume = 500 ml),
previously equilibrated with 2M PBU, at a flow rate of 30 ml/min. The buffer
was applied to the column using a Watson-Marlow model 502S peristaltic
pump. This procedure bound and hence removed unwanted proteins. The
flow-through solution was then immediately applied to a DEAE-Sepharose
Fast Flow column (5 cm x 25 cm; volume = 500 ml), previously equilibrated
with 2M PBU, at a flow rate of 30 ml/min. The DEAE-Sepharose column was
then washed with two column volumes of 2M PBU, followed by two column
volumes of PB, and then most of the bound proteins (but not lysyl oxidase or
TRAMP) were eluted with PB containing 0.3M NaCI. Fractions were collected
in 50 ml tubes with the aid of a Central Ignition Company fraction collector.
Hereafter 1 ml aliquots from fractions eluting from this column were assayed
for absorbance at 280 nm using an LKB Ultrospec II Model 4050 uv/visible
spectrophotometer. To release bound proteins containing lysyl oxidase
activity but relatively uncontaminated with TRAMP, the column was eluted, at
30 ml/min, with 3M PBU containing 0.3M NaCI. A subsequent elution with 6M
PBU containing 0.5M NaCI released predominantly TRAMP. Lysyl oxidase
and TRAMP were further purified separately, as described below.
For further purification of lysyl oxidase, the 3M PBU/0.3M NaCI eluate
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from the DEAE-Sepharose column was passed through a Sephadex G-25
medium grade gel filtration column (5 cm x 100 cm, volume = 2 litre)
previously equilibrated with PB, at a flow rate of 40 ml/min to remove the urea
and salt. Afterwards 1 ml aliquots of the eluted fractions were measured for
absorbance at 280 nm. The protein peak was pooled and loaded onto a
Sephacryl S-400 column (5 cm x 20 cm; volume = 400 ml), previously
equilibrated with PB, at a flow rate of 15 ml/min. (Sephacryl S-400 was used
instead of Sephacryl S-200 (Shackleton and Hulmes, 1990a), with no
adverse effect on recovery of enzyme activity). The column was washed with
PB until a steady reading of absorbance at 280 nm was obtained. Finally,
bound proteins were eluted with 1.5M PBU, followed by 6M PBU. Lysyl
oxidase appeared in the 6M PBU eluate.
For further purification of TRAMP, the 6M PBU/0.5M NaCI eluate from
the DEAE-Sepharose column was used. Urea and NaCI were removed by gel
filtration, using the Sephadex G-25 column, and the protein solution in PB
was loaded onto the S-400 column as above. The column was washed with
PB, then bound proteins were eluted with 1.5M PBU, followed by 6M PBU.
TRAMP appeared in the 1.5M PBU eluate and a mixture of lysyl oxidase and
TRAMP was found in the 6M PBU eluate. After use all columns were stored in
20% ethanol.
(Note: The mechanism of the interaction between Sephacryl and lysyl
oxidase or TRAMP is not clear. It may be an electrostactic interaction due to
the relatively acidic nature of both proteins, or it may be due to the formation
of large molecular weight aggregates of these proteins in the absence of
urea, or a combination of both these effects).
2.4 Fast Protein Liquid Chromatography (FPLC) and High
Pressure Liquid Chromatography (HPLC)
2.4.1 Introduction
The techniques of FPLC and HPLC have been used extensivly to purify
mixtures of proteins and peptides. It was important to ensure that the columns
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used were cleaned before and after use. Prior to running any samples the
columns were equilibrated with the appropriate buffers. After this a blank run
followed by a standard run were made. Only if these runs were satisfactory
would a sample run be made. All digest procedures were carried out in the
absence of protein in parallel with normal digests. These digest blanks were
run on reverse phase columns prior to sample digests, which enabled clearer
interpretation of chromatograms. Individual components of a digest mixture,
e.g. clostripain, could be run separately to locate their retention positions and
thus ensure that they did not co-elute with peptides of interest.
Purified water and Applied Biosystems Incorporated (ABI) chemicals
were used to prepare solvents for the Applied Biosystems 130A Microbore
Separation System (Section 2.8.10). The quality of reagents required for
FPLC were not so stringent, so buffers were made up in double distilled water.
Before use these buffers were filtered through a cellulose acetate 0.22 pm
Millipore filter. After use anion exchange and chromatofocussing columns
were stored in 24% ethanol and reverse phase columns stored in methanol.
2.4.2 Separation of different variants of lysyl oxidase and TRAMP
by anion exchange chromatography
Partially purified lysyl oxidase was further purified by loading onto a
Pharmacia Mono Q HR5/5 anion exchange column (10 pm particle size; 5 mm
x 50 mm) previously equilibrated with 6M PBU. When a linear gradient from 0
to 1M NaCI in 6M PBU was applied, at a flow rate of 2 ml/min, four forms of
lysyl oxidase were isolated (Chapter 3). When TRAMP was treated in the
same way, five forms were isolated (Chapter 3).
2.4.3 Removal of urea from lysyl oxidase and TRAMP variants by
reverse phase chromatography
Two columns were employed for this procedure according to the
amount of protein present. For preparative amounts of protein a Pharmacia
ProRPC HR5/2 (C1/C8) reverse phase column (5 pm particle size; 5 mm x 20
mm) was used at a flow rate of 2ml/min. For analytical amounts the column of
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choice was an Applied Biosystems 130A Separation System containing an
Aquapore RP-300 C8 cartridge (7 pm particle size; 2.1 mm x 30 mm) at a flow
rate of 200 pl/min. In each case the columns were previously equilibrated with
solvent A (aqueous, 0.1% (v/v) trifluoroacetic acid (TFA)), and eluted with a
linear gradient from 0 to 70% solvent B (100% acetonitrile containing 0.08%
(v/v) TFA).
2.4.4 Separation of lysyl oxidase and TRAMP peptides by reverse
phase chromatography
For separations of lysyl oxidase and TRAMP peptides, the above
procedure (Section 2.4.3) with the Aquapore RP-300 C8 cartridge was
satisfactory. For improved resolution, however, a larger RP-300 C8 column (7
pm particle size; 1mm x 250 mm) was used at a flow rate of 100 pl/min, with
the same loading and similar elution conditions.
The standard protein mixture used to check resolution of each of these
columns contained the following proteins: insulin, cytochrome c, lactalbumin,
carbonic anhydrase, and ovalbumin (ABI).
2.4.5 Measurement of the elution pH of lysyl oxidase and TRAMP
by chromatofocussing chromatography
For chromatofocussing, samples (1ml) in 1M urea were loaded on to a
Pharmacia Mono P HR5/20 chromatofocussing column (10 pm particle size; 5
mm x 200 mm) previously equilibrated with 0.025M Bis-Tris, pH 4.70
(adjusted with HCI). A pH gradient was achieved by applying Pharmacia
Polybuffer 74, diluted 1:10 with water, pH 3.15, (adjusted with HCI), from a 50
ml "superloop". A flow rate of 1 ml/min was used, and absorbance was
monitored continuously at 280 nm. The elution pH of TRAMP was found
similarly but the pH values for the two buffers used were pH 3.65 and pH 2.60,
respectively. The pH of each 0.5 ml fraction was measured. The urea passed
straight through the column leaving the protein to be eluted at its elution pH
which is dependent on its isoelectric point (pi; Fagerstam et al., 1983).
After each run 1 ml 2M NaCI was injected onto the column to remove
42
any bound substances. The column was then re-equilibrated with start buffer
until the effluent had reached the correct pH.
Initially, in this study, a wide pH interval of 7-4 was chosen. It was
found, however, that TRAMP was still bound to the the column at pH 4.00 and
only eluted when the pH was dropped to 2.20. Gradually a narrow pH interval
was found in which the different forms of TRAMP were resolved. Care was
taken at all times to avoid reaching pH 2.00 whereby the stability of the
column would have been affected.
Before any samples were run the column performance was checked by
loading 25 pi 0.2 mg/ml triglycine (Sigma), using a mobile phase of 0.005M
NH4CI, pH 9.90, at a flow rate of 0.5 ml/min, monitoring at 214 nm
absorbance.
2.5 Electrophoresis
2.5.1 Sodium Dodecyl Sulphate-Polyacrylamide Gel
Electrophoresis (SDS-PAGE)
Discontinuous SDS-PAGE (modified from the method of Laemmli,
1970) was carried out in polyacrylamide gels, where %T = total acrylamide +
bis-acrylamide (g/100 ml) and %C = cross-linker (bis-acrylamide, g/100ml).
Two types of gel electrophoresis apparatus were used. The first type
was a Hoefer SE 280 Tall Mighty Small 12 cm vertical slab mini gel system.
The second type was a LKB large format 18 cm x 18 cm gel unit. The
composition of the gels in each case remained the same but the volumes
used were greater for the large format gels.
2.5.2 Gel composition
2.5.2.1 12% Separating gel
Separating gel buffer was prepared by dissolving 36.34 g Tris base
(BioRad) and 0.8 g SDS in distilled water adjusting pH to 8.8 (with HCI) and
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making up the volume to 200 ml. The solution was then filtered through a 0.2
pm Millipore filter, and was stored at 4°C. The acrylamide stock was prepared
by dissolving 30 g acrylamide (BioRad) and 0.8 g bis-acrylamide (BioRad)
and making the volume to 100 ml. This solution was filtered through a 0.22
pm filter and stored at 4°C in a dark bottle.
The 12% separating gel was prepared by mixing 1.50 ml separating
gel buffer, 2.40 ml acrylamide: bis-acrylamide stock, 2.07 ml distilled water, 3
pi TEMED (BioRad) and 100 pi 10% (w/v) ammonium persulphate. (The
ammonium persulphate was made up fresh and was added last.) The
volumes were scaled up seven times for the large format gels.
The percentage acrylamide composition of the separating gel was
varied from 10 to15% (%T = 10.027; %C= 0.027 to %T = 15.041; %C = 0.041)
with the higher percentage acrylamide used for the separation of low
molecular weight proteins.
2.5.2.2 Stacking gel
The stacking gel buffer was prepared by dissolving 12.11g Tris base
and 0.8g SDS in water and adjusting the pH to 6.8 with HCI, and making up
the volume to 100 ml. The solution was filtered through a 0.22 pm Millipore
filter and stored at 4°C.
The stacking gel was prepared by mixing 0.75 ml stacking gel buffer,
0.5 ml acrylamide: bis-acrylamide stock, 1.75 ml distilled water, 2 pi TEMED,
and 21 pi 10% (w/v) ammomium persulphate. The volumes were scaled up
seven times for the large format gels.
2.5.3 Sample preparation
Sample buffer was prepared by mixing 1.0 ml glycerol (BRL), 0.5 ml 2-
mercaptoethanol (Sigma), 0.3 g SDS, and 1.25 ml stacking gel buffer and
making the volume up to 10.0 ml with distilled water. One volume of each
protein sample was mixed with one volume of sample buffer. An aliquot of 2pl
5% bromophenol blue (Bio-Rad; dissolved in 50% methanol) was added to
each sample, and the mixture boiled at 100°C for 5min.
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Aliquots of 10jil of protein sample containing 2-20 (ig of protein were
loaded into each of the mini gel wells. Aliquots of 60 pi of each sample
containing 10-100 pg protein were loaded into each of the large format gel
wells.
2.5.4 Assembly of gel cassette and pouring of gels
Two gel plates were washed with methanol, dried then clamped
together separated by 0.75 mm or 1.5 mm thick teflon spacers. The bottom
edge of the gel was sealed by placing it upon a strip of molton 1% agar
(Sigma), poured out onto a horizontal glass plate. Once the agar had set,
12% separating gel solution was carefully poured between the glass plates
and overlaid with a water saturated butan-2-ol solution. Upon polymerising,
the butan-2-ol/water solution was washed away with several washes of
distilled water. The stacking gel solution was carefully poured into the
remaining space between the glass plates and a teflon comb inserted. After
polymerisation the teflon comb was removed and the cassette mounted onto
the lower gel tank reservoir section. The upper and lower reservoirs were
filled with electrophoresis buffer. This buffer comprised 3.0 g Tris, 14.4 g
glycine, and 1.0 g SDS per litre of distilled water. Treated proteins were
loaded into each of the wells. A solution of SDS-PAGE low molecular weight
markers, containing approximately 4 pg of each protein, were loaded into the
first and last of the sample wells each time. The large format gels used an
additional spacer, placed horizontally, instead of using agar.
The lid was placed on the gel tank and the mini gels were run with a
constant current of 25 mA for approximately 1.5h. In contrast, the large format
gels were run at a constant current of 40 mA for approximately 3h. When the
bromophenol blue dye-front had reached the base of the gel, the power
supply was switched off, the gel cassette was removed, taken apart and the
gel was placed in gel fixing solution (10% (v/v) acetic acid, 45% (v/v)
methanol). After fixing (15 min for mini-gels, 1h for large format gels), gels
were stained with Coomassie Blue, silver stain or Alcian Blue.
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2.5.5 Coomassie Brilliant Blue staining
The gels were stained with Coomasie Blue (0.02% (w/v) Coomassie
Brilliant Blue R-250 (BDH) in 7.0% (v/v) glacial acetic acid, 50% (v/v)
methanol) for 10 min in the case of the mini gels and for 2 hours in the case of
large gels. Each type of gel was destained overnight in several changes of
gel destaining solution (10% (v/v) glacial acetic acid, 10% (v/v) methanol;
Miller and Rhodes, 1982).
2.5.6 Silver staining
Some SDS-PAGE gels were silver stained (Wray et a/.,1981). Silver
stain is at least 50 times more sensitive than Coomassie Blue stain allowing
10 ng of protein to be detected. Gels to be stained were fixed and soaked in
three changes of 50% (v/v) methanol over a period of 3 hours to remove
glycine remaining from in the electrophoresis buffer. During this process gels
shrank to about one third of their original size and so were re-hydrated in two
changes of distilled water.
All glass containers were throughly washed with methanol prior to use
and were solely used for silver staining. Silver staining solution was prepared
by adding a solution of 0.4 g AgNOg (BDH) in 2 ml distilled water dropwise,
with continuous stirring, to a mixture of 21 ml 0.36% (w/v) NaOH and 1.4 ml
14.8M NH4OH, and then making up the volume to 100 ml with distilled water.
This solution was used within 5 min of preparation. The gel was stained at
room temperature in silver stain solution for 15 min with constant agitation.
The stain solution was then discarded and the gel washed for 5 min each in
four changes of distilled water. The gel was developed in a freshly prepared
solution containing 2.5 ml of 1% (w/v) citric acid and 250 pi 38% (v/v)
formaldehyde (BDH), made up to 500 ml with distilled water, for 10-15 min
with constant agitation, until brown stained bands were visible. The
development was stopped before the background became too intensly
stained by replacing this solution with a stop solution of 10% glacial acetic
acid in 50% (v/v) methanol. If the gel had been overstained it was destained
for 1 to 5 min. Destain solution was prepared as follows: 3.7 g NaCI and 3.7 g
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cupric sulphate were dissolved in 85 ml distilled water. A few drops of 14.8M
NH4OH were added until a deep blue colour was observed and the solution
was made up to 100 ml with distilled water. A second solution of 43.6 g
sodium thiosulphate (BDH) in 100 ml distilled water was then prepared and
mixed with an equal volume of the first solution to make destain. The reaction
was stopped with 10% acetic acid and the gel stored in water.
2.5.7 Alcian Blue staining
Alcian Blue stains sulphated polyanions. After electrophoresis gels
were fixed in 50% (v/v) methanol, 7% (v/v) acetic acid for 1h. The gels were
then washed in distilled water for 1h. This fixing step followed by washing was
repeated once in order to remove SDS from the gels. Stain precipitation can
occur in the staining solution or on the gel surface if SDS is not first removed.
The gels were stained overnight in 0.2% (v/v) Alcian Blue 8GX, 3% (v/v) acetic
acid, 0.05M MgC^. Gels were destained in several changes of 3% (v/v) acetic
acid, 0.05M MgCl2 until the background became clear. The MgCl2 was added
to the stain and destain solutions to eliminate background staining according
to the critical electrolyte concentration (Wall and Gyi, 1988).
2.5.8 Calibration of SDS-polyacrylamide gels
The molecular weights of the proteins separated on SDS-
polyacrylamide gels were determined by comparing their mobilities to those
of a set of low molecular weight markers (Pharmacia). The markers were
reconstituted in 200 pi of sample buffer and incubated at 100°C for 5 min
(Section 2.5.3). They were stored as 50 pi aliquots at -20°C.
The marker kit was composed of the following proteins: phosphorylase
b (Mr = 94.0K), albumin (Mr = 67.OK), ovalbumin (Mr = 45.0K), carbonic




After gels had been stained with Coomassie Brilliant Blue, the
migration distance of the bands and the relative amounts of protein were
quantifed by scanning densitometry with a Joyce Loebl Chromoscan 3 at 530
nm using an aperture width of 0.1 mm.
2.5.10 High voltage paper electrophoresis (HVPE)
High voltage paper electrophoresis (HVPE) was used to attempt to
identify suphotyrosine in alkaline hydrolysates of TRAMP (Section 3.3.8).
Aliquots (5 pi) of 1mg/ml standards and samples were loaded for each run.
Samples were applied to a Whatman 3MM filter paper (57 cm x 46 cm) and
dried. A 5 pi aliquot of methyl green was added to one side of the sample as a
positively charged marker for runs in pH 2.1 and pH 3.5 buffers so that
progress of the separation could be monitored during the run. Orange G was
used as a positively charged marker in the pH 6.5 buffer system. The
Whatman paper was wetted with a suitable buffer (see below), placed in a
Michl tank apparatus containing coolant, and a potential gradient of 3kV was
applied across the paper for 40 min (by M. Daniel, Institute of Cellular and
Molecular Biology, University of Edinburgh). Charged molecules migrate at a
rate approximately proportional to their charge to mass ratio (Ambler, 1963).
The buffers used had adequate buffering capacity and conductvity so
that the presence of the sample did not affect the pH or the potential gradient.
The buffers were completely volatile, so that no residue was left in the paper
to interfere with subsequent operations. The buffer systems used were as
follows:
(a) pH 2.1 (formic acid: acetic acid: water; 10: 35: 355; v/v) with white
spirit used as coolant.
(b) pH 3.5 (pyridine: acetic acid: water; 1:10: 89; v/v) with white spirit
used as coolant. The buffer was diluted to half strength for wetting
the paper.
(c) pH 6.5 (pyridine: acetic acid: water; 10: 1: 89; v/v) with toluene
containing 8%(v/v) pyridine as coolant.
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After electrophoresis, the paper was removed from the Michl tank and
allowed to dry in an oven at 40°C. The paper was then dipped in 0.2% (w/v)
ninhydrin in acetone to which 10 ml collidine: concentrated acetic acid (1: 2)
was added. The collidine helped to produce a stronger colour reaction. The
paper was then dried in air for 15 min before being placed in an oven at
100°C for 30s.
2.6 Amino acid analysis
2.6.1 Introduction
Pure proteins and peptides were subjected to amino acid analysis on
an Applied Biosystems Model 420A Derivatiser with automatic hydrolysis with
an on-line Model 120A phenylthiocyanate (PTC) analyser (Cronshaw et al.,
1993). Applied Biosystems chemicals and purified water were used
throughout this automated analysis procedure (Section 2.8.10). The amino
acid standard H (2.5 pmol/ml) was supplied by Pierce Chemicals.
2.6.2 Cleaning glassware
The successful operation of an ultrasensitive amino acid analyser
demands great care in sample and reagent preparation. Dust and contact
with fingers on glassware can introduce contamination and invalidate results.
Prior to use glassware was soaked overnight in a solution of Decon 90
and rinsed thoroughly in hot, cold and then distilled water. The glassware was
then rinsed in 34.8 g/l IS^EDTA solution followed by rinsing three washes
with purified water (Section 2.8.10). The glassware was covered with cling
film when stored. Magnetic stirring bars were cleaned similarly. Separate
dedicated glassware was used to prepare each of the buffers. Microcentrifuge
tubes were rinsed twice before use with two washes of purified water.
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2.6.3 Sample preparation
Proteins and peptides which had been desalted by reverse phase
chromatography were loaded onto scintered glass frits within a glass slide.
Samples in the range of 200 pmol to 1 nmol of each amino acid were loaded.
In some cases samples were hydrolysed manually and then loaded onto the
analyser.
2.6.4 Manual hydrolysis
The samples were placed into the bottom of pyrolysed Pyrex test tubes
(6 mm x 50 mm), in a total volume of 200pl 6M HCI (Pierce Sequanol grade).
Then 500pl 6M HCI was placed at the bottom of a 25 ml borosilicate glass vial
(27 mm x 70 mm; Pierce), and the sample tubes were placed in the vial and
flushed with argon before being sealed with a black phenolic cap (size 24-
240) lined with a "Tuf-Bond" teflon/silicone septum, teflon side down.
The vial was then placed in an oven at 110°C for 22h. After manual
hydrolysis residual acid and condensation were removed by placing the
sample tubes into a small vacuum desiccator containing NaOH pellets for 2h.
The samples were then redissolved in 0.025% K3EDTA prior to amino acid
analysis (Dupont et a/., 1988).
2.6.5 Slide cleaning
New slides required preconditioning before use. This was achieved by
loading 30 pi of 1 mg/ml K3EDTA (ABI) solution onto each frit and running a
precycle procedure. After this 5 pi (50 pmol) hydrolysis standard H was run on
each frit, followed by 5 pi (500 pmol) test peptide (ABI), a peptide containing
equal amounts of each standard amino acid. Once these frits were within the




The jaws of the hydrolysis head, top and bottom, closed around the
three frits on a slide, and created a chamber around the sample which was
deoxygenated by flushing with argon. The hydrolysis head allowed hydrolysis
on the three frits simultaneously by delivering and heating 6M HCI to 200°C
for 75 min. After hydrolysis the temperature of the head was decreased to
170°C. The lower internal vapour pressure facilitated the opening of the jaws.
The slide was then rotated on the turntable to face the derivatiser head.
2.6.7 Automatic derivatisation
Once the sample had been hydrolysed, it was derivatised. Since free
amino acids do not have a strong common spectral characteristic, they must
be tagged with a reagent which will increase their detectability and make
quantitation possible. The derivatisation process used in the amino acid
analyser is the same as the first step of the Edman degradation used in the
microsequencer. During precolumn derivatisation the free amino groups,
either primary or secondary, are exposed to phenylisothiocyanate (PITC)
under alkaline conditions, in the presence of diisopropylethylamine (DIEA),
where they react quantitativly to form the phenylthiocarbamyl amino acid
derivatives (PTC-AAs). The PTC-AA derivatives have a strong UV absorbance
at 254 nm which allows picomolar detection of all amino acids. The
derivatiser head has a single set of jaws, top and bottom, which unlike the
hydrolysis head is free to move backwards and forwards into the A, B, and C
frit positions sequentially. The jaws close around the sample frit and create an
airtight chamber which is deoxygenated by the passage of argon.
Prior to derivatisation, each frit was washed with methanol containing
20 |ig/ml K3EDTA to remove any metal ions which could have interfered with
the reaction, and also to dry the sample. The airtight chamber was then
flushed with diisopropylethylamine (DIEA) vapour to both neutralise any acid
in the sample and to facilitate coupling. Following these initial steps 5% (w/v)
PITC in heptane was delivered, followed by argon to evaporate most of the
heptane. A second DIEA delivery occurred to increase the polarity of the
reaction solution and to improve the coupling yields of the polar amino acids.
DIEA saturated the derivatisation chamber. Coupling proceeded for 20 min at
room temperature. The derivatised sample was then flushed with argon to
remove most of the volatile portion of the reaction mixture. The PTC-AAs were
extracted from the frit and transferred to the the transfer flask in two washings
(one of 200 pi and one of 400 pi) of 0.029M sodium acetate, pH 5.00 transfer
buffer. The use of aqueous buffers allowed selective extraction of the PTC-
AAs, and left most of the reaction by-products behind on the frit. An argon
delivery mixed the contents of the flask and then transferred the PTC-AAs to
the on-line 120A PTC analyser. The entire derivatisation system was then
cleaned three times with methanol, and argon dried ready for the next
sample.
2.6.8 HPLC separation of PTC-amino acids
The PTC-amino acids were separated on an Applied Biosystems PTC
C-18 column (5 pm particle size, 2.1 mm x 220 mm), at a flow rate of 300
pl/min at 38°C (Heinrikson and Meredith, 1984). The column was previously
equilibrated with buffer A (3% (v/v) acetonitrile in 50mM sodium acetate, pH
5.40) and elution was by a gradient with 2% to 64% buffer B (70% acetonitrile
in 32 mM sodium acetate, pH 6.10) over 18.8 min, then 64% to 100% buffer B
over 5 min. The eluent was monitored at 254 nm. The loop size of the
automatic injector was 200 pi, filled from 600 pi in the transfer flask. A
standard chromatogram is shown in Fig. 2.1.
2.6.9 Difficult amino acids
Under normal hydrolysis conditions serine shows a 10-20% loss and
threonine a 5-15% loss. These residues can be quantitated accurately by
carrying out a time course of hydrolysis. Values for threonine and serine were
therefore found by plotting the time course values (for 30, 60, and 90 min
hydrolysis time) and extrapolating back to time zero.
Leucine, isoleucine and valine, when together in any combination,




Fig. 2.1. HPLC separation of PTC-amino acids
A 50 pmol standard of 17 PTC-amino acids was separated on an Applied Biosystems
PTC C-18 column (5 pm particle size; 2.1 mm x 200 mm) at a flow rate of 300 ml/min at 38°C. The
column was previously equilibrated with buffer A (3% (v/v) acetonitrile in 50 mM sodium acetate,
pH 5.40) and elution was by a gradient with 2% to 64% buffer B (70% acetonitrile in 32 mM
sodium acetate, pH 6.10) over 18.8 min, then 64% to 100% buffer B over 5 min.
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hydrophobic side chains prevents acid getting close to the bonds. The values
for these residues were found by plotting the time course values and taking
the values from the plateau region of maximum recovery.
It is not possible to prevent the hydrolysis of asparagine and glutamine
to aspartate and glutamate respectively. Tryptophan is also completely lost on
hydrolysis. The only sure way to determine amounts of these amino acids is
by sequencing.
If lysine residues became carbamylated, in the presence of urea, they
would form homocitruline which would be converted to lysine under acid
hydrolysis. It is not possible to detect homocitruline by sequencing because of
the contact with acid in the Edman degradation.
2.6.10 Pyridylethylation of cysteine residues
Cysteine is not recovered in quantitative amounts after amino acid
analysis, so it is necessary to modify this residue, prior to hydrolysis, to a more
stable form. Two types of methodology for determining cysteine residues were
tried.
2.6.10.1 Solution phase pyridylethylation
The protein samples were dissolved in 250 pi 6M guanidine-HCI
(Sigma) buffered with 0.25M Tris-HCI pH 8.5, containing 1mM EDTA. Then 10
pi 10% dithiothreitol (Sigma) was added and the solution allowed to incubate
in the dark under argon at room temperature for 2h. After this time, 8 pi of
undiluted 4-vinylpyridine (Aldrich) was added and the mixture incubated as
above for a further 2h (Dupont etal., 1987; Hawke and Yuan, 1987). Samples
were then desalted on an Aquapore RP-300 C8 cartridge (7 pm particle size;
2.1mm x 30 mm) using an Applied Biosystems 130 Microbore Separation
System as described previously (Section 2.4.3). It was observed that some of
the reduced protein was retained by the cartridge and continued to elute in
successive runs.
54
2.6.10.2 Vapour phase pyridylethylation
This method was found to be a simpler procedure and was preferred to
the solution phase method (Amons, 1987). It also had the advantage that less
pure reagents could be used as any contaminants would stay in solution. The
protein after collection from a reverse phase column was dried down in a
Pyrex sample tube (6 mm x 50 mm) using a Savant Speed Vac concentrator.
The glass tubes had been cleaned (Section 2.6.2) and then pyrolysed at
500°C for 5h before use.
The pyridylethylation reaction was carried out in a 25 ml borosilicate
glass vial (27 mm x 70 mm), containing 200 pi pyridine, 200 pi water, 40 pi 4-
vinyl pyridine (Aldrich), and 40 pi tributylphosphine. After flushing with argon,
the vials were sealed with PTFE/silicone sceptum, and then incubated at
60°C for 4h. The samples were then redissolved in 0.1% TFA and hydrolysed
automatically on the Applied Biosystems 420A Amino Acid Analyser or
hydrolysed manually at 110°C for 22h. After manual hydrolysis, residual acid
and condensation were removed by placing the sample tubes into a small
vacuum desiccator containing pellets of NaOH for 2 h. The samples were then
redissolved in 0.025% K3EDTA prior to amino acid analysis (Cronshaw et
ai, 1993).
2.6.11 Quantities of proteins analysed
It was possible to purify TRAMP in large quantities. Protein
concentrations that gave between 0.5 to 1.0 nmol of each amino acid, which
was a generous loading, were analysed on a single frit. In the case of lysyl
oxidase, which was a less stable protein, between 200 to 500 pmols of each
amino acid were analysed on a single frit.
2.6.12 Calculation of amino acid compositions
To obtain higly accurate amino acid analyses, samples were analysed
automatically at three hydrolysis times of 30, 60, and 90 min, and in triplicate.
Threonine and serine values were found by extrapolating back to hydrolysis
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time zero. Leucine, isoleucine, and valine values were found by plotting the
time course values on graph paper and using the values found in the plateau
region. Cysteine values were obtained by coverting cysteine to PE-cysteine in
a vapour phase reaction. The values found were normalised (Ambler, 1981)
to a given value for alanine. In the case of lysyl oxidase and TRAMP, alanine =
16 and 7 respectively.
2.7 Cleavage methods
2.7.1 Chemical unblocking of N-terminal pyroglutamate
Approximately 1 nmol of the TRAMP variant T3 was dissolved in 17%
methylamine (Sigma) in a glass vial and incubated for 17h at 37°C
(Muranova and Muranov, 1979). The methylamine was removed by desalting
through an Aquapore RP-300 cartridge C8 (Section 2.4.3). The sample was
then dried onto a glassfibre filter and placed into the sequencer. This
procedure failed to unblock the sample, so the glassfibre filter was removed
from the sequencer and exposed to 3M HCI vapour at 100°C in a special
stoppered glass tube (50 mm x 10 mm), with a constriction in the middle to
support the disc, for 15 min (Tsung and Fraenkel-Conrat, 1965). The filter was
then replaced in the sequencer and the N-terminal sequence was found.
Neither procedure on its own unblocked T3 but the combination of the two
methods described above was successful.
2.7.2 Chemical unblocking of N-termini blocked with N-formyl
groups
It was possible that lysyl oxidase may have been blocked by N-terminal
formylation. To examine this possibility, two methods were used. In the first
method approximately 200 pmol of the lysyl oxidase variant L3 was dissolved
in 0.5M HCI in methanol and left at room temperature for 48h (Sheehan and
Yang, 1957). The sample was dried and redissolved in 0.1% aq. (v/v)
trifluroacetic acid and loaded onto the sequencer. This procedure failed to
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unblock the sample. In the second method, approximately 200 pmol of L3 was
loaded onto a glassfibre filter and exposed to 3M HCI at 100°C in the vapour
phase, in a borosilicate glass vial (27 mm x 70 mm), for 15 min (Tsung and
Fraenkel-Conrat, 1965). This method also failed to unblock the sample.
2.7.3 Pyroglutamate aminopeptidase digestion
The N-terminally blocked TRAMP variant T3 was dissolved in 240 pi
buffer containing freshly prepared 0.2M NH4HCO3 (Sigma), 5% glycerol
(BRL), 5mM EDTA (BDH) and 5mM DTT (Sigma) pH 8.0. Pyroglutamate
aminopeptidase from calf liver (5-oxoprolylpeptidase, E.C.3.4.19.3; Sigma), 3
units/50 pi buffer, was added to the solution to give a final volume of 250 pi.
The reaction mixture was incubated overnight at 37°C (Podell and Abraham,
1978). Desalting was accomplished by loading 200 pi of the sample onto an
Aquapore RP-300 C8 cartridge (Section 2.4.3). The reduced, unblocked
sample was found to be more hydrophobic than the unreduced, blocked
sample as it eluted later from the reverse phase column.
2.7.4 Cyanogen bromide cleavage
Cyanogen bromide is capable of cleaving thioethers, and the
stereochemistry of the methionine residue is such that proteins are cleaved
specifically on the C-terminal side of methionine residues (Gross and Witkop,
1962).
An aliquot of 25 pi of a concentrated protein solution (0.1-1.0 mg/ml)
was placed in a microcentrifuge tube. To this 175 pi 70% (v/v) formic acid
(Sigma) was added. Working in a fume cupboard, 10 mg of CNBr was added
next. The tube was covered in foil and left at room temperature for 24h. After
this time 200 pi of water was added to improve the drying characteristics. The
sample was dried in a Savant Speed Vac vacuum concentrator. Some 2M
NaOH was placed in the cold trap to absorb any HCN present, as the NaCN
formed would be less volatile. The dry sample was stored at -20°C. The
sample then was redissolved in 250 pi 6M urea, 10mM phosphate, pH 7.8
immediately prior to running on the reverse phase column (Section 2.4.4).
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2.7.5 Succinylation and clostripain digestion
Clostripain cleaves on the C-terminal side of arginine residues, and to
a lesser extent on the C-teminal side of lysines. The latter reaction can be
eliminated by succinylation of the lysine residues (Mitchell, 1977).
2.7.5.1 Succinylation
A 0.1 ml aliquot of a concentrated protein solution (0.1-1.0 mg/ml) was
mixed with 0.1 ml of 2M Tris base in a microcentrifuge tube. A small amount of
solid succinic anhydride (Sigma) was added every 30 min. The tubes were
left at room temperature, with occasional mixing, for 4h. The succinylated
protein was then dialysed against 1% NH4HCO3 (Sigma) for 4h with several
changes (Butler et ai, 1969).
2.7.5.2 Clostripain digestion
Clostripain, from Clostridium histolyticum (Clostridiopeptidase B,
E.C.3.4.22.8; Sigma) was first activated by preincubating the enzyme at a
concentration of 2 mg/ml in 1mM calcium acetate (Sigma), 2mM dithiothretol
(DTT; Sigma), overnight at 4°C. A 400 pi aliquot of the dialysed succinylated
protein was placed in a microcentrifuge tube. (The volume increased on
dialysis.) To this, 40 pi of freshly prepared 75mM DTT solution was added.
After mixing, activated clostripain (5pl, or about 0.01 mg of clostripain) was
added and the tube was placed in a water bath at 37°C for 4h. The sample
was then stored at -20°C prior to running on a reverse phase column (Section
2.4.4).
2.7.6 Performic acid oxidation, protease V8 and endoproteinse-
Asp-N digestion
Protease V8 essentially cleaves on the C-terminal side of glutamic acid
when digestion is carried out in ammonium bicarbonate buffer. When
digestion is carried out in sodium or potassium phosphate both glutamyl and
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aspartyl bonds are cleaved. The reason for this buffer-dependent specificty is
not clear (Houmard and Drapeau, 1972; Drapeau, 1977).
Endoproteinase-asp-N cleaves on the N-terminal side of aspartic and
cysteic acid residues (Drapeau, 1980; Guild and Strominger, 1984).
The sample was initially oxidised with performic acid to break any
cystine cross-links, as treatment of unoxidised TRAMP with protease V8 and
endoproteinase-Asp-N yielded no peptides. The disadvantage of this drastic
treatment, in terms of sequencing, is that cystine (and cysteine) become
converted to cysteic acid which produces a blank cycle on the sequencer.
Also, methionine is converted to methionine sulphone, but this can be
detected on the sequencer eluting after DMPTU (Fig. 2.2).
2.7.6.1 Performic acid oxidation
Performic acid solution was prepared by adding 25 pi 30% (v/v) H2O2
(BDH) to 475 pi formic acid (Sigma) in a microcentrifuge tube at 4°C for 2h.
The mixture was incubated at room temperature for 2h, followed by 30 min at
4°C (Hirs, 1967). TRAMP variant T3 was dissolved in 50 pi formic acid, cooled
to 4°C and 100 pi ice cool performic acid solution added. The sample was
incubated at 4°C for 2h. The acid was then diluted by the addition of 350 pi
H2O and the sample was dried in a Savant Speed Vac vacuum concentrator.
2.7.6.2 Protease V8 digestion
The oxidised sample was dissolved in 250 pi 100mM NH4HCO3
(Sigma) containing 2mM EDTA (BDH), pH 7.8. To this, 50 pi of protease V8,
type XVII-B from Staphlococcus aureus strain V8, (Endoproteinase Glu-C,
E.C.3.4.21.19; Sigma) 3 units/50 pi buffer, was added to this solution. The
sample was incubated at 37°C for 5h. After this time the mixture was freeze
dried. The digest was redissolved in 250 pi 6M urea containing 10mM




The oxidised sample was dissolved in 250 pi 100 mM NH4COOH
(Sigma), pH 8.5. To this, 5 pi endoproteinase-Asp-N, Type XXXII from
Pseudomonas fragi mutant (Sigma), 0.1 pg/5 pi buffer, was added. The
sample was incubated at 37°C for 2h. After this time the mixture was freeze
dried. The digest was redissolved in 250 pi 6M urea containing 10mM
phosphate, pH 7.8 and 200 pi loaded onto an Aquapore RP-300 C8 column
(Section 2.4.3).
2.8 Amino acid sequencing
2.8.1 Introduction
The pure peptides, in the range of 10 pmol to 2 nmol, were subject to
automated sequencing on an Applied Biosystems Model 477A
Microsequencer with a Model 120A on-line phenylthiohydantoin (PTH)
analyser (Hayes et al., 1989). Applied Biosystems chemicals were used
throughout this automated analysis procedure (Section 2.8.10).
2.8.2 Sample preparation
Peptides generated by the various digests were separated by reverse
phase chromatography using an Applied Biosystems Model 130A Microbore
Separation System (Section 2.4.4). At this stage each peptide was
pyridylethylated. This is necessary because during Edman degradation
unmodified cysteine produces inconsistent results unless the reactive thiol
group is chemically modified. Cysteine and cystine would otherwise produce
two peaks which would elute in different places and the sequencer HPLC
system is not optimised to detect these peaks. The sequencer HPLC system is
optimised to detect the pyridylethylated derivative of the reduced form.
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2.8.3 Vapour phase pyridylethylation of cysteine residues
All peptides were pyridylethylated prior to sequencing (Amons, 1987).
The peptides were spotted onto a glassfibre filter disc and dried under a
stream of nitrogen. The pyridylethylation reaction was done in a special
stoppered glass tube (50 mm x 10 mm) with a constriction in the middle to
support the disc. The following components, 100 pi pyridine (Sigma), 100 pi
water, 20 pi 4-vinylpyridine (Aldrich) and 20 pi tributylphosphine (Sigma)
were placed in the lower part of the tube. The peptide coated disc was then
placed on the constriction and the tube was flushed thoroughly with argon
before sealing quickly with a stopper. The vapour phase reaction was carried
out at 60°C for 2h. Subsequently the disc was removed from the tube,
avoiding touching any liquid, and washed for 10s in glass beakers containing
2 ml of each of the following solvents: n-heptane, n-heptane: ethyl acetate
(1:1, v/v), and then ethyl acetate. The disc was then allowed to dry in air.
The disc was then wetted with 30 pi (2 mg) polybrene, a polyanion
which enables the protein or peptide to bind to the disc, dried under a stream
of nitrogen, and placed in the cartridge block of the Applied Biosystems Model
477A Microsequencer. To remove all traces of reagent, the sample was
precycled with a wash progam (n-heptane followed by butyl chloride, 12.5%
trimethylamine in water, n-heptane and ethyl acetate) before beginning the
normal sequencing program. The PTH-PE-Cys derivative is resolved with the
standard separation protocol used by the on-line Model 120A PTH analyser
and usually elutes after PTH-Pro (Hayes etal., 1989).
2.8.4 Edman degradation
The peptide loaded into the reaction cartridge was first flushed with
12% trimethylamine (TMA) to provide an alkaline environment. Then 5%
phenylisothiocyanate (PITC) in heptane was delivered, followed by argon to
evaporate off most of the heptane. This process was repeated three times.
Coupling takes place in alkaline conditions whereby the PITC is coupled to
the free uncharged N-terminal amino group of the peptide (Edman, 1967).
Coupling proceeded at 48°C for 25 min. After coupling the filter disc was
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washed with n-heptane followed by ethyl acetate.
Cleavage occurred by the delivery of 100% trifluoroacetic acid (TFA) to
the sample. Cleavage yielded an anilinothiazolinone (ATZ) amino acid
residue and a new N-terminal amino acid which could be coupled again. The
sample was rinsed with ethyl acetate, soaked in n-heptane and the ATZ
residue transferred with n-butyl chloride to an adjacent conversion flask.
The ATZ residue is unstable and cannot be easily identified. Therefore
it was converted to the more stable phenylthiohydantoin (PTH) amino acid
residue. Inside the conversion flask the ATZ residue was reacted with 25%
TFA at 64°C to form the PTH-residue. The sample was taken to dryness with
argon before it was redissolved in 20% acetonitrile prior to being transferred
from the conversion flask to the on-line Model 120A PTH Analyser. The
transfer flask was then cleaned with 20% acetonitrile, and argon dried ready
for the next cycle.
2.8.5 HPLC separation of PTH-amino acids
After Edman degradation, the PTH-residues were separated on an
Applied Biosystems PTH C-18 column (5 pm particle size; 2.1 mm x 220 mm)
that was eluted with a 13 to 38% gradient of solvent B for 21 min followed by
an isocratic elution of 38% solvent B for 7 min. Solvent A was a 1 litre aq. 5%
(v/v) solution of tetrahydrofuran containing 14 ml 3M sodium acetate buffer,
pH 3.8; 5.5 ml 3M sodium acetate buffer, pH 4.6; 200 pi 12.5% trimethylamine
(TMA) and 35 pi acetone. Solvent B was 1 litre 100% acetonitrile containing
500 nmoles DMPTU. Chromatography was performed at 55°C using a flow
rate of 210 pl/min. The eluent was monitored at 269 nm. The loop of the
automatic injector was 75 pi, which was filled from 150 pi in the conversion
flask. A standard chromatogram is shown in Fig. 2.2.
2.8.6 B-Lactoglobulin-A, standard analysis
A standard of 100 pmol 6-lactoglobulin-A (ABI) was run every 3-4
months on the ABI 477A Microsequencer as a quality control test. The







Fig. 2.2. HPLC separation of PTH-amino acids
A 75 pmol standard of 20 PTH-amino acids was separated on an Applied Biosystems
PTH C-18 column (5pm particle size; 2.1 mm x 220 mm) at a flow rate of 210 pl/min at 55°C. The
column was eluted with a 13 to 38% gradient of solvent B for 21 min followed by an isocratic
elution of 38% solvent B for 7 min, with solvent A (aq. 5% (v/v) solution of tetrahydrofuran
containing 14 mi 3M sodium acetate, pH 3.8; 5.5 mi 3M sodium acetate, pH 4.6; 200pl 12.5%
TMA and 35 pi acetone) and solvent B (100% acetonitrile containing 500 nmol
dimethylphenylthiourea (DMPTU)). Methionine sulphone (MSO2) was found to elute between
(DMPTU) and H, succinyllysine was found to elute between DMPTU and MS02.
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L, I, V, T, Q, K, and G occur more than once, which enabled their individual
repetitive yields, and hence a combined repetitive yield to be calculated.
Repetitve yield is a measure of the efficiency of Edman degradation and is
defined as:
Repetitive Yield = (Yn/Ym) 1/n"m x100
where Ym = yield at cycle m, and Yn = yield at a later cycle. The repetitive
yield is best calculated between pairs of the same amino acids occurring at
different positions. Combined repetitive yields calculated as the mean of the
individual repetitive yields of approximately 93% were regarded as
satisfactory for the successful operation of the sequencer.
2.8.7 Artefacts of Edman chemistry
The Edman reagent PITC readily reacts not only with a-amino groups
in proteins, but with a wide variety of amino groups on other molecules. Some
of these molecules are routinely present during protein sequencing, and
several artefacts are usually observed on the HPLC chromatograms.
The most abundant artefact is diphenylthiourea (DPTU) which is
formed from aniline and PITC. The aniline is derived from PITC in the
presence of water and ammonia. Another artefact is dimethylphenylthiourea
(DMPTU) which is derived from the reaction of PITC and dimethylamine.
Dimethylamine gradually forms from trimethylamine (TMA) and for this reason
TMA must be carefully stored and regularly replaced on the sequencer. A third
artefact, diphenylurea (DPU) forms from diphenylthiourea in the presence of
oxygen. DPTU and DMPTU are well resolved from the PTH-amino acids.
However DPU is more of a problem because it co-elutes with PTH-Trp (Fig.
2.2).
2.8.8 Difficult sequences
The most common problem is probably with sequences containing
proline residues. Proline differs from all other amino acids in having a side
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chain that is sterically constrained into a covalent pyrridinoline ring, with the
result that longer treatment with TFA is required to achieve complete cleavage
at the cleavage step. Thus, during Edman degradation with standard
conditions, every time a proline is encountered, the yield drops and a
substantial amount of proline is detected in the next cycle. This out-of-phase
sequencing persists, so that two sequences are obtained one residue out of
step. If a second proline is found the problem becomes worse. Where a
proline residue might be expected a special Pro cycle may be set with a
longer cleavage time. This cycle cannot be used routinely as long cleavage
times would cause loss of other residues such as Ser, Thr, and Trp.
Another problem is the recovery of the labile amino acids, Ser, Thr, and
Trp. The PTH derivatives of these amino acids are very difficult to recover in
high yield, particularly if the amount of peptide available is low.
2.8.9 Interpretation of sequence data
The traditional and still most important way of interpreting
chromatograms generated by the PTH-analyser is by the eye of an
experienced research worker. This is usually done by inspecting a series of
cycles and looking for peaks which have increased in one cycle and
decreased in the next. The sophisticated software in the computer in the 477A
Microsequencer enables this analysis to be worked out automatically and
printed out the sequence at the end of each run. This information was useful
but manual checks of the calibration and subsequent data were absolutely
essential.
2.8.10 Reagent quality
Applied Biosystems chemicals were used throughout the automatic
amino acid analysis, amino acid sequencing and microbore HPLC
procedures. A very high level of reagent purity was required in order to
achieve high repetitive yields and high quality chromatograms. The reagents
were supplied, sealed under argon, after filtration through a 0.22 pm filter.
The double distilled water used for preparing buffers for the amino acid
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analyser and microbore HPLC was further purified using an Elga Elgastat
UHQ water purification system. The quality of water was very important for
amino acid analysis because of the high sensitivity of the instrument. Metal
ion contamination in the water could cause the standard PTH-chromatogram
to become distorted.
2.9 Plasma desorption mass spectrometry (PDMS)
2.9.1 Introduction
Pure peptides collected after purification by reverse phase
chromatography were subject to mass analysis using an Applied Biosystems
Biolon 20 Mass Analyser. Several peptides were found by reverse phase
chromatography of protein digests. To facilitate sequence analysis of the
peptides, preliminary mass analysis was a useful step as the sequencer
could be used more efficiently by optimising the number of cycles.
Furthermore, if the initial protein sequence was known a series of mass
values for the peptides could be fitted to the sequence to find the peptide of
interest. The mass range measured by this instrument is from approximately
0.2K to 30K.
2.9.2 Mechanism of mass measurement using the Biolon 20 mass
analyser
The Biolon 20 utilises a time-of-flight separation system. A 10 pCi
Californium-252 (252 Qf) SOurce was positioned behind the sample foil. The
252 Cf produces two fission fragments. One hits the start detector and triggers
the time measurement. The other penetrates the sample foil and causes
desorption of a number of secondary ions. These ions are accelerated
between the foil (at a potential of 10-20 kV) and a grid (at ground potential).
After the grid, the ions are allowed to drift in a field-free region (the flight tube)
to the stop detector. The flight times are measured by the time-to-digital
convertor (TDC). As each fission event only results in the recording of a few
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ions, it is necessary to accumulate a large number of spectra. For peptides, it
is necessary to record 5 x 10 5 fission events which takes 5 to 10 minutes. The
flight time (T) is proportional to the mass of the ion (m) and inversely
proportional to the charge of the ion (z; Macfarlane, 1990).
2.9.3 Sample preparation
Volumes of 5 to 10 pi of sample (approximately 100 pmol) from a
reverse phase column were applied to a nitrocellulose-covered target. The
target was spun dry to produce a monolayer of sample. The sample was then
rinsed with 5 to 100 pi of purified water. If the sample had been supplied dry in
a microcentrifuge tube it was dissolved in 30% (v/v) acetic acid prior to
loading onto the target.
The target was then loaded into the target holder, and this was placed
into an evacuation chamber inside the instrument. The target was then
positioned and aligned with the Californium-252 source. The limits for
detection are normally approximately 20 pmoles for peptides and
approximately 1 nmole for proteins, although it may be possible to use less
material (Nielsen etal., 1988).
2.9.4 Calibration of the Biolon 20 mass analyser
Three peaks in the low mass region, H+, Na+, and NO+, were used to
calibrate the spectra. Interpretation of the plasma desorption mass
spectrometer (PDMS) spectrum is usually straight forward. For small peptides
(below Mr = 2,000) usually only the molecular ion (MH+) is observed. For
higher masses doubly charged ions (MH22+) are seen and as the mass
increases further, triply and higher charged species are generated. As the
mass increases, the intensity between the different charged states also




If several peptides from a peptide digest are loaded onto one target
and analysed on the PDMS, supression effects are observed, with perhaps
only one peptide appearing on the spectrum. This effect is probably due to
differences in hydrophobicity of different peptide components (P. Hojrup,
personal communication).
PDMS analysis is not quantitative because some peptides are more
readily emitted from the target than others. The precision of the PDMS is
usually ± 0.1% for peptides but is sample and operator dependent. The error
is around 1% when measuring proteins in the 20 to 30K region, where the
instrument is working near its limit.
2.10 Matrix-assisted laser desorption mass spectroscopy (LDMS)
2.10.1 Introduction
Precise mass determinations were made with a laser desorption ion
source coupled to a time-of-flight mass analyser (Lasermat, Finnigan MAT
Ltd., Hemel Hempstead, U.K.). The mass range measured by this instrument
is from 0.5K to 200K.
2.10.2 Mechanism of mass measurement using the Lasermat
mass analyser
The Lasermat mass analyser consists of a laser desorption ion source
coupled to a time-of-flight mass analyser. Light from a pulsed N2 laser (337
nm) is focussed on to the sample target using a single fused silica lens of 50
mm focal length. The power density is adjusted to around 106 W/cm2. Each
pulse of desorbed ions is accelerated to 20 keV energy and directed by a
cylindrical extraction lens along the axis of a 0.5 m drift tube to an electron
multiplier. The digitised detector signal is then transferred to a personal
computer for storage and report generation.
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Spectra from multiple laser shots were averaged to improve the signal
to noise ratio. All the spectra reported here were obtained in the positive ion
mode. Negative (de-protonated) ions are also produced by the ionisation
process, but for the majority of biological samples the positive ion spectra are
generally more intense (Karas etal., 1987).
2.10.3 Sample preparation
Samples (0.1-0.2 jil, approximately 6 to 10 pmol) were mixed with a 0.5
pi droplet of protein matrix (approximately 50mM sinnapinic acid in 30% (v/v)
0.1%TFA, 70% acetonitrile), in the centre of a stainless steel target and the
droplet allowed to dry before introduction into the Lasermat instrument
(Hillenkamp and Karas, 1990). The matrix is necessary to retain some of the
protein sample in solution. Absence of matrix would lead to the protein being
irreversibly adsorbed to the target surface. For the study of peptides, a-cyano-
4-hydroxycinnamic acid was used in preference to sinnapinic acid as it
showed fewer matrix interference peaks in the lower mass region of the
spectra (Beavis etal., 1992).
2.10.4 Calibration of the Lasermat mass analyser
Samples of lysyl oxidase and TRAMP variants were calibrated using
carbonic anhydrase (Mr= 29,024) as external standard. A sample of carbonic
anhydrase was run on a sample slide and its calibration constants (required
for converting time to mass), were stored and used for subsequent sample
analysis (Karas and Hillenkamp, 1988). Small molecular weight peptides
need a separate calibration. Substance P (synthetic porcine; Mr = 1,347.7)
and renin substrate (porcine; Mr = 1,759) were used as external standards to
measure the masses of lysyl oxidase CNBr and endoproteinase Asp-N
peptides.
Molecular masses measured by this technique correspond to average
(or chemical) molecular mass of the protonated species. Calculated values
used for comparison are derived from IUPAC average atomic masses (C =
12.011, H = 1.008, N = 14.007, and O = 15.999).
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2.11 Chemical deglycosylation
Chemical deglycosylation was used in the analysis of some samples
(Sojar and Bahl, 1987). For this, approximately 1 nmol protein was dried in a
microcentrifuge tube. To which 150 pi anhydrous trifluoromethanesulphonic
acid (TFMS; Aldrich) was added. The reaction mixture was incubated at 0°C
under argon for 2h. N-glycoside links require a short incubation time while O-
glycoside links, which are more stable, require a longer incubation period.
The 2h incubation period was selected to enable both types of linkage, if
present, to be cleaved. Susequently the reaction mixture was cooled to -20°C
by placing the tube in dry ice-methanol contained in a vacuum flask, and then
neutralised by the addition of 60% pyridine (also cooled to -20°C). The
temperature must be carefully controlled since pyridine-TFMS salt formation
is a strongly exothermic reaction. The neutralised reaction mixture was
dialysed at 4°C against several changes of 0.01% NH4HCO3. The sample
was then applied to a microbore HPLC system with a RP-300 C8 cartridge
and eluted with a linear gradient to 70% (v/v) acetonitrile (Section 2.4.3). The
eluted protein was collected and dried using a Savant Speed Vac vacuum
concentrator for Lasermat mass analysis.
2.12 Desulphation
For desulphation, approximately 1 nmol TRAMP was dialysed into
0.1 M sodium acetate pH 5.0, then 0.1 to 0.25 units of aryl-sulphatase (Aryl-
sulphate sulphohydrolase from Helix pomatia, EC 3.1.6.1; Boehringer) were
added in a total volume of 0.2 ml. The reaction mixture was incubated for 2h
at 37°C. After this time 80 pi was removed and immediately heated to 100°C
for 2 min in SDS-PAGE sample buffer. To the remainder of the sample 120 pi
6M PBU was added and the sample stored at -20°C (Dodgson and Spencer,
1953).
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2.13 Determination of sulphotyrosine by alkaline hydrolysis
2.13.1 Chemical synthesis of sulphotyrosine
Sulphotyrosine was synthesised (by J.R.E. MacBeath) by reaction of L-
tyrosine with concentrated sulphuric acid at low temperatures (Reitz et at.,
1946). Prior to mixing, 5g tyrosine and 10 ml concentrated sulphuric acid
were separately cooled in dry ice (-10 to -25°C) for 15 min. The reagent were
then mixed and stirred rapidly over ice for 10 min, and then neutralised with
Ba(OH)2- The sulphotyrosine was freed from unreacted tyrosine and Ba2+
ions by passage through a Bio-Rad AG 50W-X8 (200-400 mesh, H+ form)
cation exchange column. Sulphotyrosine, Ba2+ salt is stable at -20°C for at
least a year (Huttner, 1984).
2.13.2 Measurement of sulphotyrosine by alkaline hydrolysis
The ester bond of sulphotyrosine is labile in acid but stable in alkali
(Huttner, 1984). Therefore, under acid hydrolysis and protein sequencing
conditions any sulphotyrosine that may be present would be converted to
tyrosine. In view of this TRAMP was subjected to alkaline hydrolysis.
Approximately 500 pmol TRAMP was placed into a pyrolysed Pyrex
sample tube (6mm x 50 mm). Then 200 pi 0.2M Ba(OH)2 was added to the
tube and the tube placed in the bottom of the glass vial, then sealed with a
Teflon/silicone septum and screw cap. The vial was placed in an oven at
110°C for 22h. After hydrolysis the sample was neutralised with approximately
25 pi 1M H2SO4. The hydrolysate was transferred to a microcentrifuge tube
and the precipitate pelleted by centrifugation in an lEC-Centra-M-
Microcentrifuge at 15,600 g for 5 min. The supernatant was decanted for
subsequent high voltage paper electrophoresis (Section 2.5.10) or amino
acid analysis (Section 2.6). Sulphotyrosine was found to elute between Pro
and PTU (Fig. 2.1) on a PTC C-18 column. Sulphotyrosine was also found to
separate well from tyrosine by high voltage paper electrophoresis using pH
6.5 buffer (Fig. 3.31, Section 3.3.8).
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2.14 Cell culture and Immunoprecipitation of [3H]- and [35S]-
labelled TRAMP
2.14.1 Introduction
The biosynthesis of TRAMP was investigated in cell culture labelled
with [3,5-3H]tyrosine or 3^S-sulphate. Using an anti-TRAMP antibody
(provided by E. Forbes) radiolabeled TRAMP was immunoprecipitated from
both culture media and cell lysates, and then analysed by SDS-PAGE.
Following electroelution or electroblotting and alkaline hydrolysis,
radiolabeled tyrosine and sulphotyrosine were analysed by HVPE or by
amino acid analysis.
2.14.2 Cell culture
Human foreskin fibroblasts (passage 7) were obtained (from G.W.
Preistley, Dept. of Dermatology, University of Edinburgh) and stored under
liquid nitrogen. For cell culture (Freshney, 1986) a vial containing 3 x 106
cells was thawed quickly at 37°C and washed with 10 ml Dulbecco's Modified
Eagle's Medium (DMEM), 10% (v/v) foetal calf serum, 100 lU/ml penicillin,
100jj.g/ml streptomyocin, in a 15 ml sterile polystyrene graduated conical
tube. After centrifugation at 1,000 g for 3 min, the cells were resuspended in
10 ml DMEM. Two aliquots of 5 ml of resuspended cells were placed in each
of two polystyrene 75 cm^ cell culture flasks containing 15 ml DMEM. The
plastic tops on the culture flasks were opened by one full turn, to allow gas
exchange, and placed in a Grant CO2 cell culture incubator. Cells were
incubated at 37°C in an atmosphere of 5% CO2, and the medium was
changed (to remove traces of DMSO left from liquid nitrogen storage) after
24h. When the cells had reached confluency (after aproximately 5 days) they
were harvested using trypsin/EDTA (by D.J.S. Hulmes) and then plated out
into ten cell-culture flasks and incubated for a further four days. At confluency,
the medium was replaced by serum-free Minimal Essential Medium (MEM),
prepared (from a GIBCO Select Amine Kit) either without tyrosine or free of
sulphate (MgS04 and CaS04 replaced by MgCl2 and CaC^) and with the
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corresponding radiolabel, either [3,5-3H]tyrosine (5 flasks) or 35S-sulphate (5
flasks) respectively. Each medium was filtered through a 500ml disposable
0.2 pm bottle filter (Costar) prior to addition to the cells. The radiolabels, from
stock solutions in dilute HCI, were first dried in a Savant Speed Vac vacuum
concentrator, then dissolved in appropriate tyrosine-free or sulphate-free
medium) were used at final concentrations of 50 pCi/ml ([3H]tyrosine) or 100
pCi/ml (35S-sulphate), respectively. Cells were incubated in the presence of
radiolabel (10 ml medium per 75 cm2 flask) for approximately 24h.
Following incubation, the culture medium was collected and pooled to
give a total volume of 50 ml, placed on ice and proteinase inhibitors were
added to final concentrations of 20mM EDTA, 10 mM N-ethylmaleimide
(NEM), 1 ml phenylmethylsulphonylfluoride (PMSF) in 50 mM Tris-HCI, pH
7.5. The medium was spun at 10,000 g for 1 min and the supernatant stored
at -20°C. The cell layers were lysed with 1 ml (per flask) of lysis buffer (1%
Nonidet NP-40, 0.15M NaCI, 20 mM EDTA, 10 mM NEM, 1 ml PMSF, 50 mM
Tris-HCI, pH 7.50) at 4°C for 30 min. The cell layer was then released with a
cell scraper, and the lysate removed using a pipette. The flasks were
subsequently washed with 1.5 ml lysis buffer to give a final lysate volume of
6.5 ml. The combined extracts were centrifuged, at 10,000 g at 4°C for 10 min,
followed by separation of supernatant (cell lysate) and pellet.
2.14.3 Immunoprecipitation
Proteins were immunoprecipitated, from culture medium or from cell
lysates, using killed Staphylococcus aureus bacteria {Staph. A.; Calbiochem)
that were preloaded either with pre-immune serum or with anti-TRAMP anti¬
serum (Harlow and Lane, 1988). The Staph. A. were centrifuged at 10,000 g
for 1 min and resuspended twice in buffer A (9 parts MEM: 1 part 500mM Tris-
HCI, 200mM EDTA, pH 7.5). Then 500 jul Staph. A. were incubated at 4°C for
30 min with 50 pi pre-immune serum (PIS). The PIS-loaded Staph. A. were
then washed three times by centrifugation at 10,000 g for 1 min and
resuspension in buffer A, to a final volume of 250 pi.
To the cell culture medium and cell lysates, bovine serum albumin
(BSA; 1 mg/ml in buffer A) was added to a final concentration of 100 pg/ml.
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BSA was added, to reduce non-specific binding of the antibody to other
proteins. The PIS-loaded Staph. A. (50 pi) were then added to the medium
(1ml), or to the lysate (100 pi), followed by incubation with gentle agitation at
4°C for 2h. Proteins bound non-specifically to the PIS-loaded Staph. A. were
then removed by centrifugation at 10,000 g for 1 min and the supernatants
were retained for immunoprecipitation with Staph. A. pre-loaded with anti-
TRAMP anti-serum. The pellets were extracted in 250 pi SDS-PAGE sample
buffer (2% (w/v) SDS, 0.125M Tris-HCI, pH 6.8, 10% (v/v) glycerol, 3% (v/v) 2-
mercaptomethanol and 0.005% (w/v) bromophenol blue) at 100°C for 3 min,
followed by centrifugation at 10,000 g for 1 min. The supernatants were stored
at -20°C prior to SDS-PAGE. Staph. A. were pre-loaded with anti-TRAMP anti¬
serum as for the pre-immune serum, and further incubations, centrifugations
and resuspensions were as above, except that supernatants following pre¬
incubation of lysates and media with PIS-loaded Staph. A. were used.
2.15 [1 4C]-labelling of purified TRAMP and molecular weight
standards
TRAMP and molecular weight standards (Pharmacia) were
radiolabeled (by D.J.S. Hulmes) by reductive alkylation with
[14C]formaldehyde and cyanoborohydride (Dottavio-Martin and Ravel, 1978).
TRAMP (5 mg/ml), previously in 6M PBU, was resuspended in 0.04M
potassium phosphate buffer, pH 7.0, using Amicon C10 concentrators. To 125
pi of a 1 mg/ml solution of TRAMP in 0.04M potassium phosphate buffer, pH
7.0, 50 pi [14C]formaldehyde (500 pCi/ml) was added followed by 50 pi of a
freshly prepared solution of NaBHgCN (6 mg/ml) in 0.04M potassium
phosphate buffer. The reaction mixture was then incubated, with agitation, at
25°C for 3h. Unincorporated label was then removed using an Amicon C-10
microconcentrator, using several changes of 0.04M potassium phosphate




Fluorography (Bonner and Laskey, 1974) was used to detect the
labelled proteins. Directly after electrophoresis the SDS-PAGE gel was
soaked in 200 ml dimethylsulphoxide (DMSO) for 20 min, followed by a
second immersion in fresh DMSO for a further 20 min. The gel was then
soaked in 100 ml 20% (w/v) 2,5-diphenyloxazole (PPO) in DMSO for 1.5h.
The PPO acts as a fluor increasing the radioactive signal intensity by
approximately four fold. PPO was then precipitated in the gel by immersing in
200 ml water for 1h. In order to prevent the gel from cracking on drying, the
gel was soaked in 10% methanol containing 0.1% glycerol. The gel was dried
on to Whatman 3MM paper under vacuum and placed in contact with Kodak
X-OMAT AR X-ray film and exposed at -70°C for 4-72h. Exposure at -70°C
produces a more discrete, less diffuse image on the film. At lower
temperatures the neutrons from low p-emitting sources, such as 14C and
35S, have less energy and travel shorter distances. After exposure the film
was developed using an X-OGRAPH COMPACT-XZ automatic developer.
2.17 Electroelution
Electroelution of TRAMP from SDS-PAGE bands was performed in an
electroelution apparatus containing 25mM Tris-base, 192mM glycine and
0.025% SDS, pH 11.0 (Jacobs and Clad, 1986). Protein migrated from the
bands in contact with the cathode buffer reservoir, to the protein trap, in
contact with the anode buffer reservoir. After elution at constant 200V for 3h,
the electroeluate was collected from the protein trap for further analysis.
2.18 Electroblotting
The SDS-PAGE gel was electroblotted onto a ProBlott membrane (ABI;
Matsudaira, 1987). After electrophoresis the gel was transferred to CAPS
buffer (10mM 3-[cyclohexylamino]-2-hydroxy-1-propanesulphonic acid
75
(CAPS), 10% methanol, pH 11.0) and left for 5 min to reduce the amount of
Tris and glycine. The ProBlott membrane was cut to the same size as the gel
and rinsed in 100% methanol for 2-3s and then equilibrated in CAPS buffer. A
gel and ProBlott sandwich was made between three layers of Whatman 3MM
paper and assembled in a semi-dri blotting unit. Electrophoretic transfer was
carried out at a constant current of 0.8 mA/cm2 (approximately 90 mV) for 1 h.
Afterwards the membrane was removed, rinsed in water for 5 min, stained
(0.1% Coomassie Blue in 50% methanol) for 5 min, and then destained (10%
acetic acid, 50% methanol) for 10 min. The blot was left to dry and the
relevant bands cut out for alkaline hydrolysis or other procedures. Unlabelled
TRAMP standard was added to the radiolabeled immunoprecipitates to




3.1 Purification of lysyl oxidase and TRAMP
Lysyl oxidase was extracted from porcine skin following the scheme
shown in Fig. 3.1 (Section 2.3; Shackleton and Hulmes, 1990a). The crude
extract supernatant (E) was diluted to 2M PBU and loaded onto a CM-
Sepharose Fast Flow column previously equilibrated with 2M PBU. The flow-
through solution was then immediately applied to a DEAE-Sepharose Fast
Flow column, previously equilibrated with 2M PBU. The column was then
washed with 2 column volumes of 2M PBU, followed by 2 column volumes of
PB and then most of the bound proteins were eluted (but not lysyl oxidase or
TRAMP) with PB containing 0.3M NaCI (Fig. 3.2a). To release bound proteins
containing lysyl oxidase activity but relatively uncontaminated with TRAMP,
the column was then eluted with 3M PBU containing 0.3M NaCI. Fractions
were assayed for lysyl oxidase activity. The activity was completely inhibited
by 0.2 mM 6APN, and active fractions were pooled as DEAE pool 1 (Fig.
3.2b). A subsequent elution with 6M PBU containing 0.5M NaCI released,
predominantly, TRAMP. The fractions containing TRAMP were collected as
DEAE pool 2 (Fig. 3.2b). Lysyl oxidase and TRAMP were then purified
separately.
The DEAE pool 1 was passed through a Sephadex G-25 gel filtration
column, previously equilibrated with PB, to remove the urea and salt. The
eluted protein was collected and pooled as G-25 pool 1 (Fig. 3.3a). The DEAE
pool 1 (600ml) was loaded in two stages in order not to saturate the G-25
column. The second loading was collected as G-25 pool 2 (Fig. 3.3b). These
two pools were added together to form G-25 pool 1+2. The DEAE pool 2 was
desalted likewise and collected as G-25 pool 3 (Fig. 3.3c).
The G-25 pool 1+2 was then loaded onto a Sephacryl S-400 column
previously equilibrated with PB. The column was washed with two column
volumes of PB. Bound proteins were eluted first with 1.5M PBU, followed by
6M PBU (Fig. 3.4a). Lysyl oxidase appeared in the 6M PBU eluate. Individual
fractions were assayed before being collected together as S-400 pool 1.
To further purify TRAMP, the G-25 pool 3 was loaded onto the
Sephacryl S-400 column previously equilibrated with PB. The column was













Centrifuge (12,400 g; 20 min)
(Repeat 2 times)
Homogenise (6M PBU)










(Pool all 4 extracts)
= E
Fig. 3.1. Preparation of an extract of lysyl oxidase and TRAMP
This diagram shows an outline summary of the extraction procedure described in
Section 2.3.4. (Shackleton and Hulmes, 1990a).
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Fig. 3.2. Separation of piglet skin extract by DEAE-Sepharose
chromatography
(a) The CM-Sepharose flow through solution was loaded onto the DEAE-Sepharose
column (5 cm x 25 cm; volume = 500 ml) at a flow rate of 30 ml/min. The arrow shows the start of
elution of the DEAE-Sepharose column with 0.3M NaCI. The protein peak contains a mixture of
unwanted proteins. Lysyl oxidase and TRAMP remained bound to the column.
(b) The first arrow shows the start of elution of the DEAE-Sepharose column with 3M
PBU containing 0.3M NaCI. The fractions shown to have lysyl oxidase activity were collected as
DEAE pool 1. The second arrow shows the start of elution of this column with 6M PBU
containing 0.5M NaCI. The first peak to elute contained a mixture of unwanted proteins




Fig. 3.3. Desalting of lysyl oxidase and TRAMP pools from the DEAE-
Sepharose column using Sephadex G-25 chromatography
(a) 400 ml of the DEAE pool 1 were loaded onto the Sephadex G-25 column (5 cm x
100 cm, volume = 2 litre), at flow rate of 40 mi/min, previously equilibrated with PB and then
eluted with PB. The desalted lysyl oxidase was collected as G-25 pool 1.
(b) The remaining 200 ml of the DEAE pool 1 were desalted as described above. The
desalted lysyl oxidase was collected as G-25 pool 2, and G-25 pool 1 and 2 combined. The
maximum volume that this column could desalt at a time was 400 ml, hence the DEAE-
Sepharose lysyl oxidase pool 1 was loaded in two stages.
(c) 400ml of DEAE pool 2 were loaded onto the Sephadex G-25 column as described
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Fig. 3.4. Separation of lysyl oxidase and TRAMP by Sephacryl S-400 "affinity"
chromatography
(a) The Sephadex G-25 pools 1 and 2 were combined and loaded onto a Sephacryl S-
400 column (5 cm x 20 cm; volume = 400 ml), previously equilibrated with PB at a flow rate of 15
ml/min. The column was then eluted with 1.5M PBU, starting at the first arrow, to remove any
unwanted TRAMP followed by 6M PBU, starting at the second arrow. The fraction showing lysyl
oxidase activity was collected as S-400 pool 1. This activity was completely inhibited by 0.2 mM
|3APN.
(b) The Sephadex G-25 pool 3 was loaded onto the Sephacryl S-400 column
previously equilibrated with PB. The column was then eluted with 1.5M PBU, shown by the first
arrow. The TRAMP which eluted was collected as S-400 pool 2. The column was then eluted
with 6M PBU, shown by the second arrow. The protein peak, containing a mixture of lysyl
oxidase and TRAMP, was collected as S-400 pool 3.
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the 1.5M PBU eluate and was collected as S-400 pool 2. A mixture of lysyl
oxidase and TRAMP was found in the 6M PBU eluate which was collected as
S-400 pool 3.
Aliquots of the crude extract (E, diluted 1:3) DEAE pool 1, DEAE pool 2,
S-400 pool 1, S-400 pool 2, and S-400 pool 3 were run on a 12% SDS-PAGE
gel (Fig. 3.5). The highly purified lysyl oxidase in S-400 pool 1 and TRAMP in
S-400 pool 2 were used for further study. Details of the recoveries of lysyl
oxidase from this purification procedure are shown in Table 3.1.
3.2 Lysyl oxidase
3.2.1 Separation of enzyme variants
Lysyl oxidase purified by Sephacryl S-400 chromatography (S-400
pool 1; Fig. 3.4a) was further purified by Mono Q anion exchange FPLC, (Fig.
3.6a). Four variants of lysyl oxidase (L1 to L4) were resolved, with small
amounts of TRAMP variants also present. Peaks from the Mono Q column
were analysed by SDS-PAGE (Fig. 3.7), and the electrophoretic migration of
the four lysyl oxidase variants was found to be identical. Each variant was
also assayed for lysyl oxidase activity (Section 2.1; Table 3.2) and there
appeared to be very little difference in specific activity between the four
variants. Similarly, all four variants of lysyl oxidase eluted at the same position
by reverse phase HPLC (Fig. 3.8). Lysyl oxidase was found to have a shorter
retention time than TRAMP, which therefore enabled the two proteins to be
separated. Reverse phase chromatography was also used to desalt the
proteins prior to further structural and compositional analysis.
3.2.2 Chromatofocussing
A Mono P chromatofocussing column (Section 2.4.5) was equilibrated
with buffer A (0.025M Bis-Tris, pH 4.70). The lysyl oxidase sample (S-400
pool 1) in 6M PBU was applied to the column. When the pH was steady, buffer
B (Pharmacia Polybuffer 74, pH 3.15) was applied to the column, as shown
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Fig. 3.5. SDS-PAGE analysis of the different stages of purification of lysyl
oxidase and TRAMP
Proteins were analysed on a 12% SDS-PAGE gel (in reducing conditions) and stained
with Coomassie Blue. The lanes are: (1) Blank, showing some high molecular bands due to
contamination from 2-mercaptoethanol present in the sample buffer, (2) protein standard, (3)
initial 6M PBU extract E, diluted 1: 3, (4) DEAE-elution containing lysyl oxidase, (Fig. 3.2, pool
1), (5) S-400 elution of lysyl oxidase, (Fig. 3.4, pool 1), (6) S-400 elution of TRAMP, (Fig. 3.4,
pool 2), (7) S-400 elution of scavenged lysyl oxidase and TRAMP, (Fig. 3.4, pool 3). The
molecular masses (K) of protein standards are indicated.
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6M PBU extract 6.53 x 103 142.3 22 100.0 1 99
DEAE-Sepharose 33.48 36.9 1102 25.9 50 95
S-400 pool 1 0.76 15.1 19945 10.6 907 98
Protein concentrations were measured by the Bradford (1976) method, with bovine
serum albumin (BSA) standards.
Table 3.2. Assay of the four lysyl oxidase variants
Protein
Total protein Total activity SDecific activity. (% of total
Protein lua) (d-P-m.) (d-p.m./ug) recovered)
S-400 pool 1 950 22,091,000 23,300
L 1 15 366,000 24,400 11.1
L 2 32 705,000 22,000 21.1
L 3 72 1,686,000 23,400 51.4




Protein concentrations were measured by the micro BCA protein assay (Smith et al.
1985), with BSA standards. S-400 pooH = lysyl oxidase starting material prior to Mono Q anion
exchange chromatography i.e. pool 1 Fig. 3.4a. Lysyl oxidase was assayed by measurement of
tritiated water release from tritiated lathyritic elastin (Shackleton and Hulmes, 1990b). The low
yields are possibly due to permanent binding of lysyl oxidase to the Mono Q column.
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Fig. 3.6. Separation of four variants of lysyl oxidase and five variants of
TRAMP by anion exchange FPLC
Lysyl oxidase and TRAMP extracts, following purification by Sephacryl S-400
chromatography (Fig. 3.4a, pool 1 and Fig. 3.4b, pool 2, respectively) were further purified on a
Pharmacia Mono Q FIR 5/5 column, (a) Lysyl oxidase variants L1 to L4, with small amounts of
TRAMP variants T1 to T5. (b) TRAMP variants T1 to T5.
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1 2 3 4 5 6 7 8 9 10 11 12
Fig. 3.7. SDS-PAGE analysis of four variants of lysyl oxidase after anion
exchange chromatography
Lysyl oxidase variants L1 to L4 with small amounts of TRAMP variants. The lanes are:
(1) blank, (2) protein standards, (3) L1, (4) L2, (5) L3, (6) L4, (7) blank, (8) protein standards, (9)
L1, (10) L2, (11) L3, (12) L4. Lanes (1-6) were stained with Comassie Blue, whilst lanes (7-12)
were stained with silver stain. Approximately 1pg of protein was loaded in each lane and
analysed (in reducing conditions) on a 12% SDS-PAGE gel. The molecular masses (K) of
protein standards are indicated.
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Fig. 3.8. Separation of lysyl oxidase (L4) from TRAMP (T2) by reverse phase
chromatography
The different fractions of lysyl oxidase and TRAMP collected from the Mono Q HR 5/5
anion exchange column were individually loaded onto a Aquapore RP-300 C8 reverse phase
cartridge (7 pm particle size; 2.1 mm x 30 mm) at a flow rate of 100 pl/min. Lysyl oxidase was
found to have a shorter retention time than TRAMP enabling the two proteins to be separated
and collected for subsequent analysis. Preparative amounts of sample were separated on a
Pharmacia ProRPC HR 5/2 (C1/C8) reverse phase column (5 pm particle size; 5 mm x 20 mm) by
applying the same gradient as above with a flow rate of 2 ml/min. Lysyl oxidase also eluted
before TRAMP under these conditions. All four variants of lysyl oxidase eluted at the position
shown above, and all five variants of TRAMP also co-eluted.
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by the arrow in the elution profile (Fig. 3.9). The urea passed straight through
the column leaving the protein to be eluted at its elution pH which is
dependent on its pi (Fagerstam et al., 1983). The pH at which each of the
variants eluted is shown in Table 3.3.
The amino acid sequence of lysyl oxidase from various species
(Trackman et al., 1990; Trackman et al., 1991; Hamalainen et al., 1991; Wu
et al., 1992) is rich in acidic amino acids predicting a theoretical pi of
approximately 6.3. By isoelectric focussing, lysyl oxidase variants are
increasingly acidic with pi's in the pH range 5.80 +/- 0.2 to 5.20 +/- 0.2 (J.R.E.
MacBeath, personal communication).
3.2.3 Amino acid analysis
Variants of lysyl oxidase were subjected to amino acid analysis (Table
3.4). No significant differences were found in the composition of the four
variants. Their compositions are very similiar to that of the rat aorta (Trackman
et al., 1990; Trackman et al., 1991), human placenta (Hamalainen et al.,
1991) and chick aorta (Wu et al., 1992) enzymes derived from cDNA
sequencing, given certain assumptions about the position of the pro-enzyme
cleavage site (Table 3.5).
3.2.4 Mass analysis of the intact enzyme variants
The molecular masses of lysyl oxidase variants by SDS-PAGE were all
approximately 32K (Fig. 3.7). More precise molecular mass determinations
were obtained by mass spectrometry. Initially a Biolon 20 plasma desorption
mass spectrometer was used for these analyses (Table 3.6), though this
instrument was working towards the limit of its mass range. Later, a Lasermat
laser desorption mass spectrometer instrument was used to determine the
same molecular masses (Fig. 3.14a; Table 3.6). Each of the mass
spectrometer instruments gave masses of approximately 29K with the
Lasermat values being the more accurate. From the Lasermat data, the
individual variants showed an 65Da incremental increase in mass in relation
to their elution position from the Mono Q column (Fig. 3.10).
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Fig. 3.9. Measurement of the elution pH of the different variants of lysyl
oxidase by chromatofocussing chromatography
Samples were loaded onto a Mono P HR 5/20 chromatofocussing column (10 jim
particle size; 5 mm x 200 mm) at a flow rate of 1 ml/min, previously equilibrated with 0.025 M Bis-
Tris, pH 4.70 adjusted with HCI. Elution was with Pharmacia Polybuffer 74, diluted 1:10 with
water, pH 3.15, adjusted with HCI, from a 50 ml "superloop". The point of eluent application is
shown by the arrow. A flow rate of 1 ml/min was used. The pH of each 0.5 ml fraction was
measured using a pH meter, (a) Mixture of four types of lysyl oxidase (b) L3.
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Table 3.3. Mono P chromatofocussing column elution pH of different variants
of lysyl oxidase and TRAMP
Protein Elution oH (24°C +/-1.5°C ) J2l
L1 4.38 5.80 +/- 0.2
L2 4.05 5.60 +/- 0.2
L3 3.72 5.40 +/- 0.2
L4 3.61 5.20 +/- 0.2
T1 ND 4.43 +/- 0.1
T2 3.42 4.34 +/- 0.06
T3 3.25 4.27 +/- 0.08
T4 3.06 4.18 +/- 0.08
T5 2.81 4.07 +/- 0.06
The pH values are believed to be accurate to +/- 0.1 pH unit.
The pi values were found by isoelectric focussing (data with permission of J.R.E.
MacBeath).
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Table 3.4. Amino acid composition of the four variants of lysyl oxidase
Amino acid LI L2 L_2 LA Human Dlacenta'
D 26.6 29.0 28.7 29.2 33
E 16.8 17.3 18.0 18.6 17
S 21.4 20.6 22.2 22.4 18
G 14.4 14.4 14.0 14.6 15
H 11.2 12.4 12.7 10.9 11
R 17.9 18.6 19.1 17.1 18
T 12.0 11.6 11.6 12.3 14
A 16.0 16.0 16.0 16.0 15
P 21.6 22.1 21.6 21.3 16
Y 24.7 23.7 26.1 26.2 31
V 12.4 12.1 12.7 12.3 12
M 2.6 3.1 3.0 2.9 3
PEC 6.1 6.1 6.4 5.8 11
I 7.0 7.2 7.5 7.1 7
L 15.6 16.2 16.1 15.8 14
F 7.2 7.0 6.9 7.0 6
K 3.9 3.9 4.0 3.8 6
W ND ND ND ND 4
Totals 237.4 241.3 246.6 243.3 251
Values are residues per molecule, normalised on the assumption that the mature form
of lysyl oxidase contains 16 alanine residues. ND = not determined. The values shown are the
residues/molecule based on data from three time courses with hydrolysis times of 30, 60, and
90 min at 200°C. Tryptophan was not determined. The 420A amino acid analyser tends to
overestimate G and underestimate E. The precision of these values are believed to be within
5% based on amino acid analysis of 500 pmol test peptide (ABI) used to ensure that the
instrument was working within the manufacturer's specifiction.
a from cDNA sequencing of the human lysyl oxidase precursor (Hamalainen et at.,
1991), assuming the mature enzyme consists of the entire C-terminal region begining at
residue 2, (Fig. 3.13.ii; Section 3.2.6). Note: D = 20, N = 13, E = 9, and Q = 8 in human
placental lysyl oxidase cDNA derived data.
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Table 3.5. Amino acid compositions of lysyl oxidase from various species
Porcine3 Ratb Human0 Chickd Bovinee Chickf
Amino acid skin aorta placenta aorta aoda cartilage
D 28.7 32 33 34 25 33
E 18.0 19 17 17 27 26
S 22.2 23 18 23 20 20
G 14.0 13 15 14 21 24
H 12.7 12 11 10 6 7
R 19.1 18 18 18 12 14
T 11.6 12 14 12 12 13
A 16.0 15 15 14 16 16
P 21.6 16 16 16 12 14
Y 26.1 30 31 33 5 16
V 12.7 13 12 12 8 10
M 3.0 3 3 3 4 4
C 6.4 11 11 10 4 7
I 7.5 7 7 8 6 10
L 16.1 13 14 13 16 16
F 6.9 6 6 5 6 6
K 4.0 5 6 6 7 8
W ND 3 4 3 ND ND
Totals 246.6 251 251 251 207 244
ND = not determined.
avariant L3 (see Fig. 3.6a). Values are residues per molecule, normalised to 16 alanine
residues.
b from cDNA sequencing of the rat lysyl oxidase precursor (Trackman et at., 1990;
Trackman eta!., 1991), assuming the mature enzyme consists of the entire C-terminal region
begining at residue 2 (Fig. 3.13.ii).
cfrom cDNA sequence data of the human lysyl oxidase precursor (Hamalainen et a!.,
1991), assuming the mature enzyme consists of the entire C-terminal region begining at
residue 2 (Fig. 3.13.ii).
d from cDNA sequencing of the chick aorta lysyl oxidase precursor (Wu et at., 1992),
assuming the mature enzyme consists of the entire C-terminal region beginning at residue 3
(Fig. 3.13.ii).
e from data of Kagan et at. (1979) presented as an average of peaks I, II and III re-
expressed as residues per molecule assuming 16 alanine residues.
f from data of Stassen (1976). This represents the composition of the fourth
enzymically active peak eluted from DEAE-cellulose, re-expressed as residues per molecule
assuming 16 alanine residues.
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Table 3.6. Molecular masses of lysyl oxidase variants
Variant Biolon 20a Lasermatb
L1 29,496 +/- 300 29,239 +/- 30
L2 29,315 +/- 300 29,321 +/- 30
L3 29,351 +/- 300 29,377 +/- 30
L4 29,815 +/- 300 29,436 +/- 30
SDS-PAGE analysis showed that variants L1 to L4 had Mr~ 32,000
a Biolon 20 values for proteins between 20,000 and 30,000 are accurate to +/-1% as the
instrument is working at the limit of its range.
b Errors are standard deviations based on lysyl oxidase samples (n = 8), using carbonic
anhydrase (Mr= 29,024) as an external standard.
The rat aorta LO sequence Mr = 29,015 (assumes start at D4 Fig. 3.13.ii).
















L1 L2 L3 L4
Lysyl oxidase variant
Fig. 3.10. Graph showing incremental mass changes between lysyl oxidase
variants
The incremental mass difference between variants is 65Da.
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3.2.5 Cyanogen bromide peptide analysis
Lysyl oxidase variant L3 was desalted using an Aquapore RP-300 C8
cartridge (Section 2.4.3; Fig. 3.8) and loaded onto the microsequencer. The
enzyme was found to be N-terminally blocked and so it was necessary to
chemically cleave and enzymically sub-digest the protein. The results are
described below.
Variants of lysyl oxidase were treated with cyanogen bromide and the
resulting unreduced peptides were separated by reverse phase HPLC (Fig.
3.11 a-d). All the lysyl oxidase variants gave similar CNBr profiles. Four
peptides were expected from inspection of the cDNA predicted sequence
having made the assumption that mature lysyl oxidase had a Mr = 32K.
However, only three peptides were found. The peaks in the L3 CNBr digest
were sequenced and identified as the following peptides (1) DEF, (2) YNL
and DEF, and (3) the blocked N-terminal peptide (Fig. 3.13; Tables 3.7 and
3.8), where each peptide is identified by the single letter code of the first three
residues. Peptides YNL and DEF in peak 2 were attached by disulphide
bonds. As DEF appeared as a single peak (peak 1) it may have become
detached from YNL or have been sensitive to acid cleavage to the N-terminal
side of a disulphide bond.
When L3 (unreduced) was treated with CNBr using an alternative
method, whereby 20 times larger volumes of formic acid and the same CNBr
concentrations were used, and the digest was eluted under the same HPLC
conditions as described previously apart from the use of a higher flow rate
(Fig. 3.11 e), the first peak to elute was YNL and not DEF.
The peptides produced after digestion with CNBr were also analysed
on a Lasermat mass analyser (Fig. 3.14b, c; Table 3.9). Values were found for
the peptides YNL, DEF and the combined YNL + DEF peptide that was linked
by disulphide bonds. Peak 3 from Fig. 3.11c gave no sequence. Confirmation
that this was the N-terminal peptide came from mass analysis and sub-
digestion of the peptide with endoproteinase-Asp-N. Mass analysis of the N-
terminal peptide gave a value of Mr = 7,622 which was present with some
contamination of peptide YNL, with Mr = 7,822 (Fig. 3.14c). The N-terminal
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Fig. 3.11. Separation of peptides released by CNBr digestion of iysyi oxidase
by reverse phase chromatography
Samples were separated on an Aquapore RP-300 C8 column (7p.m particle size; 1 mm
x 250 mm) at a flow rate of 100 pl/min. (a) CNBr digest of L1, non-reduced, (b) CNBr digest of
L2, non-reduced, (c) CNBr digest of L3, non-reduced, (d) CNBr digest of L4, non-reduced.
The peaks in (c) were later identified by sequence analysis and mass analysis using a Lasermat
mass analyser as follows: (1) DEF, (2) YNL and DEF, (3) the blocked N-terminal peptide, (e)
CNBr digest of L3, non-reduced, prepared by an alternative method (Section 3.2.5) and eluted
under the same conditions as above but at a higher flow rate of 120 pl/min compared to 100
pl/min. The peaks were later identified by sequence analysis as follows: (1) YNL, (2) YNL and
DEF, (3) the blocked N-termninal peptide. The significance of this separation is that YNL was
eluted as peak 1 which contrasts with DEF as peak 1 in (c). The single letter code for the first
three residues is used to define each peptide.
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data from rat aorta (Trackman etal., 1990; Trackman etal., 1991), and human
placental (Hamalainen etal., 1991) lysyl oxidase, but consistent with the 29K
laser desorption mass value of the entire enzyme variant L3 (Fig. 3.14a; Table
3.9) described in Section 3.2.4.
3.2.6 N-terminal sequence of variant L3
The L3 N-terminal CNBr peptide was sub-digested with
endoproteinase-Asp-N which cleaves on the N-terminal side of aspartate, and
sometimes, glutamate residues (Fig. 3.12). The endoproteinase-Asp-N
peptides were identified by sequence analysis (Fig. 3.13; Tables 3.7 and 3.8)
and mass analysis (Table 3.10) as follows (3) DDN, (4) DPY, (6) N-terminally
blocked peptide believed to be DDP, (7) ERP, (8) endoproteinase-Asp-N, and
(9) L3 CNBr peak 3, undigested by endoproteinase-Asp-N. Some peptides,
e.g. DDN, eluted in more than one peak. They perhaps contained a post-
translational modification. The tripeptides DTY and DLV were not found as
they were probably too short to be retained by the reverse phase column.
Peak 6 gave a sequence beginning with DPY (initial yield = 10 pmol)
which was sequenced through to completion. This compared to peak 4 where
the initial yield was 40 pmol for peptide DPY. Peak 6 had a mass value of
1,272 Da (Table 3.10). After sequencing the minor peptide DPY present in
peak 6, the glass fibre filter which still retained the blocked peptide was
removed from the sequencer and exposed to 3M HCI vapour at 100°C for 15
min (Tsung and Frankel-Conrat, 1965) and then replaced in the sequencer for
re-sequencing. A new sequence, but with a low initial yield of approximately 5
pmol, was observed which was believed to be the N-terminal sequence of the
previously blocked peptide (Fig. 3.13; Tables 3.7 and 3.8). The mass value of
the peak 6 peptide and the above sequence data suggest that the sequence
of the major peptide and hence the N-terminus of the L3 variant of lysyl
oxidase starts at aspartate residue D4 (Fig. 3.13.ii) and not, as predicted for
the rat aorta lysyl oxidase, at residue R135 (= R170; Fig. 3.13.i; Trackman et
al., 1990; Trackman et a!., 1991) or for the human lysyl oxidase at residue
R141 (= R170; Fig. 3.13.i; Hamalainen et al., 1992; Trackman et al., 1991).
A schematic diagram of the lysyl oxidase sequence based on mass
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Fig. 3.12. Separationof peptides released by endoproteinase-Asp-N sub-
digestion of L3 CNBr Fraction 3 by reverse phase chromatography
Samples were separated on an Aquapore RP-300 C8 cartridge (7pm particle size; 2.1
mm x 30 mm) at a flow rate of 100 pl/min.
The fractions were subsequently found to be as follows: (1) DDN [IY=17pmol], (2) DDN
[IY = 28 pmol]. (3) DDN [IY = 75 pmol], (4) DPY [IY = 40pmol], (5) DPY [IY = 19 pmol], (6) DPY [IY
= 10 pmol] and N-terminally blocked peptide, DDP, (7) ERP [IY = 79 pmol], (8) endoproteinase-
Asp-N, (9) L3 CNBr fraction 3 undigested by endoproteinase-Asp-N. IY = initial yield.
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Fig. 3.13. Precursor region and mature form of lysyl oxidase amino acid
sequence (predicted from cDNA) from various species
The figure includes data from chick aorta (Wu etal., 1992), human placenta (Hamalainen et
al., 1991), rat aorta (Trackman efa/.,1990 and 1991) lysyl oxidase and the murine ras recision gene
(Mariani etal., 1992) and amino acid sequence determined for porcine lysyl oxidase. The following
symbols are used in the figure: - denotes identical amino acid residues; * denotes deletion in
sequence; ? denotes unknown residue; + denotes sequence continues; rrg denotes the mouse
ras recision gene. Amino acids in outlined type indicate a residue change in porcine lysyl oxidase
compared to that of a known sequence. Bold letters are used for the first three resdues of each
peptide sequenced.
i. Precursor region of Ivsvl oxidase
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
Chick M R C A P P G L L L A Q L H A C I F W S
Human - - F - W T V - L - G P - Q L - A L V H
Rat - - F - w T V - F - G Q - Q F - P L L R
rrg - - F - w A V - L - G P - Q L - P L L R
21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40
Chick G L W P A * G C Q S * * * * P P A A * *
Human C A P P - A G Q Q Q P P R E - - - - p G
Rat C A P * * ★ * * * Q A P R E - - - - p G
rrg C A P
* * * * * * Q T P R E - - - - p G
41 42 43 44 45 46 47
Chick * W R Q R I Q
Human A - - - Q - -
Rat A - - - T - -
rrg A - - - T - -





61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80
Chick GAQYQPP RRRQGAEPAS * * *
Human -S - - - - QR- DPGAAVPGAA
Rat A - - - - QQ - - DSSATAPRAD
rrg A - - - - QR - - DPSATARRPD
81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100
Chick * * * * * * * *SPVLLL RGNGSV
Human NASAQQPRT I - - I - D- RTA
Rat GNAAAQPRT - I - - L - D- RTA
rrg GDAASQPRT - I - - L - D- RTA
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101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120
Chick P R A A A * * * * * * AAAARPQPE
Human AARTRT A GSSGVT - G- - R- T
Rat SARARTPSPSGVA-G - -R-A
rrg STRARTPSPSGVA-G - - R- A
121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140
Chick PQPQAQPQPRPRSSRRQPLG
Human A ***** * *************
Rat A*******************
rrg A*******************
141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160
Chick RRHWFQAGYRAPSGSARPAP
Human * A--********





Processing site predicted by
I Trackman et a!., (1991)
161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180
Chick R R R P R G R R S R R R E R A E R R R A
Human S R A R E R G A S - A E N Q T A P G E V
Rat S G A G D G A S R - A A N R T A S P Q P
rrg S G A R D G A S R
~ A A N R T A S P Q P
181 182 183 184 185 186 187 188 189 190 191 192 193 194 195
Chick A A P S G L R P G
* R E D V M
Human P A L - N - - - P S R V - G -
Rat P Q L - N - - - P S H V - R -
rrg P Q L - N - - - P s H I
- R -
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ii. Mature form of Ivsvl oxidase
The numbering is completely arbitrary and begins at M195 (above) which has been
renumbered below as M1. The CNBr peptide beginning VGD was not found by sequence or mass
analysis. The endoproteinase-Asp-N peptide beginning DDP has been tentatively identified but
the sequencing yields were low (Section 3.2.6). The N-terminus of porcine lysyl oxidase may start
at the aspartate residue D4.
I
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
Chick M V G D D P Y S P Y K Y T D D N P Y Y N
Human - - - - - - - N - - - - S - - - - - - -
Rat - - - - - - - N - - - - S - - - - - - -
rrg - - - - - - - N - - - - s - - - - - - -
Pig CNBr
CNBr (red)
Asp-N D D P Y N P Y ? Y ? D D N P Y Y N
21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40
Chick Y Y D T Y E R P R Q G S R Y R P G Y G T
Human - - - - - - - - - P - G - Y - - - - - -
Rat - - - - - - - - - S - S - H - - - - - -
rrg - - - - - - - - - P - S - N - - - - - -
Pig CNBr
CNBr (red)
Asp-N Y Y E R P R P G s R Y R P G Y G T
41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Chick G Y F Q Y G L P D L V P D P Y Y I Q A S
Human - - - - - - - - - - - A - - - - - - - -
Rat - - - - - - - - - - - P - - - - - - - -
rrg - - - - - - - - - - - P - - - - - - - -
Pig CNBr
CNBr (red)
Asp-N G Y F Q Y G L P D P Y Y I Q A s
61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80
Chick T Y V Q R M S M Y N L R C A A E E N C L
Human - - - - K - - - - - - - - - - - - - - -
Rat K -
rrg - - - - K - - - - - - - - - - - - - - -
Pig CNBr Y N L R c A A E E N c L
CNBr (red) Y N L R c A A E E N c L
Asp-N T Y V Q K
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81 82 83 84 85 86 87 88 89 90 91 92 93 94 959 96 97 98 99 100
Chick ASSAYRA DVRDYDNRVL L RF
Human --T H
Rat - - S H
rrg - S H
PigCNBr ASTAYRA DVRDYDH RVL L RF
CNBr (red) ASTAYRA DVRDYDH RVL L RF






CNBr (red) PQRVKN7G +





Pig CNBr ?E?S+ DEFSHYD
CNBr (red) D E F S H Y D
141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160
Chick L L D A S s H R K V A E G H K A S F C L
Human - - - - N T Q - R W
Rat - - - - S T Q - R V
rrg - - - - N T Q - R V
Pig CNBr L L D A S T Q R R V A E G - - A S F C L
CNBr (red) L L D A s T Q R R V A E G H K A S F c L
161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180
Chick E D T S c D Y G Y Y R R Y A C T A H T Q
Human - - - - - - - - - H - - F - - - - - -
Rat - - - - - - - - - H - - F - - - - - -
rrg - - - - - - - - - H - - F - - - - - -
Pig CNBr E D T s c D Y G Y ? R R F A C T A ? T Q
CNBr (red) E
102
181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200




Pig CNBr GLSPG7Y +
CNBr (red)
201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220
Chick I TDVKPGNY I LKVSVNPSYL
Human ----K
Rat - - - - Q
rrg - - - - Q
221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240
Chick VPESDYS NN I VRCD I RYTGH
Human T - - V - - - D
Rat S * - V - - - E
rrg T - - V - - - D
241 242 243 244 245 246 247 248 249 250 251 252





Table 3.7. Yields of amino acid residues determined from peptide sequencing of
L 3
The columns show yields, in pmol, from sequencing different peptides. The columns show
(from left to right): lysyl oxidase cleaved by CNBr unreduced (CNBr) and reduced (CNBr(red)), and
by endoproteinase-Asp-N (D). The numbering scheme is as in Fig. 3.13.ii.













































































































































































































































































































































































The following symbols are used in the above table: ? denotes residue unknown; + denotes
sequence continues.
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Table 3.8. Repetitive yields of lysyl oxidase peptides sequenced
Unreduced CNBr peptides Repetitive yield (%) Residues used
YNL 93
DEF 93 N,E,L










Mass ( m !z ) Mass ( m /z )
Fig. 3.14. Spectra from a Finnigan MAT Lasermat laser desorption mass
analyser of L3 and L3CNBr peptides
(a) Approximately 100 pmol L3, Mr = 29,377. (b) Approximately 1 pmol L3CNBr digest.
Interpretation shows L3 with Mr= 29,692 (29,377), peptides YNL + DEF, non-reduced, Mr =
21,803 (21,283*), peptide DEF Mf = 13,742 (13,464*), and unresolved peptides, YNL + the N-
terminal peptide, Mr =7,831. (c) Approximately 1 pmol L3CNBr peak 3 (Fig. 3.11c).
Interpretation shows peptide YNL Mr= 7,821 (7,838*) and the N-terminal peptide Mr= 7,622
(7,533*). The MH+ ion gives the strongest signal with this instrument. Theoretical values are
shown in parentheses. * assumes identity with human sequence.
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Table 3.9. Mass analysis using a Lasermat mass analyser of peptides of L3
after cleavage with CNBr
Peptide Theoretical Mra Theoretical M£b Lasermat Mr
N-terminalc 7,533.1 7,533.1 7,622 +/-1
Shs 206.2 206.2 ND
YNL 7,823.6 7,837.6 7,821 +/-1
DEF 13,365.5 13,463.7 13,742 +1-2
Totald 29,015 29,107
CpmbinatiQn peptide
YNL + DEF 21,171.1 21,283.3 21,803 +7-3
aassumes identity with rat sequence (Trackman eta/., 1990; Trackman etal., 1991).
b assumes identity with human sequence (Hamalainen etal., 1991).
c
assumes N-terminal peptide starts with DDP (D4; Fig. 3.13.ii).
d from cDNA data
The following abbreviations are used in the above figure: hs = homoserine (Shs =
dipeptide, Ser-homoserine).
ND = not determined, since the masses were too low to be detected on the Lasermat
mass analyser.
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Table 3.10. Mass analysis using a Lasermat mass analyser of L3 N-terminal
CNBr fragment after sub-digestion with endoproteinase-Asp-N
Fraction PeDtide Theoretical Mra Theoretical M^b Lasermat M,
6 DDP 1,261.3 1,261.3 1,272 +/-1
3 DDN 1,226.2 1,226.2 1,245 +/-1
DTY 397.4 397.4 ND
7 ERP 2,638.9 2,675.0 2,675 +/-1
DLV 442.5 416.5 ND
4 DPY 1,676.8 1,676.8 1,678 +/-1
Total 7,553.1 7,533.1 7,622 +/-1
Combination
DeDtides
1-7 DTY + ERP
4 DLV + DPY










The peptides relate to fractions 1-7 in Fig. 3.12, and are identified in Table 3.7.
aassumes identity with the rat sequence (Trackman et at., 1990; Trackman etal.,
1991).
b
assumes identity with the human sequence (Hamalainen etal. 1991).
ND = not determined, since the masses were too low to be detected on the Lasermat
mass analyser.
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data of CNBr fragments is shown in Fig. 3.15. A peptide with Mr = 2,303 might
be expected to be present if the human lysyl oxidase began at residue R141.
A peptide of this mass was not found.
3.3 Tyrosine Rich Acidic Matrix Protein (TRAMP)
3.3.1 Separation of TRAMP variants
TRAMP, following purification by Sephacryl S-400 chromatography,
(Pool 2; Fig. 3.4), was further purified by anion exchange Mono Q FPLC (Fig.
3.6b). Five variants of TRAMP (T1 to T5) were resolved. Peaks from the Mono
Q column were analysed by SDS-PAGE (Fig. 3.16), and the electrophoretic
migration of the five TRAMP variants was found to be identical. Similarly, all
five variants of TRAMP eluted at the same position by reverse phase HPLC
(Fig. 3.8). TRAMP was assayed for lysyl oxidase activity using [3H]elastin as
substrate (Section 2.1) and found to have no lysyl oxidase activity.
3.3.2 Chromatofocussing
A Mono P chromatofocussing column was equilibrated with buffer A
(0.025M Bis-Tris, pH 3.65). The TRAMP sample in 6M PBU was applied to the
column. When the pH was steady, buffer B (Pharmacia Polybuffer 74, pH
2.60) was applied to the column, as shown in Fig. 3.17. The urea passed
straight through the column leaving the protein to be eluted at its elution pH
which is dependent on its pi (Fagerstam et al., 1983). The pH at which each of
the variants eluted is shown in Table 3.3. The amino acid sequence of the
TRAMP (Fig. 3.23) is rich in acidic amino acids. From complete sequence
data for porcine TRAMP (Section 3.3.4; Fig. 3.23) the calculated isoelectric
point (pi; determined with the University of Wisconsin GCG software package,
and allowing for pyroglutamate at the N-terminus) is 4.53 (D.J.S. Hulmes,
personal communication). To determine the pi experimentally, TRAMP
variants were analysed (by J.R.E. MacBeath) by isoelectric focussing in the
presence of 4M urea. The pi values for each variant are also shown in Table
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7,622 7,821 13,742
(2,303) (7,689) (206) (7,838) (13,464)
N I—I I 1 H I 1 I !
RAA M VGD M SM YNL M DEF M
141 167 residue numbers from Trackman etal., (1991)
1 7q ^or 2^ residue numbers from Fig. 3.l3.i and 3.13.ii.
Fig. 3.15. Schematic diagram of lysyl oxidase sequence
The diagram shows observed mass values of CNBr peptides from porcine skin lysyl
oxidase variant L3 (Fig. 3.14b, c). Shown beneath them, in parentheses, are the masses of
expected CNBr fragments of human lysyl oxidase with adjustment where the porcine sequence
is known to differ (Hamalainen etal., 1991). The peptide resulting from a putative precursor
processing site at arginine 141 (R141; = R170, Fig. 3.13; Trackman etal., 1991) was not
observed.
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Fig. 3.16. SDS-PAGE analysis of the five variants of TRAMP separated by
anion exchange chromatography
The lanes are: (1) blank, (2) protein standards, (3) T1, (4) T2, (5) T3, (6) T4, (7) T5, (8)
blank, (9) protein standards, (10) T1, (11) T2, (12) T3, (13) T4, (14) T5. Lanes (1-7) were stained
with Coomassie Blue, whilst lanes (8-14) were stained with silver stain. Approximately 1p.g of
protein was loaded in each lane and analysed (in reducing conditions) on a 12% SDS-PAGE
gel. The molecular masses (K) of protein standards are indicated.
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Elution Volume (ml) Elution Volume (ml)
Fig. 3.17. Measurement of the elution pH of the different variants of TRAMP
by chromatofocussing chromatography
Samples were loaded onto a Mono P HR 5/20 chromatofocussing column (10 pm
particle size; 5mm x200mm), previously equilibrated with 0.025 M Bis-Tris, pH 3.65 adjusted
with HCI at a flow rate of 1 ml/min. Elution was with Pharmacia Polybuffer 74, diluted 1:10 with
water (pH adjusted to 2.60 with HCI), from a 50 ml "superloop". The point of eluent application is
shown by the arrow, (a) Mixture of the five variants of TRAMP, (b) T3.
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3.3. TRAMP variants T1 to T5 are increasingly acidic with pi's in the range
4.43 to 4.07. The observed pi's are less than the theoretical value, and they
decrease as expected from the Mono Q profile. The elution pH values from
the Mono P chromatofocussing column are consistent with these data. The
elution pH values are lower because once eluting pH reaches pi of the
protein, the protein has to elute through a 200 mm column by which time the
surrounding pH has dropped. The elution pH and pi values for the TRAMP
variants were found to be more acidic than the corresponding values for the
lysyl oxidase variants.
3.3.3 Amino acid analysis
Variants T1 to T5 of porcine skin TRAMP were subjected to amino acid
analysis (Table 3.11). The most striking observation is the relative abundance
of tyrosine, which accounts for about 10% of the molecule. This compares
with an average protein composition which would normally contain about 3%
tyrosine (Croft, 1976). No significant differences were found in the
composition of the five variants. Amino acid compositions of the 23K
contaminant found in lysyl oxidase preparations from human placenta
(Kuivaniemi et al., 1984) and of the dermatan sulphate proteoglycan-
associated 22K protein from bovine skin (Neame et al., 1989) are shown in
Table 3.12. The composition of TRAMP is essentially identical to that of the
bovine skin protein, and there are some similarities with the human placental
23K protein (Kuivaniemi et al., 1984). A comparison of the amino acid
analysis of the T3 variant of TRAMP with rat aorta lysyl oxidase (Trackman et
al., 1990; Trackman et al., 1991) demonstrates how earlier workers believed
TRAMP was a breakdown product of lysyl oxidase (Table 3.13).
3.3.4 Sequence analysis of T3 variant of TRAMP
TRAMP variant T3 was desalted using an Aquapore RP-300 C8
column (Section 2.4.3; Fig. 3.8) and loaded onto the microsequencer. The
protein was found to be N-terminally blocked and so it was necessary to
chemically cleave and enzymically sub-digest the protein. The results are
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Table 3.11. Amino acid composition of the five variants of TRAMP
Porcine skin Bovine Skin Protein13
Amino acid analysis (AAA) Sequence3 AAA Sequence
11 12 12 14 15 12
D 18.6 19.7 19.6 20.4 19.6 20 20.1 20
E 22.8 23.5 23.6 23.9 24.1 25 22.9 24
S 12.1 12.4 11.9 11.7 12.5 13 12.6 13
G 12.6 12.9 13.1 12.9 13.0 13 14.6 13
H 2.8 3.0 2.9 3.0 2.9 3 3.8 4
R 11.7 12.3 12.3 12.8 12.5 12 12.8 12
T 7.3 7.0 7.4 6.7 6.5 8 7.3 9
A 7.0 7.0 7.0 7.0 7.0 7 7.1 7
P 6.6 6.5 6.7 6.6 6.5 7 9.7 6
Y 15.4 17.9 18.1 19.0 17.9 20 18.8 20
V 7.8 8.1 8.0 8.0 8.1 9 7.5 9
M 6.0 7.6 6.8 7.8 7.1 8 6.0 7
PEC 8.9 8.8 9.2 9.1 9.1 10 7.9 10
I 3.9 3.9 3.8 3.9 3.8 4 4.2 4
L 4.1 4.1 3.7 3.8 3.8 4 5.6 5
F 7.6 7.8 7.7 8.0 7.7 8 8.0 8
K 3.5 4.0 4.0 4.3 4.0 4 4.2 4
W ND ND ND ND ND 8 ND 8
a Note: D = 11, N = 9, E = 14 and Q = 11.
b D = 11, N == 9, E= 14andQ = 10. Data of Neame et al. (1989).
The values shown are the residues/molecule based on data from three time courses
with hydrolysis times of 30, 60, and 90 min at 200°C. Tryptophan was not determined. The
values were normalised on the assumption that there were 7 alanine residues/molecule as
found in the bovine skin 22K protein (Neame et al., 1989) and also in the porcine sequence
(Fig. 3.23). The precision of these values are believed to be within 5% based on amino acid
analysis of 500 pmol test peptide (ABI) used to ensure that the instrument was working within
the manufacturer's specifiction.
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Table 3.12. Amino acid composition of TRAMP and related proteins
Amino acid Porcine skin a Bovine skin 13 Human placenta0
(22K protein) (Contaminant, pool II)
D 19.6 20 14.1
E 23.6 24 21.9
S 11.9 13 10.5
G 13.1 13 14.3
H 2.9 4 2.5
R 12.3 12 9.0
T 7.4 9 6.8
A 7.0 7 7.0
P 6.7 6 5.9
Y 18.1 20 8.4
V 8.0 9 6.4
M 6.8 7 ND
C 9.2 10 ND
I 3.8 4 4.1
L 3.7 5 4.1
F 7.7 8 5.4
K 4.0 4 4.8
W ND 8 ND
ND = not determined.
a variant T3 (see Fig. 3.6b). Values are residues per molecule, normalised to 7 alanine
residues.
b from protein sequence data of Neame et al. (1989), expressed as residues per
molecule.
cfrom Kuivamiemi etal. (1984) presented as the contaminant peak in pool II eluted from
DEAE-cellulose, re-expressed as residues per molecule, assuming 7 alanine residues.
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Table 3.13. Comparison of the sequence derived amino acid composition of
T3 with rat aorta lysyl oxidase cDNA derived data





















a Data of Trackman etal. 1990 and Trackman et al. 1991 from rat aorta cDNA sequence,
assuming the mature protein starts at residue 2 (Fig. 3.13.ii).
The table demonstrates how earlier workers believed that TRAMP, as it is now called,
was a breakdown product of lysyl oxidase. Only glutamate, glutamine, methionine,
phenylalanine, and tryptophan are more abundant in TRAMP than lysyl oxidase, with glutamine,
methionine, and tryptophan being difficult to quantify by amino acid analysis.
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described below.
3.3.4.1 Pyroglutamate aminopeptidase digestion of the T3 variant
of TRAMP
The blocked N-terminus may have been due to the presence of a
pyroglutamate group. The protein was therefore treated with pyroglutamate
aminopeptidase. The digested protein was desalted by reverse phase HPLC
(Fig. 3.18). This procedure unblocked the protein yielding the sequence
beginning with YGD (Fig. 3.23; Tables 3.14 and 3.15).
3.3.4.2 Chemical removal of the blocking group of T3
T3 was also treated with 17% methylamine at 37°C for 14h, desalted
by reverse phase HPLC and subjected to amino acid sequencing (Muranova
and Muranov, 1979). This failed to unblock the protein, possibly because the
pyroglutamate was adjacent to a tyrosine group, which reduces the reactivity
of the pyrrolidone ring (Muranova and Muranov, 1979).
T3 was also dried onto a glass fibre filter and treated with 3M HCI
vapour at 100°C for 15 min and subjected to sequencing (Tsung and Frankel-
Conrat, 1965). This failed to give any sequence data. However, when the first
procedure with 17% methylamine was followed by exposure to 3M HCI
vapour at 100°C for 15 min, the N-terminal sequence of T3 was detected
(Table 3.15). The aminopeptidase treatment was the preferred method but a
chemical procedure would have been simpler if it had been more reliable.
3.3.4.3 Cyanogen bromide digestion of TRAMP
The T2 to T5 variants of TRAMP were treated with cyanogen bromide
and the resulting unreduced peptides were separated by reverse phase
HPLC (Fig. 3.19a-d). All the TRAMP variants gave similiar CNBr profiles,
which were quite distinct from the equivalent lysyl oxidase CNBr profiles (Fig.
3.11). Eight peptides were expected. However, the dipeptide, CR was too
small to be detected by reverse phase chromatography. The peaks in the T3
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Time (min)
Fig. 3.18. Separation of T3 after pyroglutamate aminopeptidase digestion by
reverse phase chromatography
The sample was desalted on an Aquapore RP-300 C8 cartridge (7pm particle size; 2.1
mm x 30 mm) at a flow rate of 100 pl/min. The peaks were identified as follows: (1) unblocked




Fig. 3.19. Separation of peptides released by CNBr digestion of the different
variants of TRAMP by reverse phase chromatography on an Aquapore RP-300
C8 column
(a) CNBr digest of T2, non-reduced, (b) CNBr digest of T3, non-reduced, (c) CNBr
digest of T4, non-reduced, (d) CNBr digest of T5, non-reduced (e) Peak 5 in (b) after reduction
with 0.1 M DTT. The peaks in (b) were identified by sequence analysis as: (1) TTE, (2) ISY, (3)
RGA, (4) pEYG, (5) EWY + PTP + TDY + CR. The peaks in (e) were identified by amino acid
analysis and sequence analysis as: (5A) PTP, (5B) TDY and (5C) EWY.
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CNBr digest profile were sequenced and identified as the following peptides:
(1) TTE, (2) ISY, (3) RGA, (4) pEYG, (5) EWY+PTP+TDY+CR (Fig. 3.23; Tables
3.14 and 3.15). Peak 4 was found to be blocked and later this was found to be
the N-terminal peptide by amino acid analysis and mass analysis. Peak 5
yielded several sequences simultaneously. Fractions from peak 5 were
collected, dried and redissolved in 6M PBU containing freshly prepared 0.1 M
dithiothreitol to reduce the disulphide bonds linking the peptides. The reverse
phase HPLC profile of this reduced sample is shown in Fig. 3.19e. The peaks
were identified by amino acid analysis and sequence analysis as follows:
(5A) PTP, (5B) TDY, and (5C) EWY.
3.3.4.4 Clostripain digestion of TRAMP
The T2 to T5 variants of TRAMP were also treated with clostripain and
the resulting peptides were separated by reverse phase HPLC (Fig. 3.20a-d).
All TRAMP variants gave similar clostripain profiles. The peaks in the T3
clostripain digest profile were sequenced and and identified as the following
peptides: (1) GAT, (2) SIF, (3) YFE, (4) QGF, (5) MTD, (6) EWQ and pEYG, (7)
AGM, (8) QWK, (9) QWN and CPY, (10) CPY and (11, 12 and 13) clostripain
(Fig. 3.23; Tables 3.14 and 3.15).
3.3.4.5 Staphylococcus aureus protease V8 digestion of T3
The elution profile of the T3 protease V8 digest is shown in Fig. 3.21.
The following peptides were identified by sequence analysis: (1) SVL + FAN,
(2) MDM, (3) YYM, (4) GSD + RDR, (5) V8 protease (Fig. 3.23; Tables 3.14
and 3.15).
3.3.4.6 Sub-digestion of the N-terminal CNBr fragment of T3 with
endoproteinase-Asp-N
The T3 CNBr N-terminal fragment (peak 4, Fig. 3.19b), was
subdigested with endoproteinase-Asp-N (Fig. 3.22). The following peptides
were identified by sequence analysis: (1) DYG, and (2) DDG + DRQ (Fig.
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(c) (d)
Fig. 3.20. Separation of peptides released by clostripain digestion of the
different variants of TRAMP by reverse phase chromatography on an
Aquapore RP-300 C8 column
(a) Clostripain digest of T2, (b) clostripain digest of T3, (c) clostripain digest of T4, (d)
clostripain digest of T5. These peptides were collected for sequence analysis, and mass
analysis on a Biolon 20 mass analyser. The peaks were subsequently found to be as follows: (1)
GAT, (2) SIF, (3) YFE, (4) QGF, (5) MTD, (6) EWQ and pEYG, (7) AGM, (8) QWK, (9) QWN and
CPY, (10) CPY', (11, 12 and 13) clostripain.
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Fig. 3.21. Separation of peptides released by protease V8 digestion of T3 by
reverse phase chromatography on an Aquapore RP-300 C8 column
The fractions were subsequently found to be as follows: (1) SVL + FAN, (2) MDM, (3)
YYM, (4) GSD and RDR, and (5) protease V8.
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Fig. 3.22. Separation of peptides released by endoproteinase-Asp-N sub-
digestion of T3 CNBr peak 4 by reverse phase chromatography on an
Aquapore RP-300 C8 column
The fractions were subsequently found to be as follows: (1) DYG, and (2) DDG + DRQ.
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3.23; Tables 3.14 and 3.15).
3.3.4.7 Sequence overlap analysis
By overlapping all the sequence data from these various digests the
complete sequence of the variant T3 from porcine skin was found (Fig. 3.23).
The amino acid sequence of the TRAMP peptides did not match any of the
cDNA predicted sequence for lysyl oxidase (Trackman et al,. 1990; Trackman
et al., 1991). However, when compared (by J.F. Collins, Institute of Cellular
and Molecular Biology, Biocomputing Unit, University of Edinburgh) with the
Protein Identification Resource database (release 30) using the program
"prosrch" (Coulson et al., 1987), the TRAMP sequence was found to be almost
identical to the 22K dermatan sulphate proteoglycan-associated extracellular
matrix protein from bovine skin (Neame et al., 1989). The sequence of porcine
TRAMP differed from the 22K bovine skin protein at only four residues, P8
(S8), Q10 (H10), S70 (T70) and M127 (L127), where the bovine skin residues
are shown in parentheses.
As previously observed by Neame et al., (1989), the protein consists of
three homologous domains. The repeating sequences of bovine (Neame et
al., 1989) and porcine TRAMP are shown in Fig. 3.24. All three domains
include a six-residue repeating segment which has a consensus sequence of
DR(Q/E)W(N/Q/K)(F/Y).
3.3.5 Mass analysis of intact TRAMP variants
Mass estimation of TRAMP variants by SDS-PAGE gave values of
approximately 24K. More precise molecular mass determinations were
obtained by mass spectroscopy. Data from the Biolon 20 and Lasermat mass
analysers are shown in Fig. 3.25a, Fig. 3.26 and Table 3.16. Based on the
complete amino acid sequence of porcine TRAMP (Fig. 3.23; Section 3.3.4),
the calculated relative molecular mass in non-reducing conditions is 21,989.
The observed relative molecular masses of all TRAMP variants are greater
than the calculated value, and the masses increase monotonically by 59Da
with decreasing isoelectric point (Fig. 3.27; Table 3.3).
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Fig. 3.23. Determination of the sequence of porcine TRAMP
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20


























41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
VRS I FNK KEGSDRQWNYACM
VRS I FNK KEGSDRQWNYACM
VRS I FNK KEGSDRQWNYACM
GSDRQWNYA - M
VRS I FNK KEGSDRQWNYAC
61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79
BOVINE P T P Q s L G E P T E C W W E E I N R
PyrE P T P
CNBr P T P Q s L G E P S E c W W E E I N R
CNBr (red) P T P Q s L G E P S E c W W E E I N R
Clostripain P T P Q s L G E P s E c W W E E I N R
V8 P T P Q s L G E
Asp-N

























141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160
BOVINE M I SYNYDYYMRGATTTFSAV
PyrE
CNBr
CNBr (red) - IS YNYDYYMRGATTTFSAV
Clostripain M I SYNYDYYMRGATTTFSAV
V8 M I SYNYDYYMRGAT
Asp-N
161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180
BOVINE ERDRQWK F I MCRMTDYDCEF
PyrE
CNBr TDYDCEF
CNBr (red) ERDRQWK F I
Clostripain ER - - QWK F I MCRMTDYDCEF
V8 ERDRQWK F I M - RMTDYD - EF
Asp-N
181 182 183
BOVINE A N V
PyrE - - -
CNBr A N V
CNBr (red) - - -
Clostripain A N V
V8 A N V
Asp-N - - -
The following symbols are used in the above figure above: - denotes residue not
sequenced; + denotes sequence continues. Amino acids in outlined type indicate a residue
change in porcine TRAMP compared to the bovine equivalent of TRAMP. Bold letters are used for
the first three letters of each peptide sequenced.
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Table 3.14. Yields of amino acid residues determined from peptide sequencing
of T3
The columns show yields, in pmol, from sequencing different peptides. The columns show,
(from left to right): T3 cleaved by 17% methylamine and 3M HCI treatment (ME), pyroglutamate
aminopeptidase (PyrE), CNBr unreduced (CNBr) and reduced (CNBr (red)), clostripain (R),
protease V8 (E/D) and endoproteinase-Asp-N (D).
osition Residue ME EyiE CNBr CNBr (red) h tin n
1 PyrE 101 YGD
2 Y 208 450
3 G 192 606 DYG
4 D 95 273 ?
5 Y 148 568 273
6 G 138 571 315
7 Y 161 565 298
8 P 76 438 270
9 Y 394 252
10 Q 368 210
11 Q 442 233
12 Y 411 194
13 H 300 18
14 D 250
15 Y 358
16 S 110 DDG
17 D 199 103
18 D 207 61
19 G 206 110
20 W 68 91
21 V 171 84
22 N 157 82
23 L 111 69
24 N 146 23
25 R 107 QGF 2
26 Q 130 98 60
27 G 155 126 64
28 F 121 163 52
29 S 49 99 24
30 Y 146 103 41
31 Q 80 101 37
32 C 74 99 33
33 P 86 70 43
34 H 82 23 9
35 G 86 65 35
36 Q 67 61 25
37 V 75 41 24
38 V 81 57 28
39 V 95 56 32
40 A 63 49 20
41 V 78 38 22
42 R 50 17 11
43 S 23 67SIF 5
44 I 36 198 10















































































E 39 63 GSD
G 46 110 120
S 17 20 57
D 20 41 73
R 24 14 28
Q 29 255 QWN 73
W 13 129 23
N 24 265 47
Y 47 259 50
A 22 244 51
C 26 110 -
M 19 PTP PTP 322 46
P 25 270 189 130 50
T 12 478 118 126 63
P 26 488 119 125 46
Q 1285 80 80 26
S 127 24 28 14
L 302 54 71 20
G 329 48 85 21
E 261 38 35 21
P 306 69 55
S 91 17 18
E 316 29 64
C 184 6 8
w 60 11 7
w 73 14 7
E 166 9 19
E 210 8 21
I 42 4 18
N 51 3 37
R 117 0.4 2
A 46 3 490 AGM










































































Residue PvrE CNBr CNBr fredl B £
F 337 242
E 204 110 SVL
S 101 164 88
V 223 175 497
L 208 169 451
D 136 150 240
R 168 39 123








Y 97 201 YSK
S 29 118
K 20 151
R 48 17 CPY'
C 59 CPY 50 5
P 48 202 1 4
Y 58 168 9
S 18 76 6
C 39 67 7
w 19 50 9
M TTE 322 6
T 247 60 3
T 219 126 4
E 166 45 5
Y 176 60 5
P 256 115 8





E 52 64 MDM
M ? 26 245
D 31 262
M IS Y 28 279
I 3956 38 369
S 1456 13 135
Y 2169 26 284
N 1998 37 234
Y 1904 26 275
D 1255 16 46
Y 1697 25 80YYM
Y 1442 26 90
M RGA 11 74
R 49 8 25
G 536 51 GAT 85
A 528 52 85
T 327 22 43
T 314 19 ND
T 326 16 ND
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Position Residue Pyr£ CNBr CNBr (redl a a
157 F 321 20
158 S 139 8
159 A 298 18
160 V 263 15
161 E 126 9 RDR
162 R 150 1 12
163 D 132 57
164 R 121 QWK 32
165 Q 114 186 149
166 W 8 53 64
167 K 17 154 108
168 F 21 135 121
169 I 6 146 126
170 M ? 125 85
171 C 116 -
172 R 36 47
173 M TDY 343 MTD 79
174 T 237 168 63
175 D 137 184 39
176 Y 152 289 56
177 D 235 201 37
178 C 190 273 -
179 E 239 139 17
180 F 449 210 433F
181 A 167 234 690
182 N 854 205 379
183 V 293 81 256
The following symbols are used in the above table: ? denotes residue unknown; + denotes
sequence continues; - denotes blank cycle due to oxidation of cysteine to cysteic acid.
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Table 3.15. Repetitive yields of T3 peptides sequenced
i. N-terminus Repetitive Yield (%) Residues used
EYG 95 Y
YGD 92 G,D,Y,P,Q,S,V,N

































The symbols are as follows: * = Repetitive yield calculated from a different run made on the same day



























































Tyrosine Residuechang s Sequenceide tity Fig.3.24.Comparisonofaminocidsequencesofb vi e(Neametal.,1989)dporcineTRAMP Thesequ ncecontainst rhomologousd mainwh chareli edf rm ximums m larity.
(a)
Mass ( m /z )
(b)
Mass (m /z)
Fig. 3.25. Spectra of T3 and T3 ciostripain peptides from a Biolon 20 plasma
desorption mass analyser
(a) Approximately 1 nmol T3 was analysed. The mass of T3 was found by taking the
mean of MH + = 22,310, MH22+= 22,251, MH33+ = 22,294 and MH44+= 22,373. This gave a
mean Mr= 22, 307. The MH2+ ion often gives the strongest signal for proteins and peptides in
the high mass range in plasma desorption mass spectrometry (P. Hojrup, personal
communication).
(b) Approximately 10 pmol of the peptide T3CL1 (i.e. peak 1 from a ciostripain digest of
T3 (Fig. 3.20b) was analysed. The peptide was found to be GAT which had a theoretical Mr =
1139.3.
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10000 20000 30000 40000 50000
Mass ( m /z )
Fig. 3.26. Spectra of T3 from a Finnigan MAT Lasermat laser desorption mass
analyser
Approximately 100 pmol T3 was analysed.
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Table 3.16. Molecular masses of TRAMP variants
Variant Biolon 20a Lasermatb
T1 N.D. 22,119+/- 22
T2 N.D. 22,183 +/- 22
T3 22,307 +/- 230 22,252 +/- 22
T4 22,147 +/- 230 22,306 +/- 22
T5 22,616 +/- 230 22,352 +/- 22
ND = not determined.
a Biolon 20 values for proteins between 20,000 and 30,000 are accurate to +/-1% as
the instrument is working at the limit of its range.
13 Errors are standard deviations based on lysyl oxidase samples (n = 8), using carbonic
anhydrase (Mr= 29,024) as an external standard.
The mass of the T3 sequence (Mr = 21,989; Cronshaw etal., 1993) compares with Mr

















T1 T2 T3 T4
TRAMP Variant
T5
Fig. 3.27. Graph showing incremental mass changes between TRAMP
variants
The incremental mass difference between variants is 59Da.
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The differences in the observed and calculated molecular masses and
isoelectric point data suggest that some amino acid residues in TRAMP may
be modified at the post-translational level. The modification(s) would be acid
labile, to account for the apparent absence of modified amino acids by
sequence or amino acid analysis, and would increase the net negative
charge, to account for the low pi. The presence of an acidic post-translational
modification was suggested by the observation (J.R.E. MacBeath) that TRAMP
stains strongly with Alcian Blue (Fig. 3.28; Cronshaw et al., 1993).
3.3.6 Mass analysis of T3 and T4 clostripain peptides and T3
CNBr peptides
Peptides from T3 and T4 clostripain digests were collected after
reverse phase HPLC and subjected to mass analysis using a Biolon 20 mass
analyser (Fig. 3.25b; Table 3.17). The values obtained confirm the sequence
data but do not indicate any differences between the two variants.
Three T3 CNBr peptides were also investigated by mass analysis
(Table 3.18). These help to confirm the sequence data, but are less accurate
than clostripain peptide values because of the difficulty in determining
whether the peptide is in the homoserine (hs) or homoserine lactone (hsl)
form (Ambler, 1965).
The masses of the following T3 clostripain peptides were fed into the
Molecular Weight Search (MOWSE) database (by D. Pappin, Imperial Cancer
Research Fund, London): pyrEYG (3,108), QGF (1,876), QWN (3,155), AGM
(2,319), YFE (1,028), EWQ (1,135), GAT (1,139), and MTD (1,305). Other data
supplied to the database included the approximate molecular mass of TRAMP
(22K), the cleavage reagent, Arg-C, and a mass error tolerance of 2Da. These
data were then scanned against 51,093 sequences in the database which
resulted in the correct sequence alignment with the 22K bovine protein
(Neame et al., 1989). No sequence match was found for peptides that
contained sequence substitutions between porcine and bovine TRAMP e.g.
pyrEYG and QWN. When the masses of the T3 CNBr peptides pyrEYG
(7,267), ISY (1,183) and RGA (2,354) were scanned in the same database,
sequence alignment was also found with the 22K bovine protein (Neame et
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Fig. 3.28. SDS-PAGE analysis of combined forms of TRAMP after treatment
with aryl-sulphatase
Approximately 1ug of each reduced sample was run on a 12% discontinuous SDS-
PAGE gel. The lanes are as follows: (1) blank, (2) protein standards, (3) aryl-sulphatase, (4)
TRAMP, (5) TRAMP + aryl-sulphatase, (6) TRAMP, (7) TRAMP + aryl-sulphatase. Lanes (1-5)
were stained with Coomassie Blue, whilst lanes (6-7) were stained with Alcian Blue. The
molecular masses (K) of protein standards are indicated.
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Table 3.17. Comparison of mass values of T3 and T4 clostripain peptides
using a Biolon 20 mass analyser
12. 1A.
Peptide Seauence Mr Biolon Mj. Biolon Mr
PyrEYG 3100.7 3108.2 ND
QGF 1875.5 1875.4 1874.9
SIF 1480.8 ND 1479.3
QWN 3151.7 3154.8 3151.9
+16 = 3167.7
AGM 2320.0 2319.4 2319.1
+16 = 2336.0
YFE 1028.2 1027.9 1027.5
EWQ 1134.5 1134.9 1134.1
YSK 651.7 ND ND
CPY 3820.9
+64 = 3884.9 3890.8 3891.8
GAT 1139.3 1139.0 1138.6
QWK 1111.6
+16 = 1127.6 1128.4 1129.0
MTD 1307.5 1305.1 ND
+16 =1323.5 1319.7
The table shows a comparison of observed mass values for peptides from TRAMP
variants T3 and T4 (Figs. 3.20b, c), produced by clostripain digestion, with theoretical mass
values. Methionine is oxidised by this method to methionine sulphoxide (MSO) thus 16 has
been added to the predicted masses of methionine containing peptides. The Biolon values
shown have an error of +/- 0.1% for peptides. ND = not determined.
Table 3.18. Mass values of T3 CNBr peptides using a Biolon 20 mass analyser
12.
PeDtide Seauence Mr Biplpn M
pyrEYG (hs) 7296.2 7287.6
pyrEYG (hsl) 7278.2 7266.6
ISY (hs) 1211.5 1207.0
ISY (hsl) 1193.5 1183.3
RGA (hs) 2381.0 2378.9
RGA (hsl) 2363.0 2354.0
Mass values from other T3CNBr peptides were not determined because of the difficulty
in determining their precise masses due to the presence of homoserine (hs) and homoserine
lactone (hsl) forms of the peptides (Ambler, 1965).
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al., 1989). No sequence match was found for peptide pyrEYG as a residue
change occured at residues 8 and 10. Remarkably the correct sequence was
identified from just two CNBr peptide masses and no amino acid sequence
information.
3.3.7 Glycosylation
Possible glycosylation of TRAMP was investigated as follows. By
amino acid analysis, there was no evidence for hexosamines in TRAMP, as
also observed by Neame et al., (1989). Derivatised galactosamine (gaIN) and
glucosamine (glcN) elute after PTC-Glu and before PTC-Ser, respectively,
when separated on an Applied Biosystems PTC C-18 column (Fig. 2.1).
Chemical deglycosylation of T3 variant of TRAMP with trifluromethane
sulphonic acid (TFMS) did not show any decrease in molecular mass after
measurement by LDMS. Furthermore, enzymic deglycosylation of TRAMP
variants (by J.R.E. MacBeath) showed no change in electrophoretic mobility
or band sharpness by SDS-PAGE (Cronshaw eta!., 1993).
3.3.8 Tyrosine sulphation
One possible post-translational modification was tyrosine sulphation.
There are five possible tyrosine residues in TRAMP that meet four of the five
empirically determined rules for tyrosine sulphation (Hortin et al., 1986;
Section 4.4.3).
The tyrosine sulphate ester bond is particularly labile to acid hydrolysis
(Huttner, 1984). Following treatment with 1M HCI at 100°C for 5 min, Alcian
Blue staining of TRAMP almost halved relative to Coomassie Blue staining
(Cronshaw et al., 1993, with permission of J.R.E. MacBeath). This is
consistent with the observation that acid hydrolysis of TRAMP did not yield
any sulphotyrosine after amino acid composition analysis.
The combined forms of TRAMP were treated with and without aryl-
sulphatase and then run in duplicate on a 12% SDS-PAGE gel. The gels
were stained with Coomassie Blue or Alcian Blue (Fig. 3.28). After treatment
with aryl-sulphatase the TRAMP band still stained with Coomassie Blue, but
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Alcian Blue staining was reduced. To further investigate possible tyrosine
sulphation, the T3 variant of TRAMP was examined on a Mono Q column
before and after treatment with 0.1 unit of aryl-sulphatase at 37°C for 2h. The
results (Fig. 3.29) show that while a small protein peak continued to be
present, after treatment with sulphatase, at the original elution position of T3,
three additional peaks (TO', T1', T2') appeared earlier in the elution gradient.
The elution positions of two of these peaks coincided with T1 and T2. When
examined by SDS-PAGE (Fig. 3.30) however, all three peaks co-migrated
with T3.
Various attempts were made to identify sulphotyrosine in TRAMP by
high voltage paper electrophoresis (HVPE) and amino acid analysis. A
standard of sulphotyrosine (prepared by J.R.E. MacBeath) was found to
separate from tyrosine by HVPE at pH 6.5 (Fig. 3.31). PTC-sulphotyrosine
was found to elute between proline and PTU on a PTC C-18 column (Fig.
2.1). The T3 variant of TRAMP was hydrolysed under alkaline conditions with
0.2M Ba(OH)2 at 100°C for 22h (Huttner, 1984). The sample was then
neutralised with 0.1M H2SO4, the precipitate removed by centrifugation, and
the supernatant analysed by both HVPE and amino acid analysis. No visible
sulphotyrosine was seen, by either method, in the T3 alkaline hydrolysate.
When sulphotyrosine standard was subjected to alkaline hydrolysis with
Ba(OH)2 and run on HVPE, sulphotyrosine was still present but there was
some hydrolysis of the ester bond to form tyrosine (Fig. 3.31, Lane 5). The
absence of sulphotyrosine in the T3 alkaline hydrolysate could be explained
either by destruction of the sulphotyrosine ester bond during hydrolysis or by
having insufficient material. Overloading a T3 alkaline hydrolysate on the
HVPE did not reveal any tyrosine sulphate (data not shown).
There is a distinct spot which is more positively charged in the 0.2M
Ba(OH)2 digest of T3, which does not show up in the standard (Fig. 3.31,
Lane 2). This is ornithine formed on alkaline hydrolysis.
3.3.9 Cell culture and immunoprecipitation of [3H]- and [35S]-
labelled TRAMP
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Fig. 3.29. Separationof T3 after digestion with aryl-sulphatase by anion
exchange chromatography
T3 following purification by Mono Q chromatography was dialysed and digested by aryl-
sulphatase and re-loaded onto the Pharmacia Mono Q HR 5/5 column.
(a) T3, undigested, (b) T3 after digestion with aryl-sulphatase, (c) aryl-sulphatase.
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Fig. 3.30. SDS-PAGE analysis of Mono Q fractions of T3 before and after
treatment with aryl-sulphatase
Approximately 1p.g of each sample was run on a 12% SDS-PAGE gel. The lanes are as
follows: (1) blank, (2) protein standards, (3) T3, undigested, (4) aryl-sulphatase, (5) TO', (6) TT,
(7) T2" (Fig. 3.29). The gel was stained with Coomassie Blue. The molecular masses (K) of
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Fig. 3.31. Separation of tyrosine and tyrosine sulphate by high voltage
paper electrophoresis (HVPE) in pH 6.5 buffer
The lanes were identified as follows: (1) amino acid standard, (2) TRAMP after 0.2M
Ba(OH)2 digestion (3) sulphotyrosine (YS04) containing some tyrosine, (4) tyrosine, (5)
sulphotyrosine after 0.2M Ba(OH)2 digestion, (6) amino acid standard.
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fibroblast cell cultures. The fibroblasts were incubated in the presence of
[3H]tyrosine for 24h. The culture media and cell lysates were
immunoprecipitated by sequential exposure to killed Staph. A. which was pre¬
loaded with either pre-immune serum or anti-TRAMP anti-serum. Subsequent
analysis by SDS-PAGE and fluorography (by U.H. Genschel and F. Simpson;
Fig. 3.32a) showed that [3H]tyrosine was incorporated into a protein that was
specifically precipitated by the anti-TRAMP anti-serum. The protein migrated
at the same position as [14C]-labelled purified porcine TRAMP (Fig. 3.32a;
Lane 2), and was mainly present in the culture media (Lane 3) with only small
amounts detected in the cell lysate (Lane 4).
Fibroblasts were also cultured in the presence of 35S-sulphate. As
with the [3H]tyrosine label, a 35S-labelled protein that co-migrated with
[14C]TRAMP standard was specifically precipitated with the anti-TRAMP anti¬
serum (Fig. 3.32b, lane 3) and this protein was mainly present in the medium.
Having shown that TRAMP secreted by human fibroblasts incorporated
both [3H]tyrosine and 35S-sulphate, the sample was transfered from the
SDS-PAGE gel, hydrolysed and analysed by HVPE and amino acid analysis
in order to detect radiolabeled sulphated tyrosine. Several attempts were
made to elute [3H]- or [33S]-labelled TRAMP from the SDS-PAGE gels of the
immunoprecipitates. The first technique was electroelution. TRAMP bands,
after addition of unlabelled TRAMP to the samples, were identified in the gels
by Coomasie Blue staining. Bands were then cut out of the gels and placed
into an electroelution device. However, according to the recovery of c.p.m.,
even after extending the elution time by several hours, the majority of the
sample still remained within the gel. As this method proved unsuccessful,
electroblotting on to ProBlott membranes was used. The blotted bands were
stained with Coomassie Blue and cut out for alkaline hydrolysis. Blotting was
found to be 80% efficient and this was the method of choice.
The alkaline hydrolysates of [3H]tyrosine and 35S-sulphate labelled
TRAMP were separated by HVPE. In order to detect any labelled amino acids,
the Whatman 3MM HVPE paper was divided into 1 cm2 areas which were cut
out and scintillation counted (by F. Simpson). The total recovery of cpm after
HVPE was low (<3%) with losses believed to have occurred during the




Fig. 3.32. Immunoprecipitation of (a) [3H]tyrosine-labelled TRAMP and (b)
35S-sulphate labelled TRAMP from human fibroblast cultures
Lanes are as follows: (1) 14C-labelled molecular weight markers, (2) 14C-labelled
TRAMP standard, (3) culture medium, anti-TRAMP antiserum, (4) cell lysate, anti-TRAMP
antiserum, (5) culture medium, pre-immune serum, (6) cell lysate, pre-immune serum. The
molecular masses (K) of protein standards are indicated.
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contamination of the toluene coolant in the Michl tank during HVPE, which
could have dissolved the hydrolysate from the Whatman 3MM paper into the
coolant.
In an attempt to improve recovery, the alkaline hydrolysates of
[3H]tyrosine and 35S-sulphate labelled TRAMP were separated on an amino
acid analyser. Sulphotyrosine and tyrosine were found to be well resolved
using the PTC C-18 column (Section 2.6.8; Fig. 3.33a-c). Fifteen second
fractions from the eluant of the PTC C-18 column were collected and
scintillation counted. The alkaline hydrolystate of 33S-sulphate labelled
TRAMP showed a distinct peak in the position of sulphotyrosine. The
hydrolysates of [3H]tyrosine labelled TRAMP showed two clear peaks one in







Fig. 3.33. Amino acid analysis of radiolabeled TRAMP alkaline hydrolysates
Sulphotyrosine and tyrosine standards and alkaline hydrolysates were separated on a
PTC C-18 column (5 pm particle size; 2.1 mm x 200 mm) at a flow rate of 300 ml/min at 38°C.
(a) Sulphotyrosine, (b) tyrosine, (c) sulphotyrosine and tyrosine, (d) hydrolysate of 35S-












Although the cDNA derived amino acid sequence for lysyl oxidase has
been found for several species, the location of the N-terminus and precise
mass of the mature protein has not been clearly defined. This study shows
that porcine lysyl oxidase has a mass of approximately 29K, which compares
with the range 28-34K found by many workers by SDS-PAGE measurements
(Table 1.2). From the results described here, I tentatively suggest that the N-
terminus of porcine lysyl oxidase begins at residue D4 (Fig. 3.13.ii).
The present study has also shown that TRAMP is clearly distinct from
lysyl oxidase and the complete amino acid sequence has been found.
TRAMP has also been shown to contain sulphotyrosine residues which may
account for the variant forms of this protein. Little is known about the function
of TRAMP. It may be involved in mediating cell adhesion (Lewandowska et al.,
1991), and it has also been found, using lathyritic rat skin collagen, to
accelerate fibril formation (MacBeath et al., 1993). These results are now
discussed in more detail below.
4.2 Lysyl oxidase
4.2.1 Amino acid sequence
4.2.1.1 Comparison with other sequences
The amino acid sequence data from porcine skin lysyl oxidase
confirm that it corresponds to lysyl oxidase from rat aorta (Trackman et al.,
1990; Trackman et al., 1991) human placenta (Hamalainen et al., 1991) and
chick aorta (Wu et al., 1992). From the peptides sequenced so far
(approximately 62% of the total sequence), porcine skin lysyl oxidase shows
98% identity with human lysyl oxidase (Hamalainen et al., 1991) with
differences at three residues S32 (G32), S145 (N145) and V150 (W150),
where the human residues are shown in parentheses (Fig. 3.13.ii). A
comparison of the amino acid sequence of the putative precursor region and
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putative mature enzyme region from different species is shown in Table 4.1.
The precursor region of lysyl oxidase (Fig. 3.13.i) shows a low level of inter¬
species sequence identity (Table 4.1a).
The protein encoded by the mouse ras recision gene shows 91%
sequence identity with the precursor region of rat iysyl oxidase and 96%
identity with the putative mature rat lysyl oxidase (Table 4.1; Kenyon et al.,
1991; Mariani et al., 1992). The ras genes are oncogenes that were first
discovered in viruses that caused mt sarcomas. These cell-derived viral
genes may in some cases confer on the virus the ability to induce
uncontrolled proliferation of infected cells and hence produce tumours in
infected organisms. Therefore in addition to cross-linking, lysyl oxidase also
appears to play a role in tumour supression, acting as a protectant against
certain types of tumour. Specific variants of lysyl oxidase may be involved in
tumour supressor activity.
4.2.1.2 N-terminus of lysyl oxidase
Prior to this study, the propeptide cleavage site of lysyl oxidase was
unknown, as N-terminal sequencing of mature bovine aorta (Trackman etal.,
1990), human placenta (Hamalainen etal., 1991) and porcine lysyl oxidase
has been unsuccessful. A sequence SRRAA (residues 168-172; Fig. 3.13.i) in
rat lysyl oxidase has been suggested as a possible cleavage site, the
cleavage taking place between the first and second arginine i.e. between
R169-R170 (Trackman etal., 1991). However, this peptide sequence is not
present in chick or human lysyl oxidase, although the residue R170 is
conserved. A highly conserved region begins about 25 residues later in the
C-terminal direction, and the data reported here suggest that the actual
cleavage site may well be close to the beginning of this conserved region.
Assuming cleavage occurs between residues G3-D4, the mature forms of
lysyl oxidase (Fig. 3.13.ii), show a high level of sequence identity (Table 4.1b).
It is not neccessarily important that the N-terminal residue is conserved.
Glycolytic enzymes, which are generally well conserved, show considerable
variation in their N-terminal residues and some species have extended N-
termini (reviewed by Fothergili-Gilmore and Michels, 1993). For example,
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Table 4.1. Sequence identities in lysyl oxidase





Human 100 72 74 34




Chick 34 30 35 100





Porcine 100 98 99 99 88
Human 98 100 94 96 91
Rat 99 94 100 97 93
Mouse
rrg
99 96 97 100 93
Chick 38 91 93 93 100
The gaps and insertions in the different sequences were treated as residue differences.
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chick muscle and human muscle pyruvate kinase have a N-terminal serine,
whilst rat muscle pyruvate kinase has a N-terminal proline. Rat erythrocyte
pyruvate kinase contains an N-terminal serine but also has an N-terminal
extension of 42 amino acids.
From the evidence in this study, which comes from a variety of sources,
I tentatively suggest that the mature lysyl oxidase enzyme starts at residue D4
(Fig. 3.13.ii). The reasoning behind this is as follows. Peptide VGD (residues
2, 3, 4; Fig. 3.13.ii), which follows a methionine residue, was not found after
CNBr digestion of L3. This suggested that the N-terminus of mature lysyl
oxidase begins somewhere on the C-terminal side of residue M1. (It must be
emphasised that the numbering scheme is arbitrary and therefore M1 has
nothing to do with its position in the mature sequence.) Further,
endoproteinase-Asp-N sub-digestion of the blocked N-terminal CNBr
fragment of L3 (Fig. 3.12) yielded several peptides which were sequenced.
The peptide DDN (residues 14, 15, 16; Fig. 3.13.ii) was found. This suggested
that the N-terminus of mature lysyl oxidase lies between residues V2 and T13.
The Asp-N peptide DDP (residues 4, 5, 6) was not found initially when
sequenced, but after exposure to 3M HCI vapour and re-sequencing, this
peptide appeared with a low yield. This result indicates that the sequence
DDP was present in the blocked N-terminal peptide, and hence the N-
terminus was localised to V2, G3, or D4. Mass analysis of the blocked N-
terminal Asp-N peptide (observed mass 1,272 +/- 1Da) was consistent with
the actual mass of (1,261 +/- 1Da) of an N-terminal peptide beginning at D4
(Table 3.10). The mass difference (11 +/- 2Da) may be indicative of the mass
of the blocking group. N-terminal Asp-N peptides beginning with V2 or G3
would have theoretical masses (excluding the blocking group) of 1,418 or
1,360 respectively. It should be noted that these comparisons of observed and
theoretical masses assume identity of the human and porcine sequences,
and also the absence of any post-translational modifications.
The nature of the blocking group is unknown. A large proportion
(approximately 70%) of eukaryotic proteins are blocked at their N-termini. The
main reason for N-terminal modification is not entirely clear but one function
may be to protect proteins from proteolytic degradation by aminopeptidases.
There is a strong preference for N-terminal blocking of amino acids which are
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over-represented at the N-terminus i.e. where a residue is relatively common
in the N-terminal region (Driessen et al., 1985). There is no explanation for
this at present. In the case of lysyl oxidase, aspartic acid is a relatively
common residue. For example, D4 is adjacent to D5 in peptide DDN, where D
is over-represented. Acetylation, the addition of an acetyl group (C2H3O;
43Da), accounts for 80-90% of blocked proteins (Aitken, 1990; Driessen et al.,
1985). The addition of a formyl group (CHO; 29Da) is also possible but less
common. The N-formyl group is present on all bacterial proteins during
biosynthesis, but is infrequently found in these proteins when isolated. Two
methods described for unblocking proteins with N-formyl groups were tried on
the intact lysyl oxidase without success (Section 2.7.2).
There is a preference for the acetylation of certain amino acids; 35-
50% of acetylated proteins have acetyl-Ser; 27-33% have acetyl-Ala; 5-8%
acetyl-Gly; 5-6% acetyl-Met; 5-6% acetyl-Thr; 1-3% acetyl-Asp; and 2-3%
acetyl-Val (Arfin and Bradshaw, 1988; Driessen et al., 1985). However, neither
acetyl-Ser nor acetyl-Ala are likely to be the N-terminal residues of lysyl
oxidase from the mass and sequence data presented here, which indicate an
N-terminal aspartic acid. Proteins with acetylated-Asp N-termini are found in
several contractile system and cytoskeleton proteins. These include actins
from vertebrates, non-vertebrates and amphibia; and tropomyosin and
troponin C from vertebrates (Driessen et al., 1985). It has in fact been
previously reported that the mature form of bovine aorta lysyl oxidase
contains an aspartic acid at the N-terminus (Sullivan and Kagan, 1982;
Kagan, 1986). In these studies, the N-terminal residue was identified by
reacting lysyl oxidase with dansyl chloride at room temperature for 90 min,
followed by acid hydrolysis. The dansyl-amino acid was then separated by
thin layer chromatography and compared to a dansyl-amino acid standard
mixture. However for a protein to react with dansyl chloride its N-terminus
must be unblocked. As the N-terminus is known to be blocked, the validity of
Sullivan and Kagan's (1982) observations is questionable. It is possible that
limited proteolysis may have exposed an internal aspartate, e.g. D5, for
subsequent dansylation.
Apart from acetyl- or formyl- groups at the N-terminus, the occurrence
of cyclised glutamine residues (pyroglutamic acid) is one of the most common
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post-translational modifications (Podell and Abraham, 1978). There are no
glutamate or glutamine groups in the conserved region of the N-terminal
mature form of lysyl oxidase (residues 1-13; Fig. 3.13.i), which suggests that
such a blocking group is unlikely.
A wide range of proteins of different function and distribution are
methylated at their N-termini (Stock et a/., 1987). Methylated N-termini may
have one or more methyl blocking groups. N-terminal monomethylation (CH2;
14Da) may occur on a methionine residue, e.g. E. coli ribosome protein L11,
or an alanine residue, e.g. E. coli ribosome protein S11, or a phenylalanine
residue, e.g. bacterial pili (Stock et al., 1987). N-dimethylated and N-
trimethylated eukaryotic proteins have proline or alanine at the N-terminus,
which is followed by a Pro-Lys sequence. A consensus sequence has been
identified for N-terminal dimethylated ((CH2)2l 28Da) and trimethylated
((CH2)3; 42Da) eukaryotic proteins, as is shown below:
(CH2)2-PPK e.g. cytochrome c557 from the protozoan Crithidia
oncopelti (Pettigrew and Smith, 1977).
(CH2)3-APK e.g. rabbit myosin (Henry et al., 1982).
Methylated amino acids are resistant to acid hydrolysis in 6M HCI at
110°C for 24h and an amino acid analyser can be used to identify the position
of methylated residues. No unusual peaks were found in the amino acid
analysis of lysyl oxidase.
A specific group of proteins have been shown to be N-terminally
acylated with fatty acids (Trowler et al., 1988). These contain myristic acid
(CH3(CH2)i 2^0; 211 Da) covalently attached to glycine at the N-terminus,
e.g. protein phosphatase inhibitor-1 from rabbit skeletal muscle (Aitken et al.,
1982). Since lysyl oxidase is believed to start at residue D4, such a large
blocking group can be ruled out.
To overcome the problem of the blocked N-terminus, it might be
possible to digest the N-terminal peptide with carboxypeptidase Y, which
sequentially removes residues from the C-terminus, and to analyse the
released amino acids on the amino acid analyser over a time course, to
obtain the sequence. However this technique requires large amounts of
peptide. It would be extremely useful to carry out C-terminal analysis of the N-
terminal Asp-N peptide, DPP. Unfortunately, however this technique is still at
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the development stage, requiring 2.5 nmols of sample due to low repetitive
yields (Boyd et al., 1992). Furthermore, certain residues cause problems, e.g.
threonine and serine, which stop sequencing, and other residues are difficult
to derivatise and detect by HPLC e.g. aspartic acid (P. Jackson, personal
communication). Hence the blocking group of lysyl oxidase remains unclear.
4.2.1.3 Consensus sequences
Copper binding motifs have been found in four copper proteins, azurin
(Ambler, 1971), plastocyanin (Milne et al., 1974), pseudoazurin and
amicyanin (Ambler and Tobari, 1985). The motif is shown below:
-H-(X)-C-X-X-H-X-X-M-
The copper binding ligands are the sulphur atom of the single cysteine
residue and the sulphur atom in the methionine residue, together with the
nitrogen atoms of the histidine imidazole groups (Hellinga and Richards,
1991).
Chick, human and rat lysyl oxidase share a common sequence
HSCHQHYHSM (residues 124-133; Fig. 3.13.ii) which is similar to the above
consensus sequence. This sequence is not found in tyrosinase, a copper-
containing mono oxygenase, from Streptomyces glancescens (Huber et al.,
1985). However two copper-binding peptide sequences, HRRY (residues
214-217) and HHAY (residues 61-64) have been implicated in tyrosinase
from St. glaucescens (Huber et al., 1985). Lysyl oxidase contains similar
sequences HRRF (residues 170-173; Fig. 3.13.ii) and HHAY (residues 240-
243; Fig. 3.13.ii). The peptide HRRF (residues 170-173; Fig. 3.13.ii) is
replaced by YRRY in chick lysyl oxidase but the peptide HHAY (residues 240-
243; Fig. 3.13.ii) is entirely conserved in chick, human and rat lysyl oxidase.
Interestingly, azurin (Ambler, 1971), plastocyanin (Milne et al., 1974),
pseudoazurin and amicyanin (Ambler and Tobari, 1985) do not contain the
HRRY or HHAY sequences.
The copper binding motif found in azurin (Ambler, 1971), described
above, is not found in the copper protein, galactose oxidase (McPherson et
al., 1992). The copper ion in galactose oxidase has five ligands in square
pyrimidal coordination. The following residues form the square base, Y272,
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H496, H581 and an acetate ion. The top of the pyramid is formed by Y495 (Ito
et al., 1991). There is also evidence for the involvement of a C-Y bridge and
stacking interaction of these residues with a tryptophan.
4.2.1.4 Secondary structure prediction
The histogram in Fig. 4.1 shows the results of joint secondary structure
prediction (Sawyer eta!., 1986) with the heavy horizontal bars indicating the
regions of likely secondary structure of mature human lysyl oxidase
(Hamalainen et al., 1991) assuming that the N-terminal residue is D4 (Fig.
3.13.ii). This figure suggests that human lysyl oxidase contains 16% (3-sheet
and 18% a-helix.
The N-terminal region appears to consist of (3-turns (residues 2-21, 28-
33 and 33-40) which are proceeded by (3-sheets (residues 40-45 and 54-64).
There then follow a-helical regions (residues 70-90 and 92-96), a (3-sheet
region (residues 96-100), and a (3-turn region (residues 95-111 and 113-118).
The structure continues with a second split a-helix region (residues 113-136,
139-144, 147-153 and 157-160) followed by two (3-turns (residues 161-169
and 181-186). In the C-termminal region, the structure alternates between (3-
sheet and p-turn as follows: (3-sheet (residues 197-201), p-turn (residues 204-
209), p-sheet (residues 208-216), p-turn (residues 222-228), p-sheet
(residues 228-237) and p-turn (residues 243-248).
The secondary structure prediction described is based on seven
separate prediction methods (Sawyer et al., 1986). This is believed to be
considerably more accurate than relying on individual prediction methods.
Flowever, it is interesting to compare the information in Fig. 4.1 with some of
the separate predictions and also to look at the hydrophilicity of the enzyme.
The prediction of p-turns, p-sheets and a-helices by the Chou-Fasman
method (CF; Chou and Fasman, 1974) and Gamier, Osguthorpe and Robson
method (GOR; Gamier et al., 1978) are shown in Fig. 4.2. Analysis for regions
of hydrophilicity by the Kyte-Doolittle method (KD; Kyte and Doolittle, 1982;
Figs. 4.2 and 4.3) and by the GOR method (Fig. 4.4) indicate that lysyl oxidase
is very hydrophilic, with small pockets of hydrophobicty (near residues 48, 82,
97, 157, 166, 202, 209-214, 218, and 232) and a hydrophobic C-terminus
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(residues 245-252).
4.3 TRAMP
4.3.1 Amino acid sequence
The complete amino acid sequence of TRAMP has shown that this
protein is not a degradation product of lysyi oxidase, as was originally
suggested (Sullivan and Kagan, 1982; Kuivaniemi etal., 1984; Burbelo et al.,
1986). The database search revealed that the TRAMP sequence showed
98% identity with the 22K dermatan sulphate proteoglycan-associated
extracellular matrix protein from bovine skin (Neame etal., 1989), differing at
only four residues (Fig. 3.23).
4.3.2 Secondary structure prediction
The histogram in Fig. 4.5 shows the results of joint secondary structure
prediction (Sawyer etal., 1986) with the heavy horizontal bars indicating the
regions of likely secondary structure of porcine TRAMP. This figure suggests
that porcine TRAMP contains 13% p-sheet and 18% a-helix.
The N-terminal region appears to consist of p-turns (residues 2-8, 13-
19, and 31-34) which then form a distinct p-sheet (residues 35-45) and then
revert back to p-turns (residues 48-53, 59-64 and 67-70).
There then follows the first of four a-helices (residues 72-77),
proceeded by a p-turn (residues 87-91), a p-sheet (residues 92-96) and the
second a-helix (residues 102-111). The structure continues with a p-sheet
(residues 111-117), p-turns (residues 120-124 and 130-135), followed by the
third a-helix (residues 137-142). The p-turn (residues 143-147) forms a p-
sheet (residues 153-158), and this is immediately followed by the fourth a-
helix (residues 159-172) before entering into a final p-turn (residues 175-
178).
As with lysyl oxidase, it is interesting to compare the information in Fig.
4.5 with some of the individual predictions and also to look at the
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Fig. 4.5. Combined secondary structure predictions for fi-turn (top), [3-sheet
(centre) and a-helix (bottom) for TRAMP
The vertical axis represents the number of separate predictions for each structural
element and the horizontal axis gives the residue and residue number. The heavy horizontal
bars are those regions that are deemed to be in the specification discussed in the text.
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hydrophilicity of TRAMP. The prediction of (3-turns, p-sheets and a-helices by
the Chou-Fasman method (Chou and Fasman, 1974) and Gamier,
Osguthorpe and Robson method (Gamier etal., 1978) are shown in Fig. 4.6.
Analysis for regions of hydrophilicity by the Kyte-Doolittle method (Kyte and
Doolittle, 1982; Figs. 4.6 and 4.7) and by the GOR method (Fig. 4.8) indicate
that TRAMP is very hydrophilic, with four regions of hydrophobicity (residues
35-43, 93-97, 155-158 and 167-172) and a hydrophobic C-terminus (residues
180-183).
4.3.3 Function of TRAMP
The function of TRAMP is not well understood. Interestingly, sequence
analysis suggests it may be an amine oxidase. Recently, a consensus
sequence for topa quinone has been identified at the active site of several
copper amine oxidases (Mu et al., 1992; Janes et al., 1992). The motif is
shown below:
- (Y/L/G/A) - N - X - (D/E) - (Y/N) -
where X is the tyrosine residue that is modified to topa quinone. The
biogenesis of topa quinone is thought to involve the sequential conversion of
tyrosine to dopa, to dopa quinone, to topa, and topa to topa quinone (Fig. 4.9;
Mu et al., 1992). The TRAMP sequence YNYDY (residues 144-148; Fig.3.23)
shows identity with this motif, and to a tryptic digest peptide of pig kidney
diamine oxidase (Janes et al., 1992). (I am grateful for discussions with E.
Forbes on this sequence motif).
TRAMP also contains a six-residue consensus sequence of
DR(Q/E)W(N/Q/K)(Y/P) (Neame et al., 1989; Fig. 3.24). It is possible that these
repeating domains may have collagen binding activity and this could promote
binding between collagen molecules in a D-staggered array, thereby
accounting for the acceleration of collagen fibril formation by TRAMP recently
observed by MacBeath et al. (1993).
It has been observed that TRAMP binds to collagen and accelerates
fibril formation in vitro (MacBeath et al., 1993). Monomeric collagen can self-
associate into fibrils by incubation at 30°C at neutral pH. The growth of fibrils
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1986). TRAMP may stimulate collagen synthesis by aggregating collagen
monomers in preparation to cross-linking by lysyl oxidase. TRAMP may also
work in conjunction with dermatan sulphate proteoglycan with which the
bovine form of the protein has been shown to interact (Choi et al., 1989;
Neame et al., 1989; Lewandowska et al., 1991). The dermatan sulphate
proteoglycan, decorin is known to inhibit fibril formation (Brown and Vogel,
1989; L. Rosenberg, personal communication). After fibril formation decorin
becomes displaced to the outside of the collagen fibril (Scott, 1992). It is
possible therefore that TRAMP acts antagonistically to decorin as part of a
complex regulatory mechanism for the control of collagen fibril formation. Cell
adhesion to bovine TRAMP (Lewandowska et al., 1991) suggests a further
role for this protein in cellular control of fibril deposition.
4.4 Comparison of lysyl oxidase and TRAMP
4.4.1 Amino acid sequence
Neither lysyl oxidase nor TRAMP have an RGD cell binding motif
(Ruoslahti and Pierschbacher, 1986) as found in fibronectin, laminin and
other glycoproteins. However, TRAMP contains a RGAT sequence (residues
151-154) which may be a cell-binding domain that can be recognised by
members of the integrin family (Lewandowska et al., 1991).
A feature that is common to both lysyl oxidase and TRAMP is the
presence of very few lysines, i.e. four or five in lysyl oxidase and four in
TRAMP. A further observation is that both proteins have two distinct tyrosine-
rich domains (Fig. 4.10), one near the N-terminus (residues 4 to 25 in lysyl
oxidase (Fig. 3.13.ii), residues 1 to 5 in TRAMP (Fig. 3.23) and another
approximately 65% towards the lysyl oxidase C-terminus (residues 167
to173, Fig. 3.13.ii), and 80% towards the TRAMP C-terminus (residues 144 to
149, Fig. 3.23). Comparison of the entire sequences of lysyl oxidase and
TRAMP (Fig. 4.11) showed 22% identity when aligned for maximum homology
using the Wisconsin GCG program "Bestfit".

































Fig.4.10Comparisonftyros nerichd i sandp ss blesul hatitesil syoxid sTRAMP Thenumb rss ownindicatethresiduer(F gs.3.13.iiand24)
TRAMP 1 ZYGDYGYS. . . . YHQYHDYSDDGWVNLN.RQGFS. . . YQCPHGQVWAV. 41
. I . . I I I I . . I . I : . : . . . | | : : I : . . : : I . . .
LO 6 PYNPYKYSDDNPYYNYYDTYERPRPGGRYRPGYGTGYFQYGLPDLVADPY 55
TRAMP 42 ...RSIFNKKEGSDRQWNYACMPTPQSLGEPTECW...WEEINRAGMEWY 85
LO 56 YIQASTYVQKMS...MYNLRCAAEENCLA.STAYRADVRDYDHRVLLRFP 101
TRAMP 86 QTCSNNGLVAGFQSRYFESVLDREWQFYCCRYSKRCPYSCW..LTTEYPG 133
I . . I . I . : . I I . . . : I I : : : I . . . : I : I . . : .
LO 102 QRVKNQGTSDFLPSR...PRYSWEWHSCHQHYHSMDEFSHYDLLDANTQR 148
TRAMP 134 HYGEE MDMIS^NYDYYMRGATT
LO 149 RVAEGHKASFCLEDTSCD
TFSAVERDRQWKFIMCRMTDYD 177
: . . .1.1
YGYHRRFACTAHTQGLSPGCYDTY...GADID 195
TRAMP178 CEFANV 183
I : : : :
LO 196 CQWIDI 201
Fig. 4.11. Comparison of amino acid sequences of bovine TRAMP (Neame et al.,
1989) and human lysyi oxidase (LO; Hamalainen et al., 1991)
The alignment symbols used are: (I) identity, (:) strongly positively conserved substitution, (.)
weakly positively conserved substitution. The shaded box indicates the location of the consensus
sequence for topa quinone. The open box indicates a region of homology to certain conserved
copper-binding sequences (Trackman et al., 1990).
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is similar to the lysyl oxidase sequence YGYHRRFACT (residues 167-176;
Fig. 3.13.ii) which resembles certain conserved copper-binding sequences
(Trackman et al., 1990; Fig. 4.11). This stretch of sequence overlaps with the
suggested site of topa quinone in TRAMP (Section 4.3.1). TRAMP does not
have a sequence similar to the other copper-binding consensus sequence in
lysyl oxidase, HHAY (residues 240-243; Fig. 3.13.ii), nor does it have a
PISCPIQHYPISM (residues 124-133; Fig. 3.13.ii) copper binding motif,
although it does have a sequence GMEWYQTCSN (residues 81-90; Fig.
3.23) which shows some similarity in reverse. Flowever, the histidine residues,
crucial for copper binding, are absent in this sequence.
The sequence SCDYGYH in L3 (residues 164 to 170, Fig. 3.13.ii)
shows some similiarity to the sequence SYNYDYY in T3 (residues 143 to
149, Fig. 3.23), as shown in Fig. 4.11. This may suggest some similarity in
function of the two proteins. Surprisingly, lysyl oxidase does not contain a
topa quinone consensus sequence, though the exact nature of the organic
quinone-type co-factor in lysyl oxidase is yet to be established (Kagan and
Trackman, 1991).
4.4.2 Secondary structure prediction
The N-termini of lysyl oxidase and TRAMP each consist of a (3-turn
region (Figs. 4.1 and 4.5). Lysyl oxidase contains 16% (3-sheet compared to
13% (3-sheet in TRAMP. However, both lysyl oxidase and TRAMP each
contain 18% a-helix. There are two split a-heliclal regions in lysyl oxidase
and four distinct a-helices in TRAMP. Both proteins are very hydrophilic with
each containing a highly hydrophilic N-terminus and a hydrophobic C-
terminus (Figs. 4.3, 4.4, 4.7 and 4.8).
4.4.3 Significance of variant forms of lysyl oxidase and TRAMP
It has not been clear why both lysyl oxidase and TRAMP should exist in
several variant forms. The presence of multiple, ionic variants of lysyl oxidase
has also been observed in enzyme preparations from chick cartilage
(Stassen, 1976), bovine aorta (Sullivan and Kagan, 1982) and human
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placenta (Kuivaniemi eta!., 1984). Only one gene for lysyl oxidase has been
found in rat genomic DNA (Trackman et al., 1990), so post-translations are a
likely cause of the variation. A possible modification considered was
carbamylation at lysine residues while proteins are in 6M urea (Means and
Feeney, 1971). In TRAMP, the decreasing isoelectric points (pi) for variants T1
to T5 are consistent with an increasing extent of carbamylation since, from
complete amino acid sequence data (Fig. 3.23), the theoretical pi's would be
4.53, 4.44, 4.36, 4.28 and 4.20 (with pyroglutamate at the N-terminus and 0, 1,
2, 3 or 4 lysines carbamylated respectively; Table 3.3). In lysyl oxidase, the
decreasing pi values for variants L1 to L4 are also consistent with an
increasing extent of carbamylation. However, the observations from mass
spectrometry are inconsistent with carbamylation. The additional mass for
each lysine residue carbamylated should be 43Da, while the average mass
increment between consecutive lysyl oxdase and TRAMP variants was found
to be 65 and 59Da, respectively (Tables 3.6 and 3.16; Figs. 3.10 and 3.27). If
carbamylation was the basis for variation, conversion to more acidic form
would be expected when separated variants are further exposed to 6M urea.
Prolonged incubations of purified TRAMP variants in 6M urea showed no
evidence for such conversion. Similar observations were also reported by
Kagan et al. (1979) on purified lysyl oxidase variants.
The experimental data reported here demonstrate the presence of
tyrosine sulphation in TRAMP (Cronshaw et al., 1993). Incubation of variant
T3 with sulphatase showed that removal of sulphate changed the elution
position of this protein on a Mono Q column. The appearance of three new
peaks on the Mono Q column following sulphatase treatment of T3 suggests
that up to three sulphate groups were removed, resulting in a corresponding
increase in pi and hence earlier elution from the column. The elution positions
of the two peaks to the left of T3 (following sulphatase treatment) correspond
to those of the T1 and T2 variants (without sulphatase treatment).
The incremental mass difference due to tyrosine sulphation should be
79Da, which is greater than the mass increment found using the Lasermat
mass analyser (Tables 3.6 and 3.16; Figs. 3.10 and 3.27). There is no clear
explanation for this at present. More accurate mass analyses could be
obtained using an electrospray mass spectrometer, if the proteins were
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suitable for this form of analysis (Edmonds and Smith, 1990).
There are five empirical rules for predicting the location of sites of
tyrosine sulphation (Hortin et al., 1986). There must be an acidic residue at
position -1 or -2, and at least three acidic residues within five residues
(positions -5 to +5) of the tyrosine residue. No more than one basic residue
must be within five residues of the tyrosine and no more than three
hydrophobic residues (lie, Leu, Phe and Val) also within five residues of the
tyrosine. No cysteine residues must be within 15 residues of the tyrosine
(Huttner, 1984). Sequence analysis indicates five possible tyrosine sulphation
sites in TRAMP (residues 5, 15, 148, 149, and 176; Fig. 4.10). The difference
between the observed and calculated molecular mass for variant T1
(approximately 130Da) is consistent with sulphation of two tyrosine residues
(i.e. additional mass 2 x 79Da), within experimental error. The presence of two
sulphated tyrosines would be expected to lower the isoelectric point of each
TRAMP variant by about 0.17 pH unit, which corresponds to the difference
between the observed and calculated pi's.
Tyrosine sulphation is a widespread post-translational modification in
extracellular matrix proteins, e.g. nidogen/entactin (Paulson et al., 1985),
procollagen V (Fessler et al., 1986), procollagen III (Jukkola et al., 1986),
bone sialoprotein II (Ecarot-Charrier et al., 1989; Midura et al., 1990),
fibronectin (Liu and Lipman, 1985), dermatan sulphate proteoglycan (Huttner,
1988) and fibromodulin (Antonsson et al., 1991). The site of tyrosine
sulphation in fibromodulin is in an N-terminal tyrosine-rich region in which
tyrosine is every second or third residue (Antonsson et al., 1991). This feature
is also present in TRAMP (Neame et al., 1989), though the sequences are not
homologous. Multiple variants of fibromodulin have also been observed but
the effect of sulphatase on these variants has not been studied (R.M. Lauder,
I.A. Nieduszynski and T.N. Huckerby, personal communication). The post-
translational modification of tyrosine takes place in the trans-Golgi, by a
tyrosylprotein sulphotransferase that uses 3'-phosphoadenosine 5'-
phosphosulphate as a sulphate donor. The biological role of tyrosine
sulphation in extracellular proteins is generally not clear, though desulphation
of fibronectin affects binding affinities to several ligands (Suiko and Liu,
1988).
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Tyrosine sulphation also occurs in plasma proteins, e.g. complement
protein C4 and several peptide hormones, e.g. gastrin and cholecystokinin
(Brand et al., 1984). The activation of complement C4 is modulated by
sulphation (Hortin et al., 1989). This modification increases its haemolytic
activity and its proteolysis by complement factor C1s. The hormone
cholecystokinin (CCK) regulates pancreatic enzyme secretion. Sulphation of
CCK increases its ability to stimulate secretion 100 fold (Brand et al., 1984).
Sulphation of gastrin makes the peptide more potent in pancreatic secretion
(Brand et at., 1984).
In comparison to TRAMP, lysyl oxidase does not stain with Alcian Blue
(Cronshaw et al., 1993). This suggests that lysyl oxidase is not sulphated.
However, sequence analysis of lysyl oxidase indicates seven possible sites of
tyrosine sulphation (residues 19, 22, 56, 92, 167, 170 and 226; Fig. 4.10).
4.5 Future work
4.5.1 Lysyl oxidase
Future work on porcine lysyl oxidase should concentrate on
determining the complete sequence of the protein. As the next stage lysyl
oxidase should be incubated with 5% formic acid at 60°C for 16h to try to
cleave the Asp-Pro bonds at residues D6-P7 and D53-P54 (Fig. 3.13ii;
Ambler et al., 1984). This should also help in determining the N-terminus. It is
also necessary to address the question of the variants of lysyl oxidase. The L3
variant of lysyl oxidase should be treated with sulphatase and run on the
Mono Q colunn to see if there is a shift in elution position, as observed for the
T3 variant of TRAMP (Fig. 3.29). Tyrosine sulphation however may not be the
answer as lysyl oxidase did not stain with Alcian Blue (Cronshaw et al., 1993).
An antibody to lysyl oxidase should be prepared and used to purify
[3H]tyrosine and 35S-sulphate labelled lysyl oxidase from cultured fibroblasts
in similar experiments to those described for TRAMP should a change in




Possible future work on TRAMP can concentrate on either its
biosynthesis or function. Using degenerate primers based on the amino acid
sequence data, it may be possible to identify a precursor form of TRAMP by
polymerase chain reaction (PCR) amplification of cDNA libraries. The use of
chlorate as an inhibitor of tyrosine sulphation may facilitate studies of
sulphated and unsulphated forms of TRAMP (Baeuerle and Huttner, 1986). To
further study the function of TRAMP immunohistochemistry could be used to
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TRAMP (Tyrosine Rich Acidic Matrix Protein), a Protein
that Co-purifies with Lysyl Oxidase from Porcine Skin
Identification of TRAMP as the dermatan sulphate proteoglycan-
associated 22K extracellular matrix protein
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Abstract
A protein (Mr 24 K) that co-purifies with porcine skin lysyl oxidase (Mr 34 K) has been isolated
and characterised. Five variants of the 24 K protein were identified by Mono Q ion-exchange
FPLC, as were four variants of lysyl oxidase. Amino acid analysis and partial sequencing revealed
near identity of a 36-residue CNBr peptide from porcine skin lysyl oxidase to corresponding
regions of the putative lysyl oxidase precursor derived from rat and human cDNA. The 24 K
protein was found to be unrelated to lysyl oxidase, but comparison with a protein sequence
database showed it to be the same as a recently described protein from bovine skin that is
associated with dermatan sulphate proteoglycans. The 24 K protein is relatively rich in tyrosine,
and isoelectric focussing shows it to be acidic, with pi's in the range 4.1 to 4.4. In view of these
properties, we propose the name TRAMP (Tyrosine Rich Acidic Matrix Protein) to identify this
protein. Though TRAMP appears not to be glycosylated, several experiments indicate the
presence of sulphotyrosine residues. When assayed using an elastin substrate, the activity of lysyl
oxidase is unaffected by TRAMP.
Key words: lysyl oxidase, protein structure, skin, TRAMP.
Introduction
Covalent cross-linking in collagens and elastin is essential
or connective tissue structure and function (Kagan, 1986;
Cagan and Trackman, 1991). The enzyme that initiates
;ross-linking, lysyl oxidase (EC 1.4.3.13), has been purified
rorn several sources, including chick cartilage (Stassen,
1976); bovine aorta (Kagan et al., 1979; Sullivan and
Cagan, 1982), ligament (Jordan et al., 1977) and lung
Cronlund and Kagan, 1986); human placenta (Kuivaniemi
:t al., 1984) and umbilical cord (Burbelo et al., 1986);
torcine skin (Shackleton and Hulmes, 1990 a) and rat skin
■Romero-Chapman et al., 1991). Amino acid sequences of
rat (Trackman et al., 1990; Trackman et al., 1991) and
human (Hamalainen et al., 1991) lysyl oxidase precursors
have recently been deduced from cDNA analysis. In many
preparations of enzyme (Sullivan and Kagan, 1982;
Kuivaniemi et al., 1984; Burbelo et al., 1986; Shackleton
and Hulmes, 1990a), lysyl oxidase (30—34 K) is contami¬
nated with one or more low molecular mass proteins
(22—24 K). These contaminants have previously been sug¬
gested to be either degradation products of lysyl oxidase
(Sullivan and Kagan, 1982; Kuivaniemi et al., 1984; Bur¬
belo et al., 1986) or unrelated proteins (Kuivaniemi et al.,
1984).
We have recently identified a 24 K protein in prepara-
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tions of porcine skin lysyl oxidase (34 K) when purified by
specific interaction with Sephacryl S-200 (Shackleton and
Hulmes, 1990a). Here we describe an improved purifica¬
tion procedure and the identification of multiple variants of
both the 24 K protein and lysyl oxidase. The 24 K protein is
unrelated to lysyl oxidase. It is acidic and rich in tyrosine, so
we propose the name TRAMP (Tyrosine Rich Acidic Mat¬
rix Protein) to identify this protein. By amino acid sequenc¬
ing, we show that TRAMP is the same as a recently
described 22 K protein front bovine skin that is associated
with dermatan sulphate proteoglycans (Neame et al., 1989;
Lewandowska et al., 1991).
Materials and Methods
Reagents
Unless stated otherwise, all reagents were obtained from
BDH (Merck Ltd., Poole, Dorset, UK) or Sigma (Poole,
Dorset, UK). Chromatography media (Sephacryl S-400,
Sephadex G25, DEAE-Sepharose Fast Flow, CM-Sephar-
ose Fast Flow) and reagents for isoelecric focussing
(Ampholines, protein pi standards) were from Pharmacia,
Milton Keynes, Bucks, UK. Reagents for the ['HJelastin
lysyl oxidase assay were as described (Shackleton and Hul¬
mes, 1990 a, b). Ultrafree-MC ultrafiltration units (10000
NMWL, PLGC membranes) were from Millipore (UK) Ltd,
Watford, Herts, UK. Centricon C-10 microconcentrators
(10000 MW cut-off) were from Amicon Ltd, Stonehouse,
Glos, UK. Amino acid standards solvents and all reagents
for HPLC, amino acid analysis and sequencing were from
Applied Biosystems (UK), Warrington, Lanes, UK. 4-vinyl
pyridine was from Aldrich (Gillingham, Dorset, UK).
Neuraminidase (Vibrio cbolerae), O-glycosidase (BSA
free), arylsulfatase (Helix pomatia) and ^-glucuronidase
(E. coli) were from Boehringer Mannheim, Lewes, East
Sussex, UK. Fetuin, endoglycosidase F/N-glycosidase F,
sulphatases (typeV (limpet) and type VII (abalone)) were
from Sigma.
Purification of lysyl oxidase and TRAMP
Piglet skin lysyl oxidase was prepared using a procedure
similar to that described previously (Shackleton and Hul¬
mes, 1990a), but with the following modifications to
improve separation, increase capacity and reduce the time
required. Typically skins from 15 stillborn piglets were used
(approximately 1 to 2 kg wet weight). After discarding the
initial extracts in phosphate buffered saline (0.1 M sodium
phosphate pH7.8, 0.15 M NaCl) and phosphate buffer
(PB; 10 rnM sodium phosphate, pH7.8), extracts in 6M
PBU (PB containing 6 M urea) were pooled and filtered
through Whatman No. 113V and Whatman No. 3 filters.
(To remove cyanate, all urea containing buffers were pre¬
pared from fresh stock solutions of 8 M urea that were de-
ionised with BioRad AG 501-X8 mixed bed resin immedi
ately before use.) Prior to anion-exchange chromatogra
phy, filtered urea extracts (approximately 2 litres) wer
diluted with PB to 2 M PBU and then passed through
500 ml column (5 cm x 25 cm) of CM-Sepharose Fas
Flow, previously equilibrated in 2 M PBU, at a flow rate c
30ml/min. The flow-through solution was then immed
ately applied to a 500 ml column (5 cm x 25 cm) of DEAF
Sepharose Fast Flow, previously equilibrated in 2 M PBl
at a flow rate of 30 ml/min. The DEAE-Sepharose colum
was then washed with two column volumes of 2 M PBL
followed by two column volumes of PB, and then most c
the bound proteins (but not lysyl oxidase or TRAMP) wer
eluted with PB containing 0.3 M NaCl. To release boun
proteins containing lysyl oxidase activity but relativel
uncontaminated with TRAMP, the column was eluted, a
30 ml/min, with 3 M PBU containing 0.3 M NaCl. A subse
quent elution with 6 M PBU containing 0.5 M NaC
released predominantly TRAMP. Lysyl oxidase an
TRAMP were then further purified separately, as describe
below.
For further purification of lysyl oxidase, the 3 M PBL
0.3 M NaCl eluate from the DEAE-Sepharose column wa
passed through a 2 litre gel-permeation column (Sephade:
G25, medium grade; 5 cm X 100 cm; flow rate 40ml/mir
previously equilibrated in PB) to quickly remove urea ao
NaCl. A 400 ml column (5 cm X 20 cm) of Sephacryl S-401
was equilibrated with PB, and the protein solution in PI
was loaded at 15 ml/min. (Sephacryl S-400 was used instea<
of Sephacryl S-200 (Shackleton and Hulmes, 1990 a), wit
no effect on recovery of enzyme activity). The column wa
washed with PB until a steady reading of absorbance a
280 nm was obtained. Finally, bound proteins were elutei
with 1.5 M PBU, followed by 6 M PBU. Lysyl oxidas
appeared in the 6 M PBU eluate.
For further purification of TRAMP, the 6 M PBU/0.5 h
NaCl eluate from the DEAE-Sepharose column was usee
Urea and NaCl were removed by gel permeation and th
protein solution in PB was loaded on to Sephacryl S-400, a
above. The column was washed with PB, then bound pro
teins were eluted with 1.5 M PBU, followed by 6 M PBL
TRAMP appeared in the 1.5 M PBU eluate.
Lysyl oxidase activity was assayed by ultrafiltratio
using a "Hfelastin] substrate, as described (Shackleton an<
Hulmes, 1990 b), with the following modifications. Prior t
the initial centrifugation step, 50% (w/v) trichloracetic acf
was added to a final concentration of 5% (w/v). From th
supernatants, 400 |il aliquots were ultrafiltered usin
Ultrafree-MC units and a Beckman JA 18.1 rotor. Fo
scintillation counting, 300 pi of the ultrafiltrate were adde
to 2.7 ml Cocktail T. Control assays contained 0.2 mM f
aminopropionitrile (BAPN), a specific inhibitor of lysy
oxidase. Where necessary, results were corrected for parti,'
inhibition by urea (Shackleton and Hulmes, 1990 b).
Variants of both lysyl oxidase and TRAMP were sep?
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ated by anion-exchange FPLC using a procedure similar to
hat of Burbelo et al. (1986). Lysyl oxidase or TRAMP
^reparations in 6 M PBU were applied to a Pharmacia
vlono Q HR 5/5 column pre-equilibrated in 6 M PBU and
jperated at room temperature on either a Pharmacia FPLC
)r Gilson HPLC system. After washing the column with
5 M PBU, bound proteins were eluted, at 1 ml/min, with a
10-ml linear gradient from 0 to 1 M NaCl in 6 M PBU.
Prior to the preparation of peptides for amino acid
;equencing, solvent exchange and further purification in
lenaturing conditions were achieved by preparative
everse-phase FPLC. Peak fractions (approximately 1 mg)
rorn the Mono Q column were applied to a ProRPC HR
)/2 column (Pharmacia; 5 pm particle size; 5 mm X 20 mm)
>re-equilibrated in solvent A (aqueous 0.1 % (v/v) trifluoro-
icetic acid (TFA)). Proteins were eluted at 2 ml/min with a
ZOml linear gradient of 10 to 70% solvent B (100%
icetonitrile, 0.08% (v/v) TFA).
SDS-PAGE
Proteins were analysed by discontinuous gel electro¬
phoresis (Laemmli, 1970) with 12% acrylamide, 0.32%
pis-acrylamide in the separating gel. The gels were stained
vith Coomassie Brilliant Blue R250 (Miller and Rhodes,
1982) or Alcian Blue in the presence of 50 mM MgCl2 (Wall
tnd Gyi, 1988). Gels were scanned with a Joyce-Loebl
Lhromoscan 3 densitometer.
Mass determinations
Precise mass determinations were made with a laser
iesorption ion source coupled to a time-of-flight mass
malyser (Lasermat, Finnigan MAT Ltd., Hemel Hemp-
;tead, UK). Samples (0.1—0.2 pi, approximately 6 — 10
pmol) were mixed with a 0.5 pi droplet of protein matrix
approximately 50 mM sinnapinic acid in 30% (v/v) 0.1%
TFA, 70% acetonitrile) in the centre of the stainless steel
arget and the droplet was allowed to dry before introduc-
:ion into the Lasermat (Karas et ah, 1987). Specra from
nultiple laser shots were averaged to improve the signal to
toise ratio. In some experiments, carbonic anhydrase
(29,024 Da) was used as an internal calibrant.
Preparation ofcyanogen bromide peptides
Cyanogen bromide was used to cleave proteins specifi¬
cally on the C-terminal side of methionine residues (Gross
and Witkop, 1962). An 175 pi aliquot of 70% (v/v) formic
acid was added to 25 pi of protein solution (0.1 —1.0 mg/
ml). The sample was transferred to a fume cupboard, a
small crystal of CNBr added, and the tube was covered in
foil to exclude light. After 24 h at room temperature, water
(200 pi) was added (to improve drying characteristics), then
the sample was dried in a Savant Speed Vac vacuum cen¬
trifuge. To trap any HCN present, the Speedvac was con¬
nected to a chemical trap containing 2 M NaOH. The dried
samples were stored at — 20 °C until required for reverse-
phase HPLC, at which point they were redissolved in 250 pi
6 M PBU immediately before use.
CNBr peptides were separated by HPLC on an Applied
Biosystems 130 A separation system containing an Aqua-
pore RP-300 cartridge (7 pm particle size; 2.1 X 30 mm) or,
for greater resolution, an Aquapore RP-300 column (7 pm
particle size; 1 mm X 250 mm). Solvents A and B were the
same as for preparative reverse-phase FPLC (above). Elu-
tion conditions are shown in Fig. 4.
Amino acid analysis and sequencing
Purified peptides were sequenced using an Applied
Biosystems 477 A pulsed-liquid microsequencer, as
described previously (Hayes et al., 1989).
Amino acid analysis was carried out on an Applied
Biosystems 420 A Derivatiser with automatic hydrolysis
and an on-line Model 120 A phenylthiocarbamyl (PTC)
analyser (Applied Biosystems Ltd., Warrington, Cheshire,
UK). Each sample was analysed in triplicate after hydrolysis
in 6M HC1 under argon for 30, 60 and 90min at 200 °C.
Values for serine and threonine were found by extrapola¬
tion to zero hydrolysis time. Values for leucine, isoleucine
and valine were found from the plateau region of maximum
recovery. Values for cysteine were found after vapour phase
pyridylethylation of samples prior to analysis, carried out
as follows. Protein samples from the reverse phase column
were dried down in Pyrex tubes (6 mm X 50 mm) which
were subsequently inserted into borosilicate glass vials
(27 mm X 70 mm) containing 200 pi pyridine, 200 pi H20,
40 pi 4-vinyl pyridine and 40 pi tributylphosphine. After
flushing with argon, the vials were sealed with PTFE/
silicone septa, and then incubated at 60 °C for 4 h. Samples
were then hydrolysed automatically (see above) or manu¬
ally at 110°C for 22 h. After manual hydrolysis, residual
acid and condensation were removed in a vacuum desic¬
cator containing pellets of NaOH, then the samples were
re-dissolved in 0.025% K3EDTA prior to amino acid analy¬
sis. The PTC-amino acids were separated at 38 °C on an
Applied Biosystems PTC C-18 column (5 pm particle size;
2.1mm X 250mm), at a flow rate of 0.3 ml/min. The
column was previously equilibrated with Buffer A (3%
(v/v) acetonitrile in 50 mM sodium ethanoate, pH 5.4), and
elution was by a gradient of Buffer B (70% v/v) acetonitrile
in 32 mM sodium ethanoate, pH4.7) with 2% to 64%
buffer B over 18.8 min, then 64% to 100% Buffer B over
5 min. The eluate was monitored by absorbance at 254 nm.
Isoelectric point determinations
Isoelectric focussing was carried out using a BioRad Mini
IEF Cell Model III. Prior to loading, samples were dialysed
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into 4 M urea and adjusted to a protein concentration of
approximately 1 mg/ml, using Centricon-10 microconcen-
trators. Samples (2 pi) were focussed on polyacrylamide
gels (125 X 65 X 0.4 mm) containing 2% Ampholines
(Pharmacia, UK; Ampholine mixture of pH3.5 to 5
(5 parts) and pH3.5 to 10 (lpart)). Protein standards of
known pi were used to calibrate the pH gradients. Focus¬
sing was carried out under constant voltage conditions in a
stepped fashion; 100 V for 15 min, 200 V for 15 min and
finally 450 V for 1 h. When focussing was complete, pro¬
teins were stained for 2h in 0.04% (w/v) Coomassie Bril¬
liant Blue R250, 0.5% (w/v) CuS04, 0.05% (w/v) Crocein
Scarlet 7B, 27% (v/v) ethanol, 10% (v/v) ethanoic acid.
Crocein scarlet 7B was included to ensure rapid fixation of
the bands, while CuS04 effectively eliminates any back¬
ground staining due to the presence of Ampholines
(Righetti, 1983). The gels were destained in 12% (v/v)
ethanol, 7% (v/v) ethanoic acid, 0.5% (w/v) CuS04 (three
changes over 45 min), followed by 25% (v/v) ethanol, 7%
(v/v) ethanoic acid, until the background cleared (normally
30 min). Finally gels were air-dried in dust free conditions.
Desulphation and deglycosylation
For mild acid hydrolysis (Huttner, 1984), TRAMP vai
iants were dialysed against distilled water, diluted with 2 h
HC1 to a final 1 M HC1, heated for 5 min at 100 °C, freeze
dried and finally dissolved in SDS-PAGE sample buffer. Fo
sulphatase treatment, 30 pg TRAMP were dialysed inti
0.1 M sodium ethanoate (pH5.0), 0.1 unit of sulphatas
was added in a total volume of 0.2 ml, and the reactioi
mixture was incubated for 2h at 37 °C. Aliquots (20 pi
were removed at set times and immediately heated for 2 mil
at 100 °C in SDS-PAGE sample buffer. The small amount o
(3-glucuronidase activity that was present as a contaminan
in both sulphatases was inactivated by temporarily adjust
ing the pH to 2.2 (Dodgson and Spencer, 1953). Separat
experiments with purified ^-glucuronidase were also car
ried out, in identical conditions to the sulphatase treat
ments, at twice the levels present in the commercial sulphat
ase preparations.
For neuraminidase treatment, 50 pg TRAMP in 50 mJV
sodium ethanoate, pH 5.5, 4 mM CaCl2, 100 pg/ml bovini
Coomassie Blue Alcian Blue
T
L T E L T E
Fig. 1. SDS-PAGE of porcine skin lysyl oxidase anc
TRAMP partially separated by elution from DEAE-
Sepharose and Sephacryl S-400 columns at differenl
urea concentrations (see Materials and Methods). L =
lysyl oxidase, T = TRAMP, E = initial 6M PBL
extract. Duplicate gels were run and equal amounts ol
protein were loaded in corresponding lanes for stain¬
ing with either Coomassie Blue or Alcian Blue. The
diffuse bands in the lower part of the Alcian Blue gel
are a staining artefact.
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;erum albumin, 0.2 raM phenyl methyl sulphonyl fluoride
PMSF), 0.2 pM N-tosyl-L-phenylalanine chloromethyl-
tetone (TPCK) was incubated, in a total volume of 40 pi,
vith 0.0008 unit neuraminidase for 18 h at 37 °C, followed
ry a further 6h at 37 °C with the same amount of freshly
idded enzyme. The reaction was stopped by addition of
IDS-PAGE sample buffer and heating for 3 min at 100 °C.
For endoglycosidase F/N-glycosidase F treatment, 50 pg
TRAMP was first denatured by heating at 100 °C for 3 min
n the presence of 10 mg/ml SDS. To 10 pi, 90 pi of digestion
?uffer (0.25 M sodium ethanoate, 20 mM EDTA, 10 mM
Z-mercaptoethanol, 6 mg/ml Nonidet P-40, 5 mg/ml
7HAPS, 0.2 mM PMSF, 0.2 pM TPCK, pH6.25) was
idded, followed by 7.2 pi endoglycanase F/N-glycosidase F
0.36 unit), and the mixture was incubated at 37 °C for
18 h. Incubations were also carried out at pH4.5 and
)H 7.5, to favour the activities of endoglycosidase F and N-
'lycosidase F, respectively. Reactions were stopped by
iddition of SDS-PAGE sample buffer and heating for 3 min
itl00°C.
For treatment with O-glycosidase, 200 pg protein (in
100 pi of 20 mM sodium cacodylate buffer pH6.0) was
ncubated in the presence of 0.001 unit enzyme for 16 h at
37°C and the reaction was stopped by addition of SDS-
?AGE sample buffer and heating for 2 min at 100 °C, fol-
owed directly by electrophoresis or storage at — 30 °C.
Fetuin was used as a positive control, and as the presence of
sialic acid interferes with O-glycosidase activity, incuba-
ions with O-glycosidase were done both with and without
rrior neuraminidase treatment.
Results
Identification of lysyl oxidase and TRAMP variants
Lysyl oxidase and TRAMP were almost completely sepa¬
rated when the DEAE-Sepharose and Sephacryl S-400 col¬
umns were eluted at different urea concentrations, as
shown by SDS-PAGE (Fig. 1). Lysyl oxidase eluted from
DEAE-Sepharose in the presence of 0.3 M NaCl at a rela¬
tively low concentration of urea, while a relatively high
urea concentration was required to elute the enzyme from
Sephacryl S-400. The converse was true of TRAMP. After
further purification by anion-exchange Mono Q FPLC,
both proteins eluted in the form of several peaks, with some
overlap between individual lysyl oxidase and TRAMP var¬
iants (Fig. 2). Peaks from the Mono Q column were anal¬
ysed by SDS-PAGE (not shown), and the electrophoretic
migration of the four lysyl oxidase variants (Fig. 2(a)) was
identical. Similarly, all four variants of lysyl oxidase eluted
at the same position by reverse phase FPLC (e. g. Fig. 3). By
the same criteria, all five variants of TRAMP (Fig. 2(b))
were identical, but their electrophoretic migration and
reverse-phase chromatographic elution positions were dis¬
10 20
Elution volume (ml) B
Fig. 2. Separation of lysyl oxidase and TRAMP variants by Mono
Q FPLC, following partial purification by DEAE-Sepharose and
Sephacryl S400 chromatography, (a) lysyl oxidase variants LI to
L4, with small amounts of TRAMP variants T1 to T5 (b) TRAMP
variants T1 to T5.
tinct from lysyl oxidase. No lysyl oxidase activity was
associated with TRAMP.
Peptide analysis and sequencing
Variants of lysyl oxidase and TRAMP were subjected to
amino acid analysis. The amino acid composition of por¬
cine skin lysyl oxidase (variant L3) is shown in Table I. The
composition is very similar to that of the rat aorta (Track¬
man et ah, 1990; Trackman et ah, 1991) and human




















Fig. 3. Separation of lysyl oxidase and TRAMP in denaturing
conditions by preparative reverse-phase FPLC.
placenta (Hamalainen et al., 1991) enzymes derived from
cDNA sequencing, given certain assumptions about the
position of the pro-enzyme cleavage site (see Table I). No
obvious differences were found in the compositions of the
four lysyl oxidase variants (data not shown). The amino
acid composition of TRAMP variant T3 is shown in Tab¬
le II. The most striking feature is the relative abundance of
tyrosine. No obvious differences were found in the
compositions of the five TRAMP variants. Also shown in
Table II are the amino acid compositions of the 23 K conta¬
minant found in lysyl oxidase preparations from human
placenta (Kuivaniemi et al., 1984) and of the dermatan
sulphate proteoglycan-associated 22 K protein from bovine
skin (Neame et al., 1989). The composition of TRAMP is
essentially identical to that of the bovine skin protein, and
there are some similarities with the human placental 23 K
protein of Kuivaniemi et al. (1984).
Variants of lysyl oxidase were treated with cyanogen
bromide and the resulting peptides separated by reverse-
phase HPLC. The elution profile for variant L3 is shown in
Fig. 4(a). All the lysyl oxidase variants gave similar CNBr
profiles (data not shown). Variants of TRAMP were also
treated with CNBr, and the HPLC analysis of peptides from
variant T3 is shown in Figs. 4(b) and 4(c). Similar CNBr
profiles for the other TRAMP variants were obtained (data
not shown). There were no similarities between the CNBr
profiles of lysyl oxidase and TRAMP.
Fig. 5 shows amino acid sequence data for selected CNBr
peptides of lysyl oxidase and TRAMP. The sequence of the
36 residue peptide from porcine skin lysyl oxidase is identi¬
cal to residues 291 to 326 in the rat aorta lysyl oxidase
Amino acid Porcine skin3 Rat aortab Human placentac
D 28.7 32 33
E 18.0 19 17
S 22.2 23 18
G 14.0 13 15
H 12.7 12 11
R 19.1 18 18
T 11.6 12 14
A 16.0 15 15
P 21.6 16 16
Y 26.1 30 31
V 12.7 13 12
M 3.0 3 3
C 6.4 11 11
I 7.5 7 7
I. 16.1 13 14
F 6.9 6 6
K 4.0 5 6
W N.D. 3 4
Totals 246.6 251 251
a Variant L3 (see Fig. 2(a)) Values are residues per molecule, nor¬
malised on the assumption that the mature form of lysyl oxidase
contains 16-alanine residues (see notes b and c). ND = not
determined.
b From cDNA sequencing of the rat lysyl oxidase precursor
(Trackman et al., 1990; Trackman et al., 1991), assuming the
mature enzyme consists of the entire C-terminal region begin¬
ning at residue 161 (based on preliminary observations on por¬
cine skin lysyl oxidase by mass spectrometry (Cronshaw, Shack-
leton, Hulmes and Fothergill-Gilmore, unpublished observa¬
tions).
c From cDNA sequencing of the human lysyl oxidase precursor
(Hamalainen et al., 1991), assuming the mature enzyme consists
of the entire C-terminal region beginning at residue 167 (see note
b).
precursor (Trackman et al., 1990; Trackman et al., 1991)
and it differs in only four positions from residues 299 to
334 of the human placental enzyme precursor (Hamalainen
et al., 1991). The amino acid sequence of the 44-residue
TRAMP peptide was not found in lysyl oxidase. However,
when compared with the Protein Identification Resource
database (release 30) using the program 'prosrch' (Coulson
et al., 1987), the TRAMP sequence was found in the 22 K
dermatan sulphate proteoglycan-associated extracellular
matrix protein from bovine skin (Neame et al., 1989). The
sequence from TRAMP is identical to residues 83 to 126 of
the bovine skin protein, and this degree of matching is
highly significant (Collins et al., 1988). From the
similarities in sequence and molecular mass, we conclude
that TRAMP is the same as the protein of Neame et al.
(1989).
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Fable II. Amino acid composition of TRAMP and related pro-
eins.
Amino Porcine Bovine skin1' Human placenta"
icid skin" (22K protein) (Contaminant, pool II)
9 19.6 20 14.1
z 23.6 24 21.9
> 11.9 13 10.5
J 13.1 13 14.3
4 2.9 4 2.5
I 12.3 12 9.0
r 7.4 9 6.8
A 7.0 7 7.0
> 6.7 6 5.9
18.1 20 8.4
7 8.0 9 6.4
■A 6.8 7 ND
2 9.2 10 ND
3.8 4 4.1
3.7 5 4.1
7 7.7 8 5.4
4.0 4 4.8
V ND 8 ND
4D = not determined.
Variant T3 (see Fig. 2(b)). Values are residues per molecule,
normalised to 7 alanine residues (from Neame et al., 1989;
Cronshaw, Hulmes and Fothergill-Gilmore, manuscript in prep¬
aration).
From protein sequence data of Neame et al. (1989), expressed as
residues per molecule.
From Kuivaniemi et al. (1984), re-expressed as residues per
molecule, assuming 7 alanine residues.
■ig. 4. Reverse phase HPLC elution profiles of CNBr peptides, (a)
ysyl oxidase variant L3 (b) TRAMP variant T3, non-reduced (c)
'eak 5 in (b) after reduction with 0.1 M dithiothreitol.
Further characterisation ofTRAMP
The amino acid sequence of TRAMP (Neame et al.,
1989) is rich in acidic amino acids. From complete sequence
data for porcine TRAMP (Cronshaw, Hulmes and Fother-
gill-Gilmore, manuscript in preparation) the calculated
isoelectric point (pi; determined with the University of
Wisconsin GCG software package, and allowing for pyro-
glutamate at the N-terminus) is 4.53. To determine the pi
experimentally, TRAMP variants were analysed by iso¬
electric focussing in the presence of 4M urea. The results
(Table III) show that TRAMP variants T1 to T5 are increas¬
ingly acidic, with pi's in the pH range 4.43 to 4.07. The
observed pi's are less than the theoretical value, and they
decrease as expected from the Mono Q elution profile
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(Fig. 2). Similar observations were made by chromatofo-
cussing (data not shown).
More precise molecular mass determinations of TRAMP
variants were obtained by mass spectrometry. Molecular
masses for all TRAMP variants are shown in Table III.
Based on the complete amino acid sequence of porcine
TRAMP (Cronshaw, Hulmes and Fothergill-Gilmore,
manuscript in preparation), the calculated relative molecu¬
lar mass in non-reducing conditions is 21989. The observed
relative molecular masses of all TRAMP variants are grea¬
ter than the calculated value, and the masses increase
monotonically with decreasing isoelectric point (Table III).
The differences in the observed and calculated molecular
masses and isoelectric points suggest that some amino acid
(a) Lysyl oxidase (L3, CNBr peptide 1)
porcine
human
15 10 15 20
I I I I I
DEFSHYDLLDASTQRRVAEG






(b) TRAMP (T3, CNBr peptide 5C)
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Fig. 5. Amino acid sequences of CNBr peptides, (a) Lysyl oxidase
variant L3, peak 1 from Fig. 4(a). (b) TRAMP variant T3, peak 5C
from Fig. 4(c). The sequence of the peptide from lysyl oxidase is
identical to residues 291 to 326 of the rat enzyme precursor
(Trackman et al., 1990; 1991). Differences from residues 299 to
334 of the human pro-enzyme (Hamalainen et al., 1991) are
indicated. The sequence of the TRAMP peptide is identical to
residues 83 to 126 of the 22 K protein from bovine skin (Neame et
al., 1989). Initial yields and repetitive yields were lOOpmol and
91% (based on phenylalanine) for the lysyl oxidase peptide, and










Con E/N Neu O-G Glu HCI Sul
Fig. 6. Effects of various deglycosylation and desulphation treat¬
ments on TRAMP staining by Alcian Blue. Staining of SDS-PAGE
gels was quantitated with a scanning densitometer and expressed
relative to Coomassie Blue staining of equal amounts of protein
treated in identical conditions. Error bars are standard deviations
based on at least three measurements. TRAMP was analysed aftei
purification by DEAE-Sepharose and Sephacryl S400 chromato¬
graphy, without subsequent separation of ionic variants. Con =
control; E/N = endoglycosidase F/N-glycosidase F; Neu =
neuraminidase; O—G = O-glycosidase; Glu = (^-glucuronidase;
HCI = 1 M HCI; Sul = sulphatase (type V).
residues in TRAMP may be modified at the post-transla-
tional level. The modification(s) would be acid labile, to
account for the apparent absence of modified amino acids
by sequence analysis, and would increase the net negative
charge, to account for the low pi. The presence of an acidic
post-translational modification was suggested by the obser¬
vation that TRAMP stains strongly with Alcian Blue
(Fig. 1). Following SDS-PAGE, a protein with the elec-
trophoretic migration of TRAMP was the only one to stain
with Alcian Blue in the original 6M urea extract (Fig. 1).
On the basis of the Alcian Blue staining is was possible to
estimate that 1 g of piglet skin (wet weight) contains
approximately 4 pg of TRAMP.
Possible glycosylation of TRAMP was investigated as
follows. By amino acid analysis, there was no evidence for
hexosamines in TRAMP, as also observed by Neame et al.
(1989). Furthermore, after digestion of TRAMP variants
with endoglycosidase F/N-glycosidase F, neuraminidase,
O-glycosidase or [3-glucuronidase, there were no changes in
electrophoretic mobility or band sharpness by SDS-PAGE
(not shown) or in Alcian Blue staining relative to Coomas¬
sie Blue staining (Fig. 6).
Table III. Molecular masses and isoelectric points (pi) of TRAMP variants.













a Errors are standard deviations based on standards (carbonic anhydrase, n = 8).
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Fig. 7. Chromatography of TRAMP variant T3 on Mono Q FPLC,
before (a) and after (b) treatment with sulphatase (Boehringer
enzyme). The elution profile of sulphatase alone is shown in (c).
One possible post-translational modification is tyrosine
sulphation. There are five tyrosine residues in TRAMP that
meet four of the five empirically determined rules for
tyrosine sulphation (Hortin et ah, 1986) involving the
proximity of acidic residues and relative paucity of basic
residues, hydrophobic residues and cysteine. These putative
tyrosine sulphation sites are residues 5, 15, 148, 149 and
176 in the sequence of Neame et al. (1989). The tyrosine
sulphate ester bond is particularly labile to acid hydrolysis
(Huttner, 1984). Following treatment of TRAMP with 1 M
HC1 for 5 min at 100 °C, Alcian Blue staining almost halved
relative to Coomasie Blue staining (Fig. 6), though there
was evidence of partial hydrolysis (not shown). To further
investigate possible tyrosine sulphation, TRAMP was incu¬
bated with sulphatase (either typeV or type VII) prior to
Elution Volume (ml) C
SDS-PAGE. Following treatment with either enzyme,
Alcian Blue staining relative to Coomassie Blue staining
decreased almost 3-fold (Fig. 6), with no apparent changes
in electrophoretic mobility or band sharpness (not shown).
In still further experiments, the chromatographic
behaviour of the T3 variant was examined on Mono Q
FPLC before and after sulphatase treatment. The results
(Fig. 7) show that while a small protein peak continued to
be present after sulphatase treatment at the original elution
position of T3, three additional peaks appeared earlier in
the elution gradient. When examined by SDS-PAGE (not
shown), all three peaks co-migrated with T3.
As TRAMP co-purifies with lysyl oxidase, possible
interactions between these proteins were examined. We
found that increasing concentrations of TRAMP, up to a 40
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to 1 molar ratio of TRAMP to lysyl oxidase, had no effect
on lysyl oxidase activity using the 3H[elastin] substrate.
These observations do not exclude the possibility of a phys¬
ical interaction with no effect on enzyme activity.
Discussion
Our amino acid sequence data confirm that the enzyme
purified from porcine skin by selective interaction with
Sephacryl (Shackleton and Hulmes, 1990a) corresponds to
both rat aorta (Trackman et al., 1990; Trackman et al.,
1991) and human placental (Hamalainen et al., 1991) lysyl
oxidase.
Initially we were surprised to find that TRAMP was
unrelated to lysyl oxidase, as the presence of a degradation
product with approximately the same molecular mass as
TRAMP had been suggested in the literature (Sullivan and
Kagan, 1982; Kuivaniemi et al., 1984; Burbelo et al.,
1986). The similarity between TRAMP and the 22 K
extracellular matrix protein (Neame et al., 1989) only
became apparent on searching the protein sequence data¬
base. By urea extraction and DEAE-Sephacel chromatogra¬
phy, the 22 K protein (TRAMP) from bovine skin co-
purifies with dermatan sulphate proteoglycans (Choi et al.,
1989; Neame et al., 1989). A similar procedure is used in
the initial purification of lysyl oxidase from porcine skin
(Shackleton and Hulmes, 1990 a), though TRAMP con¬
tinues to co-purify with lysyl oxidase in the subsequent
Sephacryl interaction step. It is possible that TRAMP is also
related to the 23 K protein found as a contaminant in
preparations of human placental lysyl oxidase (Table II;
Kuivaniemi et al., 1984), but without amino acid sequence
data it is impossible to make any firm conclusions. TRAMP
does not appear to be present in urea extracts of cartilage
(Choi et al., 1989).
We have shown that TRAMP is not a degradation pro¬
duct of lysyl oxidase. There is, however, a distinct protein
of similar molecular mass (22 — 24 K) which, from peptide
mapping (Sullivan and Kagan, 1982) or immunoblotting
(Kuivaniemi etal., 1984; Burbelo et al., 1986), does appear
to be a genuine degradation product of the enzyme.
It is not clear why both lysyl oxidase and TRAMP should
exist in several variant forms. The presence of multiple,
ionic variants of lysyl oxidase has also been observed in
enzyme preparations from chick cartilage (Stassen, 1976),
bovine aorta (Sullivan and Kagan, 1982) and human
placenta (Kuivaniemi et al., 1984). Only one gene for lysyl
oxidase has been found in rat genomic DNA (Trackman et
al., 1990), so post-translational modifications are a likely
cause of the variation. Another possibility is carbamylation
at lysine residues while proteins are in 6 M urea (Means and
Feeney, 1971); both TRAMP (Neame et al., 1989) and lysyl
oxidase (Trackman et al., 1990; Trackman et al., 1991;
Hamalainen et al., 1991) contain small numbers of lysine
residues (Tables I and II). In TRAMP, the decreasing
isoelectric points (pi) for variants T1 to T5 are consistent
with an increasing extent of carbamylation since, from
complete amino acid sequence data (Cronshaw, Hulmes
and Fothergill-Gilmore, manuscript in preparation), the
theoretical pi's would be 4.53, 4.44, 4.36, 4.28 and 4.20
(with pyroglutamate at the N-terminus and 0, 1, 2, 3 or 4
lysines carbamylated, respectively; cf. (Table III). The
observations from mass spectrometry are also consistent
with carbamylation, since the additional mass for each
lysine residue carbamylated (43 Da) is within the experi¬
mental range of the average mass increment between con¬
secutive TRAMP variants (32 to 76 Da). If carbamylation is
the basis of the variation, however, conversion to more
acidic forms would be expected when separated variants
are further exposed to 6 M urea. We have carried out
prolonged incubations of purified TRAMP variants in 6 M
urea but have found no evidence for such conversion. Simi¬
lar observations were reported by Kagan et al. (1979) on
purified lysyl oxidase variants.
Several observations suggest the presence of tyrosine
sulphation in TRAMP. Sequence analysis indicates five
possible sites. Staining by Alcian Blue, which is relatively
specific for sulphated biopolymers in 50 mM MgCK (Scott,
1973; Newton et al., 1974) and susceptibility to mild acid
hydrolysis and sulphatase treatment are also consistent
with tyrosine sulphation. The difference between the
observed and calculated molecular mass for variant T1 is
consistent, within experimental error, with sulphation of
two tyrosine residues (i. e. additional mass 2 x 79 Da). The
presence of two sulphated tyrosines would be expected to
lower the isoelectric point of each TRAMP variant by about
0.17 pH unit, which corresponds to the difference between
the observed and calculated pi's. The appearance of three
new peaks on the Mono Q column following sulphatase
treatment of T3 suggests that up to three sulphate groups
were removed, resulting in a corresponding increase in pi
and hence earlier elution from the column. The elution
positions of the two peaks to the left of T3 (following
sulphatase treatment) correspond to those of the T1 and T2
variants (without sulphatase treatment) but we cannot con¬
clude from this that variants TI to T5 differ in their extent
of sulphation. It may be that each isoform is sulphated to
the same extent and the variation arises from an additional
modification (e.g. carbamylation) in which case each var¬
iant would generate up to three products on sulphatase
treatment. Experiments are in progress to examine these
possibilities. Taken together however, these observations
are consistent with, but do not establish, the presence of
tyrosine sulphation in TRAMP. Tyrosine sulphation is,
however, a widespread post-translational modification in
extracellular matrix proteins, e.g. nidogen/entactin (Pauls-
son et al., 1985), procollagen V (Fessler et al., 1986),
procollagen III (Jukkola et al., 1986), bone sialoprotein II
(Ecarot-Charrier et al., 1989; Midura et al., 1990), fibro-
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nectin (Liu et al., 1985), dermatan sulphate proteoglycan
(Huttner, 19 8 8) and fibromodulin (Antonsson et al., 1991).
The site of tyrosine sulphation in fibromodulin is in an N-
terminal tyrosine-rich region in which tyrosine is every
second or third residue (Antonsson et ah, 1991). This fea¬
ture is also present in TRAMP (Neame et al., 1989), though
the sequences are not homologous. Multiple variants of
fibromodulin have also been observed (Lauder, R.M.,
Nieduszynski, I. A. and Huckerby, T. N., personal com¬
munication). The role of tyrosine sulphation in extracellu¬
lar matrix proteins has not been extensively investigated,
though desulphation of fibronectin affects binding affinities
to several ligands (Suiko and Liu, 1988). The absence of
staining by Alcian Blue (Fig. 1) suggests that lysyl oxidase is
not sulphated.
The function of TRAMP is not well understood. A pos¬
sible role in cell adhesion has been suggested for the equiva¬
lent 22 K protein from bovine skin (Lewandowska et al.,
1991). We have found that TRAMP has no lysyl oxidase
activity on an elastin substrate, nor does it affect the activity
of added lysyl oxidase. This lack of interaction with elastin
is consistent with the apparent absence of TRAMP in lysyl
oxidase when purified from rat skin by an elastin affinity
method (Romero-Chapman et al., 1991). We have
observed, however, that TRAMP binds to collagen and
accelerates fibril formation in vitro (MacBeath, Shackleton
and Hulmes, unpublished observations). As it is known
that lysyl oxidase activity on collagen increases following
fibril formation (Siegel, 1979), it is possible that TRAMP
may influence lysyl oxidase activity indirectly, via aggrega¬
tion of the substrate. The observations that the bovine skin
22 K protein interacts with dermatan sulphate proteo¬
glycan (DSPG; Choi et al., 1989; Neame et al., 1989;
Lewandowska et al., 1991) and that DSPG II (decorin) is
known to inhibit collagen fibril formation (Brown and
Vogel, 1989) suggest a complex regulatory role for
TRAMP in interactions with other extracellular matrix
components.
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